id	sid	tid	token	lemma	pos
njb-69	1	1	nepal	nepal	ADJ
njb-69	1	2	journal	journal	NOUN
njb-69	1	3	of	of	ADP
njb-69	1	4	biotechnology	biotechnology	NOUN
njb-69	1	5	.	.	PUNCT
njb-69	2	1	d	d	X
njb-69	2	2	e	e	PROPN
njb-69	2	3	c	c	PROPN
njb-69	2	4	.	.	PUNCT
njb-69	3	1	2	2	NUM
njb-69	3	2	0	0	NUM
njb-69	3	3	1	1	NUM
njb-69	3	4	9	9	NUM
njb-69	3	5	vol	vol	NOUN
njb-69	3	6	.	.	PUNCT
njb-69	4	1	7	7	NUM
njb-69	4	2	,	,	PUNCT
njb-69	4	3	no	no	NOUN
njb-69	4	4	.	.	NOUN
njb-69	4	5	1	1	NUM
njb-69	4	6	:	:	SYM
njb-69	4	7	74	74	NUM
njb-69	4	8	-	-	SYM
njb-69	4	9	81	81	NUM
njb-69	4	10	doi	doi	NOUN
njb-69	4	11	:	:	PUNCT
njb-69	4	12	https://doi.org/10.3126/njb.v7i1.26954	https://doi.org/10.3126/njb.v7i1.26954	PROPN
njb-69	4	13	©	©	PROPN
njb-69	4	14	njb	njb	PROPN
njb-69	4	15	,	,	PUNCT
njb-69	4	16	biotechnology	biotechnology	NOUN
njb-69	4	17	society	society	NOUN
njb-69	4	18	of	of	ADP
njb-69	4	19	nepal	nepal	ADJ
njb-69	4	20	74	74	NUM
njb-69	4	21	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-69	4	22	.	.	PUNCT
njb-69	5	1	original	original	ADJ
njb-69	5	2	research	research	NOUN
njb-69	5	3	article	article	NOUN
njb-69	5	4	phenotypic	phenotypic	ADJ
njb-69	5	5	characterization	characterization	NOUN
njb-69	5	6	of	of	ADP
njb-69	5	7	beta	beta	NOUN
njb-69	5	8	-	-	PUNCT
njb-69	5	9	lactamases	lactamase	NOUN
njb-69	5	10	producing	produce	VERB
njb-69	5	11	gram	gram	ADJ
njb-69	5	12	-	-	PUNCT
njb-69	5	13	negative	negative	ADJ
njb-69	5	14	bacteria	bacteria	NOUN
njb-69	5	15	in	in	ADP
njb-69	5	16	a	a	DET
njb-69	5	17	tertiary	tertiary	ADJ
njb-69	5	18	hospital	hospital	NOUN
njb-69	5	19	,	,	PUNCT
njb-69	5	20	nepal	nepal	ADJ
njb-69	5	21	elina	elina	NOUN
njb-69	5	22	maharjan1,2	maharjan1,2	PROPN
njb-69	5	23	,	,	PUNCT
njb-69	5	24	pooja	pooja	ADJ
njb-69	5	25	shakya1	shakya1	NOUN
njb-69	5	26	,	,	PUNCT
njb-69	5	27	balkrishna	balkrishna	PROPN
njb-69	5	28	bhattachan3	bhattachan3	PROPN
njb-69	5	29	,	,	PUNCT
njb-69	5	30	bharat	bharat	PROPN
njb-69	5	31	prasad	prasad	PROPN
njb-69	5	32	baral4	baral4	PROPN
njb-69	5	33	,	,	PUNCT
njb-69	5	34	dhiraj	dhiraj	PROPN
njb-69	5	35	shrestha5,6	shrestha5,6	PROPN
njb-69	5	36	*	*	PROPN
njb-69	5	37	1department	1department	NUM
njb-69	5	38	of	of	ADP
njb-69	5	39	microbiology	microbiology	NOUN
njb-69	5	40	,	,	PUNCT
njb-69	5	41	kathmandu	kathmandu	PROPN
njb-69	5	42	college	college	NOUN
njb-69	5	43	of	of	ADP
njb-69	5	44	science	science	PROPN
njb-69	5	45	&	&	CCONJ
njb-69	5	46	technology	technology	PROPN
njb-69	5	47	(	(	PUNCT
njb-69	5	48	kcst	kcst	PROPN
njb-69	5	49	)	)	PUNCT
njb-69	5	50	,	,	PUNCT
njb-69	5	51	nepal	nepal	ADJ
njb-69	5	52	.	.	PUNCT
njb-69	6	1	2research	2research	NUM
njb-69	6	2	center	center	NOUN
njb-69	6	3	for	for	ADP
njb-69	6	4	applied	apply	VERB
njb-69	6	5	science	science	NOUN
njb-69	6	6	and	and	CCONJ
njb-69	6	7	technology	technology	NOUN
njb-69	6	8	(	(	PUNCT
njb-69	6	9	recast	recast	NOUN
njb-69	6	10	)	)	PUNCT
njb-69	6	11	,	,	PUNCT
njb-69	6	12	tribhuvan	tribhuvan	PROPN
njb-69	6	13	university	university	PROPN
njb-69	6	14	,	,	PUNCT
njb-69	6	15	nepal	nepal	ADJ
njb-69	6	16	.	.	PUNCT
njb-69	7	1	3siddhi	3siddhi	NUM
njb-69	7	2	memorial	memorial	ADJ
njb-69	7	3	hospital	hospital	NOUN
njb-69	7	4	,	,	PUNCT
njb-69	7	5	bhaktapur	bhaktapur	PROPN
njb-69	7	6	,	,	PUNCT
njb-69	7	7	nepal	nepal	NOUN
njb-69	7	8	.	.	PUNCT
njb-69	8	1	4annapurna	4annapurna	NUM
njb-69	8	2	child	child	NOUN
njb-69	8	3	and	and	CCONJ
njb-69	8	4	women	woman	NOUN
njb-69	8	5	hospital	hospital	PROPN
njb-69	8	6	,	,	PUNCT
njb-69	8	7	pokhara	pokhara	PROPN
njb-69	8	8	,	,	PUNCT
njb-69	8	9	nepal	nepal	ADJ
njb-69	8	10	.	.	PUNCT
njb-69	9	1	5department	5department	NUM
njb-69	9	2	of	of	ADP
njb-69	9	3	microbiology	microbiology	NOUN
njb-69	9	4	,	,	PUNCT
njb-69	9	5	tri	tri	ADJ
njb-69	9	6	-	-	ADJ
njb-69	9	7	chandra	chandra	ADJ
njb-69	9	8	multiple	multiple	ADJ
njb-69	9	9	campus	campus	NOUN
njb-69	9	10	,	,	PUNCT
njb-69	9	11	kathmandu	kathmandu	PROPN
njb-69	9	12	,	,	PUNCT
njb-69	9	13	nepal	nepal	ADJ
njb-69	9	14	.	.	PUNCT
njb-69	10	1	6department	6department	NUM
njb-69	10	2	of	of	ADP
njb-69	10	3	microbiology	microbiology	NOUN
njb-69	10	4	,	,	PUNCT
njb-69	10	5	shi	shi	PROPN
njb-69	10	6	-	-	PUNCT
njb-69	10	7	gan	gan	PROPN
njb-69	10	8	international	international	PROPN
njb-69	10	9	college	college	PROPN
njb-69	10	10	of	of	ADP
njb-69	10	11	science	science	NOUN
njb-69	10	12	and	and	CCONJ
njb-69	10	13	technology	technology	NOUN
njb-69	10	14	(	(	PUNCT
njb-69	10	15	sicost	sicost	PROPN
njb-69	10	16	)	)	PUNCT
njb-69	10	17	,	,	PUNCT
njb-69	10	18	kathmandu	kathmandu	NOUN
njb-69	10	19	,	,	PUNCT
njb-69	10	20	nepal	nepal	ADJ
njb-69	10	21	.	.	PUNCT
njb-69	11	1	abstract	abstract	ADJ
njb-69	11	2	infections	infection	NOUN
njb-69	11	3	caused	cause	VERB
njb-69	11	4	by	by	ADP
njb-69	11	5	beta	beta	NOUN
njb-69	11	6	-	-	PUNCT
njb-69	11	7	lactamases	lactamase	NOUN
njb-69	11	8	producing	produce	VERB
njb-69	11	9	gram	gram	ADJ
njb-69	11	10	-	-	PUNCT
njb-69	11	11	negative	negative	ADJ
njb-69	11	12	bacteria	bacteria	NOUN
njb-69	11	13	are	be	AUX
njb-69	11	14	increasing	increase	VERB
njb-69	11	15	,	,	PUNCT
njb-69	11	16	thus	thus	ADV
njb-69	11	17	posing	pose	VERB
njb-69	11	18	a	a	DET
njb-69	11	19	challenge	challenge	NOUN
njb-69	11	20	to	to	ADP
njb-69	11	21	the	the	DET
njb-69	11	22	management	management	NOUN
njb-69	11	23	of	of	ADP
njb-69	11	24	such	such	ADJ
njb-69	11	25	infections	infection	NOUN
njb-69	11	26	.	.	PUNCT
njb-69	12	1	the	the	DET
njb-69	12	2	surveillance	surveillance	NOUN
njb-69	12	3	data	datum	NOUN
njb-69	12	4	of	of	ADP
njb-69	12	5	such	such	ADJ
njb-69	12	6	bacteria	bacteria	NOUN
njb-69	12	7	is	be	AUX
njb-69	12	8	limited	limit	VERB
njb-69	12	9	in	in	ADP
njb-69	12	10	nepal	nepal	ADJ
njb-69	12	11	so	so	SCONJ
njb-69	12	12	this	this	DET
njb-69	12	13	study	study	NOUN
njb-69	12	14	aimed	aim	VERB
njb-69	12	15	to	to	PART
njb-69	12	16	detect	detect	VERB
njb-69	12	17	the	the	DET
njb-69	12	18	beta	beta	NOUN
njb-69	12	19	-	-	PUNCT
njb-69	12	20	lactamase	lactamase	NOUN
njb-69	12	21	producing	produce	VERB
njb-69	12	22	gram	gram	ADJ
njb-69	12	23	-	-	PUNCT
njb-69	12	24	negative	negative	ADJ
njb-69	12	25	bacteria	bacteria	NOUN
njb-69	12	26	in	in	ADP
njb-69	12	27	a	a	DET
njb-69	12	28	tertiary	tertiary	ADJ
njb-69	12	29	setting	setting	NOUN
njb-69	12	30	.	.	PUNCT
njb-69	13	1	a	a	DET
njb-69	13	2	total	total	NOUN
njb-69	13	3	of	of	ADP
njb-69	13	4	604	604	NUM
njb-69	13	5	clinical	clinical	ADJ
njb-69	13	6	samples	sample	NOUN
njb-69	13	7	,	,	PUNCT
njb-69	13	8	including	include	VERB
njb-69	13	9	urine	urine	NOUN
njb-69	13	10	,	,	PUNCT
njb-69	13	11	blood	blood	NOUN
njb-69	13	12	,	,	PUNCT
njb-69	13	13	sputum	sputum	NOUN
njb-69	13	14	and	and	CCONJ
njb-69	13	15	body	body	NOUN
njb-69	13	16	fluids	fluid	NOUN
njb-69	13	17	,	,	PUNCT
njb-69	13	18	were	be	AUX
njb-69	13	19	cultured	cultured	ADJ
njb-69	13	20	and	and	CCONJ
njb-69	13	21	identified	identify	VERB
njb-69	13	22	by	by	ADP
njb-69	13	23	the	the	DET
njb-69	13	24	routine	routine	ADJ
njb-69	13	25	standard	standard	ADJ
njb-69	13	26	laboratory	laboratory	NOUN
njb-69	13	27	protocols	protocol	NOUN
njb-69	13	28	.	.	PUNCT
njb-69	14	1	antibiotic	antibiotic	ADJ
njb-69	14	2	susceptibility	susceptibility	NOUN
njb-69	14	3	testing	testing	NOUN
njb-69	14	4	was	be	AUX
njb-69	14	5	done	do	VERB
njb-69	14	6	by	by	ADP
njb-69	14	7	kirby	kirby	PROPN
njb-69	14	8	bauer	bauer	PROPN
njb-69	14	9	disc	disc	NOUN
njb-69	14	10	diffusion	diffusion	NOUN
njb-69	14	11	method	method	NOUN
njb-69	14	12	following	follow	VERB
njb-69	14	13	clinical	clinical	ADJ
njb-69	14	14	and	and	CCONJ
njb-69	14	15	laboratory	laboratory	PROPN
njb-69	14	16	standard	standard	PROPN
njb-69	14	17	institute	institute	PROPN
njb-69	14	18	guidelines	guideline	NOUN
njb-69	14	19	(	(	PUNCT
njb-69	14	20	2014	2014	NUM
njb-69	14	21	)	)	PUNCT
njb-69	14	22	.	.	PUNCT
njb-69	15	1	extended	extend	VERB
njb-69	15	2	-	-	PUNCT
njb-69	15	3	spectrum	spectrum	NOUN
njb-69	15	4	betalactamases	betalactamase	NOUN
njb-69	15	5	(	(	PUNCT
njb-69	15	6	esbl	esbl	PROPN
njb-69	15	7	)	)	PUNCT
njb-69	15	8	producers	producer	NOUN
njb-69	15	9	were	be	AUX
njb-69	15	10	identified	identify	VERB
njb-69	15	11	by	by	ADP
njb-69	15	12	combined	combine	VERB
njb-69	15	13	disk	disk	NOUN
njb-69	15	14	method	method	NOUN
njb-69	15	15	and	and	CCONJ
njb-69	15	16	metallo	metallo	NOUN
njb-69	15	17	-	-	PUNCT
njb-69	15	18	betalactamases	betalactamase	NOUN
njb-69	15	19	(	(	PUNCT
njb-69	15	20	mbl	mbl	NOUN
njb-69	15	21	)	)	PUNCT
njb-69	15	22	producers	producer	NOUN
njb-69	15	23	were	be	AUX
njb-69	15	24	identified	identify	VERB
njb-69	15	25	by	by	ADP
njb-69	15	26	imipenemedta	imipenemedta	PROPN
njb-69	15	27	combined	combine	VERB
njb-69	15	28	disk	disk	NOUN
njb-69	15	29	method	method	NOUN
njb-69	15	30	.	.	PUNCT
njb-69	16	1	out	out	ADP
njb-69	16	2	of	of	ADP
njb-69	16	3	604	604	NUM
njb-69	16	4	samples	sample	NOUN
njb-69	16	5	,	,	PUNCT
njb-69	16	6	282	282	NUM
njb-69	16	7	(	(	PUNCT
njb-69	16	8	46.7	46.7	NUM
njb-69	16	9	%	%	NOUN
njb-69	16	10	)	)	PUNCT
njb-69	16	11	samples	sample	NOUN
njb-69	16	12	showed	show	VERB
njb-69	16	13	significant	significant	ADJ
njb-69	16	14	growth	growth	NOUN
njb-69	16	15	,	,	PUNCT
njb-69	16	16	of	of	ADP
njb-69	16	17	which	which	PRON
njb-69	16	18	229	229	NUM
njb-69	16	19	(	(	PUNCT
njb-69	16	20	81.2	81.2	NUM
njb-69	16	21	%	%	NOUN
njb-69	16	22	)	)	PUNCT
njb-69	16	23	were	be	AUX
njb-69	16	24	gramnegative	gramnegative	ADJ
njb-69	16	25	bacteria	bacteria	NOUN
njb-69	16	26	.	.	PUNCT
njb-69	17	1	of	of	ADP
njb-69	17	2	229	229	NUM
njb-69	17	3	gram	gram	ADJ
njb-69	17	4	-	-	PUNCT
njb-69	17	5	negative	negative	ADJ
njb-69	17	6	bacteria	bacteria	NOUN
njb-69	17	7	,	,	PUNCT
njb-69	17	8	200	200	NUM
njb-69	17	9	(	(	PUNCT
njb-69	17	10	87.3	87.3	NUM
njb-69	17	11	%	%	NOUN
njb-69	17	12	)	)	PUNCT
njb-69	17	13	were	be	AUX
njb-69	17	14	multidrug	multidrug	NOUN
njb-69	17	15	resistant	resistant	ADJ
njb-69	17	16	,	,	PUNCT
njb-69	17	17	67	67	NUM
njb-69	17	18	(	(	PUNCT
njb-69	17	19	29.3	29.3	NUM
njb-69	17	20	%	%	NOUN
njb-69	17	21	)	)	PUNCT
njb-69	17	22	were	be	AUX
njb-69	17	23	esbl	esbl	NOUN
njb-69	17	24	producers	producer	NOUN
njb-69	17	25	and	and	CCONJ
njb-69	17	26	16	16	NUM
njb-69	17	27	(	(	PUNCT
njb-69	17	28	7.0	7.0	NUM
njb-69	17	29	%	%	NOUN
njb-69	17	30	)	)	PUNCT
njb-69	17	31	were	be	AUX
njb-69	17	32	mbl	mbl	NOUN
njb-69	17	33	producers	producer	NOUN
njb-69	17	34	.	.	PUNCT
njb-69	18	1	klebsiella	klebsiella	PROPN
njb-69	18	2	pneumoniae	pneumoniae	PROPN
njb-69	18	3	were	be	AUX
njb-69	18	4	among	among	ADP
njb-69	18	5	higher	high	ADJ
njb-69	18	6	esbl	esbl	NOUN
njb-69	18	7	producers	producer	NOUN
njb-69	18	8	and	and	CCONJ
njb-69	18	9	pseudomonas	pseudomonas	PROPN
njb-69	18	10	aeruginosa	aeruginosa	PROPN
njb-69	18	11	were	be	AUX
njb-69	18	12	among	among	ADP
njb-69	18	13	higher	high	ADJ
njb-69	18	14	mbl	mbl	ADJ
njb-69	18	15	producers	producer	NOUN
njb-69	18	16	.	.	PUNCT
njb-69	19	1	the	the	DET
njb-69	19	2	findings	finding	NOUN
njb-69	19	3	suggest	suggest	VERB
njb-69	19	4	higher	high	ADJ
njb-69	19	5	antibacterial	antibacterial	ADJ
njb-69	19	6	resistance	resistance	NOUN
njb-69	19	7	among	among	ADP
njb-69	19	8	gram	gram	ADJ
njb-69	19	9	-	-	PUNCT
njb-69	19	10	negative	negative	ADJ
njb-69	19	11	bacteria	bacteria	NOUN
njb-69	19	12	with	with	ADP
njb-69	19	13	the	the	DET
njb-69	19	14	added	add	VERB
njb-69	19	15	burden	burden	NOUN
njb-69	19	16	of	of	ADP
njb-69	19	17	beta	beta	NOUN
njb-69	19	18	-	-	PUNCT
njb-69	19	19	lactamase	lactamase	NOUN
njb-69	19	20	production	production	NOUN
njb-69	19	21	.	.	PUNCT
njb-69	20	1	imipenem	imipenem	PROPN
njb-69	20	2	was	be	AUX
njb-69	20	3	effective	effective	ADJ
njb-69	20	4	against	against	SCONJ
njb-69	20	5	125	125	NUM
njb-69	20	6	of	of	ADP
njb-69	20	7	229	229	NUM
njb-69	20	8	gramnegative	gramnegative	ADJ
njb-69	20	9	bacteria	bacteria	NOUN
njb-69	20	10	tested	test	VERB
njb-69	20	11	.	.	PUNCT
njb-69	21	1	thus	thus	ADV
njb-69	21	2	,	,	PUNCT
njb-69	21	3	imipenem	imipenem	PROPN
njb-69	21	4	can	can	AUX
njb-69	21	5	be	be	AUX
njb-69	21	6	the	the	DET
njb-69	21	7	drug	drug	NOUN
njb-69	21	8	of	of	ADP
njb-69	21	9	choice	choice	NOUN
njb-69	21	10	for	for	ADP
njb-69	21	11	empirical	empirical	ADJ
njb-69	21	12	management	management	NOUN
njb-69	21	13	.	.	PUNCT
njb-69	22	1	the	the	DET
njb-69	22	2	higher	high	ADJ
njb-69	22	3	multidrug	multidrug	NOUN
njb-69	22	4	resistance	resistance	NOUN
njb-69	22	5	and	and	CCONJ
njb-69	22	6	higher	high	ADJ
njb-69	22	7	beta	beta	NOUN
njb-69	22	8	-	-	PUNCT
njb-69	22	9	lactamases	lactamase	NOUN
njb-69	22	10	production	production	NOUN
njb-69	22	11	among	among	ADP
njb-69	22	12	gram	gram	ADJ
njb-69	22	13	-	-	PUNCT
njb-69	22	14	negative	negative	ADJ
njb-69	22	15	bacteria	bacteria	NOUN
njb-69	22	16	warrant	warrant	VERB
njb-69	22	17	the	the	DET
njb-69	22	18	continuous	continuous	ADJ
njb-69	22	19	monitoring	monitoring	NOUN
njb-69	22	20	,	,	PUNCT
njb-69	22	21	surveillance	surveillance	NOUN
njb-69	22	22	,	,	PUNCT
njb-69	22	23	early	early	ADJ
njb-69	22	24	detection	detection	NOUN
njb-69	22	25	,	,	PUNCT
njb-69	22	26	and	and	CCONJ
njb-69	22	27	infection	infection	NOUN
njb-69	22	28	control	control	NOUN
njb-69	22	29	practices	practice	NOUN
njb-69	22	30	of	of	ADP
njb-69	22	31	such	such	ADJ
njb-69	22	32	bacteria	bacteria	NOUN
njb-69	22	33	.	.	PUNCT
njb-69	23	1	keywords	keyword	NOUN
njb-69	23	2	:	:	PUNCT
njb-69	23	3	antibacterial	antibacterial	ADJ
njb-69	23	4	resistance	resistance	NOUN
njb-69	23	5	,	,	PUNCT
njb-69	23	6	extended	extend	VERB
njb-69	23	7	-	-	PUNCT
njb-69	23	8	spectrum	spectrum	NOUN
njb-69	23	9	beta	beta	PROPN
njb-69	23	10	-	-	PUNCT
njb-69	23	11	lactamases	lactamase	NOUN
njb-69	23	12	,	,	PUNCT
njb-69	23	13	esbl	esbl	PROPN
njb-69	23	14	,	,	PUNCT
njb-69	23	15	gram	gram	NOUN
njb-69	23	16	-	-	PUNCT
njb-69	23	17	negative	negative	ADJ
njb-69	23	18	,	,	PUNCT
njb-69	23	19	metallo	metallo	ADJ
njb-69	23	20	-	-	PUNCT
njb-69	23	21	beta	beta	NOUN
njb-69	23	22	-	-	PUNCT
njb-69	23	23	lactamase	lactamase	NOUN
njb-69	23	24	,	,	PUNCT
njb-69	23	25	mbl	mbl	PROPN
njb-69	23	26	*	*	NOUN
njb-69	23	27	corresponding	correspond	VERB
njb-69	23	28	author	author	NOUN
njb-69	23	29	email	email	NOUN
njb-69	23	30	:	:	PUNCT
njb-69	23	31	hiraj.diamond@gmail.com	hiraj.diamond@gmail.com	X
njb-69	23	32	introduction	introduction	NOUN
njb-69	23	33	antibacterial	antibacterial	ADJ
njb-69	23	34	resistance	resistance	NOUN
njb-69	23	35	(	(	PUNCT
njb-69	23	36	abr	abr	NOUN
njb-69	23	37	)	)	PUNCT
njb-69	23	38	is	be	AUX
njb-69	23	39	an	an	DET
njb-69	23	40	increasingly	increasingly	ADV
njb-69	23	41	serious	serious	ADJ
njb-69	23	42	threat	threat	NOUN
njb-69	23	43	to	to	ADP
njb-69	23	44	human	human	ADJ
njb-69	23	45	health	health	NOUN
njb-69	23	46	,	,	PUNCT
njb-69	23	47	challenging	challenge	VERB
njb-69	23	48	the	the	DET
njb-69	23	49	effective	effective	ADJ
njb-69	23	50	management	management	NOUN
njb-69	23	51	of	of	ADP
njb-69	23	52	infections	infection	NOUN
njb-69	23	53	.	.	PUNCT
njb-69	24	1	abr	abr	PROPN
njb-69	24	2	increase	increase	VERB
njb-69	24	3	the	the	DET
njb-69	24	4	health	health	NOUN
njb-69	24	5	care	care	NOUN
njb-69	24	6	cost	cost	NOUN
njb-69	24	7	as	as	ADP
njb-69	24	8	a	a	DET
njb-69	24	9	result	result	NOUN
njb-69	24	10	of	of	ADP
njb-69	24	11	prolonged	prolong	VERB
njb-69	24	12	illness	illness	NOUN
njb-69	24	13	,	,	PUNCT
njb-69	24	14	additional	additional	ADJ
njb-69	24	15	tests	test	NOUN
njb-69	24	16	and	and	CCONJ
njb-69	24	17	pricier	pricy	ADJ
njb-69	24	18	drugs	drug	NOUN
njb-69	24	19	[	[	X
njb-69	24	20	1	1	NUM
njb-69	24	21	]	]	PUNCT
njb-69	24	22	.	.	PUNCT
njb-69	25	1	annually	annually	ADV
njb-69	25	2	,	,	PUNCT
njb-69	25	3	more	more	ADJ
njb-69	25	4	than	than	ADP
njb-69	25	5	750,000	750,000	NUM
njb-69	25	6	deaths	death	NOUN
njb-69	25	7	are	be	AUX
njb-69	25	8	caused	cause	VERB
njb-69	25	9	by	by	ADP
njb-69	25	10	resistant	resistant	ADJ
njb-69	25	11	bacteria	bacteria	NOUN
njb-69	25	12	.	.	PUNCT
njb-69	26	1	the	the	DET
njb-69	26	2	median	median	ADJ
njb-69	26	3	overall	overall	ADV
njb-69	26	4	increased	increase	VERB
njb-69	26	5	cost	cost	NOUN
njb-69	26	6	to	to	PART
njb-69	26	7	treat	treat	VERB
njb-69	26	8	a	a	DET
njb-69	26	9	resistant	resistant	ADJ
njb-69	26	10	bacterial	bacterial	ADJ
njb-69	26	11	infection	infection	NOUN
njb-69	26	12	is	be	AUX
njb-69	26	13	around	around	ADV
njb-69	26	14	700	700	NUM
njb-69	26	15	usd	usd	NOUN
njb-69	26	16	[	[	NOUN
njb-69	26	17	2	2	NUM
njb-69	26	18	]	]	X
njb-69	26	19	.	.	PUNCT
njb-69	27	1	abr	abr	PROPN
njb-69	27	2	is	be	AUX
njb-69	27	3	a	a	DET
njb-69	27	4	natural	natural	ADJ
njb-69	27	5	genetic	genetic	ADJ
njb-69	27	6	change	change	NOUN
njb-69	27	7	,	,	PUNCT
njb-69	27	8	thus	thus	ADV
njb-69	27	9	newer	new	ADJ
njb-69	27	10	mechanisms	mechanism	NOUN
njb-69	27	11	are	be	AUX
njb-69	27	12	emerging	emerge	VERB
njb-69	27	13	and	and	CCONJ
njb-69	27	14	spreading	spread	VERB
njb-69	27	15	,	,	PUNCT
njb-69	27	16	raising	raise	VERB
njb-69	27	17	multidrug	multidrug	NOUN
njb-69	27	18	-	-	PUNCT
njb-69	27	19	resistant	resistant	ADJ
njb-69	27	20	(	(	PUNCT
njb-69	27	21	mdr	mdr	PROPN
njb-69	27	22	)	)	PUNCT
njb-69	27	23	bacteria	bacteria	NOUN
njb-69	28	1	[	[	X
njb-69	28	2	1	1	NUM
njb-69	28	3	]	]	PUNCT
njb-69	28	4	.	.	PUNCT
njb-69	29	1	one	one	NUM
njb-69	29	2	of	of	ADP
njb-69	29	3	the	the	DET
njb-69	29	4	most	most	ADV
njb-69	29	5	worrisome	worrisome	ADJ
njb-69	29	6	resistance	resistance	NOUN
njb-69	29	7	mechanisms	mechanism	NOUN
njb-69	29	8	is	be	AUX
njb-69	29	9	the	the	DET
njb-69	29	10	production	production	NOUN
njb-69	29	11	of	of	ADP
njb-69	29	12	betalactamases	betalactamase	NOUN
njb-69	29	13	,	,	PUNCT
njb-69	29	14	of	of	ADP
njb-69	29	15	which	which	PRON
njb-69	29	16	extended	extend	VERB
njb-69	29	17	-	-	PUNCT
njb-69	29	18	spectrum	spectrum	NOUN
njb-69	29	19	betalactamases	betalactamase	NOUN
njb-69	29	20	(	(	PUNCT
njb-69	29	21	esbls	esbls	PROPN
njb-69	29	22	)	)	PUNCT
njb-69	29	23	and	and	CCONJ
njb-69	29	24	metallo	metallo	PROPN
njb-69	29	25	-	-	PUNCT
njb-69	29	26	betalactamases	betalactamase	NOUN
njb-69	29	27	(	(	PUNCT
njb-69	29	28	mbls	mbls	NOUN
njb-69	29	29	)	)	PUNCT
njb-69	29	30	are	be	AUX
njb-69	29	31	the	the	DET
njb-69	29	32	most	most	ADV
njb-69	29	33	impacting	impact	VERB
njb-69	29	34	ones	one	NOUN
njb-69	29	35	.	.	PUNCT
njb-69	30	1	esbls	esbls	PROPN
njb-69	30	2	can	can	AUX
njb-69	30	3	hydrolyze	hydrolyze	VERB
njb-69	30	4	all	all	DET
njb-69	30	5	beta	beta	ADJ
njb-69	30	6	-	-	PUNCT
njb-69	30	7	lactam	lactam	NOUN
njb-69	30	8	antibiotics	antibiotic	NOUN
njb-69	30	9	including	include	VERB
njb-69	30	10	cephalosporins	cephalosporin	NOUN
njb-69	30	11	except	except	SCONJ
njb-69	30	12	cephamycins	cephamycin	NOUN
njb-69	30	13	or	or	CCONJ
njb-69	30	14	carbapenems	carbapenem	NOUN
njb-69	30	15	[	[	X
njb-69	30	16	3	3	NUM
njb-69	30	17	]	]	X
njb-69	30	18	.	.	PUNCT
njb-69	31	1	esbls	esbls	PROPN
njb-69	31	2	are	be	AUX
njb-69	31	3	often	often	ADV
njb-69	31	4	plasmid	plasmid	ADJ
njb-69	31	5	-	-	PUNCT
njb-69	31	6	mediated	mediate	VERB
njb-69	31	7	.	.	PUNCT
njb-69	32	1	since	since	SCONJ
njb-69	32	2	it	it	PRON
njb-69	32	3	was	be	AUX
njb-69	32	4	first	first	ADV
njb-69	32	5	reported	report	VERB
njb-69	32	6	from	from	ADP
njb-69	32	7	germany	germany	PROPN
njb-69	32	8	in	in	ADP
njb-69	32	9	1983	1983	NUM
njb-69	32	10	,	,	PUNCT
njb-69	32	11	it	it	PRON
njb-69	32	12	has	have	AUX
njb-69	32	13	then	then	ADV
njb-69	32	14	spread	spread	VERB
njb-69	32	15	worldwide	worldwide	ADV
njb-69	32	16	[	[	X
njb-69	32	17	4	4	NUM
njb-69	32	18	]	]	X
njb-69	32	19	.	.	PUNCT
njb-69	33	1	in	in	ADP
njb-69	33	2	nepal	nepal	ADJ
njb-69	33	3	,	,	PUNCT
njb-69	33	4	esbls	esbls	PROPN
njb-69	33	5	were	be	AUX
njb-69	33	6	first	first	ADV
njb-69	33	7	reported	report	VERB
njb-69	33	8	in	in	ADP
njb-69	33	9	2006	2006	NUM
njb-69	33	10	[	[	NUM
njb-69	33	11	5	5	NUM
njb-69	33	12	]	]	PUNCT
njb-69	33	13	.	.	PUNCT
njb-69	34	1	similarly	similarly	ADV
njb-69	34	2	,	,	PUNCT
njb-69	34	3	mbls	mbls	ADJ
njb-69	34	4	can	can	AUX
njb-69	34	5	hydrolyze	hydrolyze	VERB
njb-69	34	6	all	all	DET
njb-69	34	7	broad	broad	ADJ
njb-69	34	8	-	-	PUNCT
njb-69	34	9	spectrum	spectrum	NOUN
njb-69	34	10	beta	beta	NOUN
njb-69	34	11	-	-	PUNCT
njb-69	34	12	lactams	lactams	NOUN
njb-69	34	13	including	include	VERB
njb-69	34	14	cephalosporins	cephalosporin	NOUN
njb-69	34	15	,	,	PUNCT
njb-69	34	16	and	and	CCONJ
njb-69	34	17	carbapenems	carbapenems	PROPN
njb-69	34	18	,	,	PUNCT
njb-69	34	19	except	except	SCONJ
njb-69	34	20	monobactams	monobactams	PROPN
njb-69	34	21	[	[	PUNCT
njb-69	34	22	6	6	NUM
njb-69	34	23	]	]	PUNCT
njb-69	34	24	.	.	PUNCT
njb-69	35	1	since	since	SCONJ
njb-69	35	2	its	its	PRON
njb-69	35	3	first	first	ADJ
njb-69	35	4	report	report	NOUN
njb-69	35	5	from	from	ADP
njb-69	35	6	japan	japan	PROPN
njb-69	35	7	in	in	ADP
njb-69	35	8	1991	1991	NUM
njb-69	35	9	,	,	PUNCT
njb-69	35	10	it	it	PRON
njb-69	35	11	has	have	AUX
njb-69	35	12	also	also	ADV
njb-69	35	13	been	be	AUX
njb-69	35	14	reported	report	VERB
njb-69	35	15	nepal	nepal	ADJ
njb-69	35	16	journal	journal	NOUN
njb-69	35	17	of	of	ADP
njb-69	35	18	biotechnology	biotechnology	NOUN
njb-69	35	19	.	.	PUNCT
njb-69	36	1	d	d	X
njb-69	36	2	e	e	PROPN
njb-69	36	3	c	c	PROPN
njb-69	36	4	.	.	PUNCT
njb-69	37	1	2	2	NUM
njb-69	37	2	0	0	NUM
njb-69	37	3	1	1	NUM
njb-69	37	4	9	9	NUM
njb-69	37	5	vol	vol	NOUN
njb-69	37	6	.	.	PUNCT
njb-69	38	1	7	7	NUM
njb-69	38	2	,	,	PUNCT
njb-69	38	3	no	no	NOUN
njb-69	38	4	.	.	NOUN
njb-69	38	5	1	1	NUM
njb-69	38	6	:	:	SYM
njb-69	38	7	74	74	NUM
njb-69	38	8	-	-	SYM
njb-69	38	9	81	81	NUM
njb-69	38	10	maharjan	maharjan	NOUN
njb-69	38	11	et	et	PROPN
njb-69	38	12	al	al	PROPN
njb-69	38	13	.	.	PROPN
njb-69	39	1	2019	2019	NUM
njb-69	40	1	©	©	ADP
njb-69	40	2	njb	njb	PROPN
njb-69	40	3	,	,	PUNCT
njb-69	40	4	biotechnology	biotechnology	NOUN
njb-69	40	5	society	society	NOUN
njb-69	40	6	of	of	ADP
njb-69	40	7	nepal	nepal	ADJ
njb-69	40	8	75	75	NUM
njb-69	40	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	40	10	.	.	PUNCT
njb-69	40	11	worldwide	worldwide	ADV
njb-69	41	1	[	[	X
njb-69	41	2	7	7	NUM
njb-69	41	3	]	]	X
njb-69	41	4	.	.	PUNCT
njb-69	42	1	mbls	mbls	NOUN
njb-69	42	2	were	be	AUX
njb-69	42	3	first	first	ADV
njb-69	42	4	reported	report	VERB
njb-69	42	5	in	in	ADP
njb-69	42	6	nepal	nepal	NOUN
njb-69	42	7	in	in	ADP
njb-69	42	8	2009	2009	NUM
njb-69	42	9	[	[	PUNCT
njb-69	42	10	8	8	NUM
njb-69	42	11	]	]	PUNCT
njb-69	42	12	.	.	PUNCT
njb-69	43	1	the	the	DET
njb-69	43	2	acquisition	acquisition	NOUN
njb-69	43	3	,	,	PUNCT
njb-69	43	4	expression	expression	NOUN
njb-69	43	5	,	,	PUNCT
njb-69	43	6	and	and	CCONJ
njb-69	43	7	dissemination	dissemination	NOUN
njb-69	43	8	of	of	ADP
njb-69	43	9	beta	beta	NOUN
njb-69	43	10	-	-	PUNCT
njb-69	43	11	lactamase	lactamase	NOUN
njb-69	43	12	producing	produce	VERB
njb-69	43	13	genes	gene	NOUN
njb-69	43	14	in	in	ADP
njb-69	43	15	pathogens	pathogen	NOUN
njb-69	43	16	have	have	AUX
njb-69	43	17	posed	pose	VERB
njb-69	43	18	the	the	DET
njb-69	43	19	major	major	ADJ
njb-69	43	20	public	public	ADJ
njb-69	43	21	health	health	NOUN
njb-69	43	22	concern	concern	NOUN
njb-69	43	23	today	today	NOUN
njb-69	43	24	[	[	X
njb-69	43	25	9	9	NUM
njb-69	43	26	]	]	X
njb-69	43	27	.	.	PUNCT
njb-69	44	1	limited	limited	ADJ
njb-69	44	2	data	datum	NOUN
njb-69	44	3	are	be	AUX
njb-69	44	4	available	available	ADJ
njb-69	44	5	on	on	ADP
njb-69	44	6	surveilling	surveille	VERB
njb-69	44	7	beta	beta	NOUN
njb-69	44	8	-	-	PUNCT
njb-69	44	9	lactamase	lactamase	NOUN
njb-69	44	10	producing	produce	VERB
njb-69	44	11	clinical	clinical	ADJ
njb-69	44	12	isolates	isolate	NOUN
njb-69	44	13	in	in	ADP
njb-69	44	14	nepal	nepal	ADJ
njb-69	44	15	.	.	PUNCT
njb-69	45	1	abr	abr	PROPN
njb-69	45	2	surveillance	surveillance	NOUN
njb-69	45	3	data	datum	NOUN
njb-69	45	4	can	can	AUX
njb-69	45	5	guide	guide	VERB
njb-69	45	6	the	the	DET
njb-69	45	7	physician	physician	NOUN
njb-69	45	8	in	in	ADP
njb-69	45	9	choosing	choose	VERB
njb-69	45	10	appropriate	appropriate	ADJ
njb-69	45	11	therapy	therapy	NOUN
njb-69	45	12	for	for	ADP
njb-69	45	13	effective	effective	ADJ
njb-69	45	14	management	management	NOUN
njb-69	45	15	of	of	ADP
njb-69	45	16	infectious	infectious	ADJ
njb-69	45	17	disease	disease	NOUN
njb-69	45	18	without	without	ADP
njb-69	45	19	extensive	extensive	ADJ
njb-69	45	20	testing	testing	NOUN
njb-69	45	21	.	.	PUNCT
njb-69	46	1	thus	thus	ADV
njb-69	46	2	,	,	PUNCT
njb-69	46	3	this	this	DET
njb-69	46	4	study	study	NOUN
njb-69	46	5	aimed	aim	VERB
njb-69	46	6	to	to	PART
njb-69	46	7	produce	produce	VERB
njb-69	46	8	updated	updated	ADJ
njb-69	46	9	data	datum	NOUN
njb-69	46	10	on	on	ADP
njb-69	46	11	surveilling	surveille	VERB
njb-69	46	12	beta	beta	NOUN
njb-69	46	13	-	-	PUNCT
njb-69	46	14	lactamase	lactamase	NOUN
njb-69	46	15	producing	produce	VERB
njb-69	46	16	clinical	clinical	ADJ
njb-69	46	17	isolates	isolate	NOUN
njb-69	46	18	in	in	ADP
njb-69	46	19	a	a	DET
njb-69	46	20	tertiary	tertiary	ADJ
njb-69	46	21	healthcare	healthcare	NOUN
njb-69	46	22	setting	setting	NOUN
njb-69	46	23	.	.	PUNCT
njb-69	47	1	this	this	PRON
njb-69	47	2	would	would	AUX
njb-69	47	3	help	help	VERB
njb-69	47	4	to	to	PART
njb-69	47	5	formulate	formulate	VERB
njb-69	47	6	antimicrobial	antimicrobial	ADJ
njb-69	47	7	stewardship	stewardship	NOUN
njb-69	47	8	policy	policy	NOUN
njb-69	47	9	to	to	PART
njb-69	47	10	circumvent	circumvent	VERB
njb-69	47	11	the	the	DET
njb-69	47	12	rising	rise	VERB
njb-69	47	13	threat	threat	NOUN
njb-69	47	14	of	of	ADP
njb-69	47	15	abr	abr	NOUN
njb-69	47	16	.	.	PUNCT
njb-69	48	1	materials	material	NOUN
njb-69	48	2	and	and	CCONJ
njb-69	48	3	methods	method	NOUN
njb-69	48	4	study	study	NOUN
njb-69	48	5	setting	setting	NOUN
njb-69	48	6	,	,	PUNCT
njb-69	48	7	design	design	NOUN
njb-69	48	8	and	and	CCONJ
njb-69	48	9	study	study	NOUN
njb-69	48	10	population	population	NOUN
njb-69	48	11	a	a	DET
njb-69	48	12	prospective	prospective	ADJ
njb-69	48	13	hospital	hospital	NOUN
njb-69	48	14	-	-	PUNCT
njb-69	48	15	based	base	VERB
njb-69	48	16	study	study	NOUN
njb-69	48	17	was	be	AUX
njb-69	48	18	conducted	conduct	VERB
njb-69	48	19	in	in	ADP
njb-69	48	20	the	the	DET
njb-69	48	21	department	department	NOUN
njb-69	48	22	of	of	ADP
njb-69	48	23	microbiology	microbiology	NOUN
njb-69	48	24	at	at	ADP
njb-69	48	25	annapurna	annapurna	PROPN
njb-69	48	26	neurological	neurological	PROPN
njb-69	48	27	institute	institute	PROPN
njb-69	48	28	and	and	CCONJ
njb-69	48	29	applied	apply	VERB
njb-69	48	30	science	science	NOUN
njb-69	48	31	,	,	PUNCT
njb-69	48	32	kathmandu	kathmandu	NOUN
njb-69	48	33	,	,	PUNCT
njb-69	48	34	nepal	nepal	ADJ
njb-69	48	35	from	from	ADP
njb-69	48	36	march	march	PROPN
njb-69	48	37	to	to	ADP
njb-69	48	38	november	november	PROPN
njb-69	48	39	2014	2014	NUM
njb-69	48	40	.	.	PUNCT
njb-69	49	1	a	a	DET
njb-69	49	2	total	total	NOUN
njb-69	49	3	of	of	ADP
njb-69	49	4	604	604	NUM
njb-69	49	5	clinical	clinical	ADJ
njb-69	49	6	samples	sample	NOUN
njb-69	49	7	from	from	ADP
njb-69	49	8	patients	patient	NOUN
njb-69	49	9	of	of	ADP
njb-69	49	10	all	all	DET
njb-69	49	11	ages	age	NOUN
njb-69	49	12	and	and	CCONJ
njb-69	49	13	both	both	DET
njb-69	49	14	sexes	sex	NOUN
njb-69	49	15	,	,	PUNCT
njb-69	49	16	visiting	visit	VERB
njb-69	49	17	the	the	DET
njb-69	49	18	hospital	hospital	NOUN
njb-69	49	19	and	and	CCONJ
njb-69	49	20	requesting	request	VERB
njb-69	49	21	a	a	DET
njb-69	49	22	routine	routine	ADJ
njb-69	49	23	investigation	investigation	NOUN
njb-69	49	24	,	,	PUNCT
njb-69	49	25	was	be	AUX
njb-69	49	26	included	include	VERB
njb-69	49	27	in	in	ADP
njb-69	49	28	the	the	DET
njb-69	49	29	study	study	NOUN
njb-69	49	30	.	.	PUNCT
njb-69	50	1	the	the	DET
njb-69	50	2	samples	sample	NOUN
njb-69	50	3	include	include	VERB
njb-69	50	4	263	263	NUM
njb-69	50	5	urines	urine	NOUN
njb-69	50	6	(	(	PUNCT
njb-69	50	7	clean	clean	ADJ
njb-69	50	8	catch	catch	NOUN
njb-69	50	9	urine	urine	NOUN
njb-69	50	10	and	and	CCONJ
njb-69	50	11	catheter	catheter	NOUN
njb-69	50	12	tip	tip	NOUN
njb-69	50	13	)	)	PUNCT
njb-69	50	14	,	,	PUNCT
njb-69	50	15	140	140	NUM
njb-69	50	16	sputum	sputum	NOUN
njb-69	50	17	samples	sample	NOUN
njb-69	50	18	,	,	PUNCT
njb-69	50	19	73	73	NUM
njb-69	50	20	blood	blood	NOUN
njb-69	50	21	samples	sample	NOUN
njb-69	50	22	and	and	CCONJ
njb-69	50	23	128	128	NUM
njb-69	50	24	body	body	NOUN
njb-69	50	25	fluids	fluid	NOUN
njb-69	50	26	(	(	PUNCT
njb-69	50	27	pus	pus	X
njb-69	50	28	,	,	PUNCT
njb-69	50	29	pus	pus	NOUN
njb-69	50	30	swab	swab	NOUN
njb-69	50	31	,	,	PUNCT
njb-69	50	32	csf	csf	NOUN
njb-69	50	33	,	,	PUNCT
njb-69	50	34	bile	bile	NOUN
njb-69	50	35	fluid	fluid	ADJ
njb-69	50	36	,	,	PUNCT
njb-69	50	37	pleural	pleural	ADJ
njb-69	50	38	fluid	fluid	NOUN
njb-69	50	39	,	,	PUNCT
njb-69	50	40	peritoneal	peritoneal	ADJ
njb-69	50	41	fluid	fluid	ADJ
njb-69	50	42	,	,	PUNCT
njb-69	50	43	synovial	synovial	ADJ
njb-69	50	44	fluid	fluid	NOUN
njb-69	50	45	,	,	PUNCT
njb-69	50	46	and	and	CCONJ
njb-69	50	47	tracheal	tracheal	ADJ
njb-69	50	48	secretion	secretion	NOUN
njb-69	50	49	)	)	PUNCT
njb-69	50	50	.	.	PUNCT
njb-69	51	1	contaminated	contaminate	VERB
njb-69	51	2	samples	sample	NOUN
njb-69	51	3	and	and	CCONJ
njb-69	51	4	repeated	repeat	VERB
njb-69	51	5	samples	sample	NOUN
njb-69	51	6	from	from	ADP
njb-69	51	7	the	the	DET
njb-69	51	8	same	same	ADJ
njb-69	51	9	patient	patient	NOUN
njb-69	51	10	were	be	AUX
njb-69	51	11	excluded	exclude	VERB
njb-69	51	12	to	to	PART
njb-69	51	13	avoid	avoid	VERB
njb-69	51	14	selection	selection	NOUN
njb-69	51	15	bias	bias	NOUN
njb-69	51	16	.	.	PUNCT
njb-69	52	1	laboratory	laboratory	NOUN
njb-69	52	2	processing	processing	NOUN
njb-69	52	3	of	of	ADP
njb-69	52	4	the	the	DET
njb-69	52	5	samples	sample	NOUN
njb-69	52	6	the	the	DET
njb-69	52	7	samples	sample	NOUN
njb-69	52	8	were	be	AUX
njb-69	52	9	subjected	subject	VERB
njb-69	52	10	to	to	ADP
njb-69	52	11	the	the	DET
njb-69	52	12	standard	standard	ADJ
njb-69	52	13	microbiological	microbiological	ADJ
njb-69	52	14	procedures	procedure	NOUN
njb-69	52	15	for	for	ADP
njb-69	52	16	isolation	isolation	NOUN
njb-69	52	17	and	and	CCONJ
njb-69	52	18	identification	identification	NOUN
njb-69	52	19	of	of	ADP
njb-69	52	20	bacteria	bacteria	NOUN
njb-69	52	21	.	.	PUNCT
njb-69	53	1	in	in	ADP
njb-69	53	2	short	short	ADJ
njb-69	53	3	,	,	PUNCT
njb-69	53	4	the	the	DET
njb-69	53	5	samples	sample	NOUN
njb-69	53	6	were	be	AUX
njb-69	53	7	inoculated	inoculate	VERB
njb-69	53	8	onto	onto	ADP
njb-69	53	9	macconkey	macconkey	NOUN
njb-69	53	10	agar	agar	NOUN
njb-69	53	11	(	(	PUNCT
njb-69	53	12	himedia	himedia	PROPN
njb-69	53	13	,	,	PUNCT
njb-69	53	14	india	india	PROPN
njb-69	53	15	)	)	PUNCT
njb-69	53	16	and	and	CCONJ
njb-69	53	17	blood	blood	NOUN
njb-69	53	18	agar	agar	NOUN
njb-69	53	19	(	(	PUNCT
njb-69	53	20	himedia	himedia	PROPN
njb-69	53	21	,	,	PUNCT
njb-69	53	22	india	india	PROPN
njb-69	53	23	)	)	PUNCT
njb-69	53	24	plate	plate	NOUN
njb-69	53	25	by	by	ADP
njb-69	53	26	streaking	streaking	NOUN
njb-69	53	27	,	,	PUNCT
njb-69	53	28	followed	follow	VERB
njb-69	53	29	by	by	ADP
njb-69	53	30	incubation	incubation	NOUN
njb-69	53	31	at	at	ADP
njb-69	53	32	37	37	NUM
njb-69	53	33	℃	℃	NOUN
njb-69	53	34	.	.	PUNCT
njb-69	54	1	growths	growth	NOUN
njb-69	54	2	of	of	ADP
njb-69	54	3	bacteria	bacteria	NOUN
njb-69	54	4	were	be	AUX
njb-69	54	5	observed	observe	VERB
njb-69	54	6	after	after	ADP
njb-69	54	7	18	18	NUM
njb-69	54	8	-	-	PUNCT
njb-69	54	9	48hrs	48hrs	NUM
njb-69	54	10	.	.	PUNCT
njb-69	55	1	the	the	DET
njb-69	55	2	identification	identification	NOUN
njb-69	55	3	of	of	ADP
njb-69	55	4	gram	gram	ADJ
njb-69	55	5	-	-	PUNCT
njb-69	55	6	negative	negative	ADJ
njb-69	55	7	bacteria	bacteria	NOUN
njb-69	55	8	was	be	AUX
njb-69	55	9	done	do	VERB
njb-69	55	10	by	by	ADP
njb-69	55	11	gram	gram	PROPN
njb-69	55	12	’s	’s	PART
njb-69	55	13	stain	stain	NOUN
njb-69	55	14	morphology	morphology	NOUN
njb-69	55	15	,	,	PUNCT
njb-69	55	16	cultural	cultural	ADJ
njb-69	55	17	characteristics	characteristic	NOUN
njb-69	55	18	,	,	PUNCT
njb-69	55	19	and	and	CCONJ
njb-69	55	20	conventional	conventional	ADJ
njb-69	55	21	biochemical	biochemical	ADJ
njb-69	55	22	tests	test	NOUN
njb-69	55	23	.	.	PUNCT
njb-69	56	1	biochemical	biochemical	ADJ
njb-69	56	2	tests	test	NOUN
njb-69	56	3	employed	employ	VERB
njb-69	56	4	were	be	AUX
njb-69	56	5	catalase	catalase	NOUN
njb-69	56	6	test	test	NOUN
njb-69	56	7	,	,	PUNCT
njb-69	56	8	oxidase	oxidase	NOUN
njb-69	56	9	test	test	NOUN
njb-69	56	10	,	,	PUNCT
njb-69	56	11	indole	indole	NOUN
njb-69	56	12	test	test	NOUN
njb-69	56	13	,	,	PUNCT
njb-69	56	14	citrate	citrate	VERB
njb-69	56	15	utilization	utilization	NOUN
njb-69	56	16	test	test	NOUN
njb-69	56	17	,	,	PUNCT
njb-69	56	18	methyl	methyl	PROPN
njb-69	56	19	red	red	ADJ
njb-69	56	20	test	test	NOUN
njb-69	56	21	,	,	PUNCT
njb-69	56	22	voges	voges	PROPN
njb-69	56	23	-	-	PUNCT
njb-69	56	24	proskauer	proskauer	PROPN
njb-69	56	25	test	test	PROPN
njb-69	56	26	,	,	PUNCT
njb-69	56	27	christensen	christensen	PROPN
njb-69	56	28	’s	’s	PART
njb-69	56	29	urease	urease	NOUN
njb-69	56	30	test	test	NOUN
njb-69	56	31	,	,	PUNCT
njb-69	56	32	triple	triple	ADJ
njb-69	56	33	sugar	sugar	NOUN
njb-69	56	34	iron	iron	NOUN
njb-69	56	35	test	test	NOUN
njb-69	56	36	,	,	PUNCT
njb-69	56	37	decarboxylase	decarboxylase	NOUN
njb-69	56	38	test	test	NOUN
njb-69	56	39	,	,	PUNCT
njb-69	56	40	and	and	CCONJ
njb-69	56	41	phenylalanine	phenylalanine	NOUN
njb-69	56	42	deaminase	deaminase	NOUN
njb-69	56	43	test	test	NOUN
njb-69	56	44	.	.	PUNCT
njb-69	57	1	antimicrobial	antimicrobial	ADJ
njb-69	57	2	susceptibility	susceptibility	NOUN
njb-69	57	3	testing	test	VERB
njb-69	57	4	the	the	DET
njb-69	57	5	antimicrobial	antimicrobial	ADJ
njb-69	57	6	susceptibility	susceptibility	NOUN
njb-69	57	7	test	test	NOUN
njb-69	57	8	of	of	ADP
njb-69	57	9	all	all	DET
njb-69	57	10	identified	identify	VERB
njb-69	57	11	bacteria	bacteria	NOUN
njb-69	57	12	against	against	ADP
njb-69	57	13	antibiotics	antibiotic	NOUN
njb-69	57	14	of	of	ADP
njb-69	57	15	various	various	ADJ
njb-69	57	16	classes	class	NOUN
njb-69	57	17	was	be	AUX
njb-69	57	18	done	do	VERB
njb-69	57	19	in	in	ADP
njb-69	57	20	vitro	vitro	X
njb-69	57	21	by	by	ADP
njb-69	57	22	kirby	kirby	PROPN
njb-69	57	23	-	-	PUNCT
njb-69	57	24	bauer	bauer	NOUN
njb-69	57	25	disc	disc	NOUN
njb-69	57	26	diffusion	diffusion	NOUN
njb-69	57	27	method	method	NOUN
njb-69	57	28	[	[	PUNCT
njb-69	57	29	10	10	NUM
njb-69	57	30	]	]	PUNCT
njb-69	57	31	.	.	PUNCT
njb-69	58	1	a	a	DET
njb-69	58	2	zone	zone	NOUN
njb-69	58	3	of	of	ADP
njb-69	58	4	inhibitions	inhibition	NOUN
njb-69	58	5	(	(	PUNCT
njb-69	58	6	zoi	zoi	NOUN
njb-69	58	7	)	)	PUNCT
njb-69	58	8	for	for	ADP
njb-69	58	9	each	each	DET
njb-69	58	10	disc	disc	NOUN
njb-69	58	11	was	be	AUX
njb-69	58	12	measured	measure	VERB
njb-69	58	13	and	and	CCONJ
njb-69	58	14	the	the	DET
njb-69	58	15	results	result	NOUN
njb-69	58	16	were	be	AUX
njb-69	58	17	interpreted	interpret	VERB
njb-69	58	18	as	as	ADP
njb-69	58	19	per	per	ADP
njb-69	58	20	clsi	clsi	NOUN
njb-69	58	21	guideline	guideline	NOUN
njb-69	58	22	m100	m100	PROPN
njb-69	58	23	-	-	PUNCT
njb-69	58	24	s24	s24	PROPN
njb-69	58	25	[	[	PUNCT
njb-69	58	26	11	11	NUM
njb-69	58	27	]	]	PUNCT
njb-69	58	28	.	.	PUNCT
njb-69	59	1	control	control	NOUN
njb-69	59	2	strains	strain	VERB
njb-69	59	3	escherichia	escherichia	NOUN
njb-69	59	4	coli	coli	NOUN
njb-69	59	5	atcc	atcc	NOUN
njb-69	59	6	25922	25922	NUM
njb-69	59	7	and	and	CCONJ
njb-69	59	8	pseudomonas	pseudomonas	PROPN
njb-69	59	9	aeruginosa	aeruginosa	PROPN
njb-69	59	10	atcc	atcc	PROPN
njb-69	59	11	27853	27853	NUM
njb-69	59	12	were	be	AUX
njb-69	59	13	used	use	VERB
njb-69	59	14	for	for	ADP
njb-69	59	15	the	the	DET
njb-69	59	16	quality	quality	NOUN
njb-69	59	17	control	control	NOUN
njb-69	59	18	of	of	ADP
njb-69	59	19	the	the	DET
njb-69	59	20	test	test	NOUN
njb-69	59	21	.	.	PUNCT
njb-69	60	1	detection	detection	NOUN
njb-69	60	2	of	of	ADP
njb-69	60	3	extended	extended	ADJ
njb-69	60	4	-	-	PUNCT
njb-69	60	5	spectrum	spectrum	NOUN
njb-69	60	6	betalactamase	betalactamase	NOUN
njb-69	60	7	producing	produce	VERB
njb-69	60	8	strain	strain	NOUN
njb-69	60	9	esbl	esbl	X
njb-69	60	10	producing	produce	VERB
njb-69	60	11	isolates	isolate	NOUN
njb-69	60	12	were	be	AUX
njb-69	60	13	identified	identify	VERB
njb-69	60	14	by	by	ADP
njb-69	60	15	a	a	DET
njb-69	60	16	phenotypic	phenotypic	ADJ
njb-69	60	17	method	method	NOUN
njb-69	60	18	as	as	SCONJ
njb-69	60	19	described	describe	VERB
njb-69	60	20	in	in	ADP
njb-69	60	21	clsi	clsi	NOUN
njb-69	60	22	guideline	guideline	NOUN
njb-69	60	23	m100	m100	PROPN
njb-69	60	24	-	-	PUNCT
njb-69	60	25	s24	s24	PROPN
njb-69	60	26	[	[	PUNCT
njb-69	60	27	11	11	NUM
njb-69	60	28	]	]	PUNCT
njb-69	60	29	.	.	PUNCT
njb-69	61	1	screening	screen	VERB
njb-69	61	2	test	test	NOUN
njb-69	61	3	for	for	ADP
njb-69	61	4	esbl	esbl	PROPN
njb-69	61	5	:	:	PUNCT
njb-69	62	1	isolates	isolate	NOUN
njb-69	62	2	exhibiting	exhibit	VERB
njb-69	62	3	resistance	resistance	NOUN
njb-69	62	4	against	against	ADP
njb-69	62	5	ceftriaxone	ceftriaxone	PROPN
njb-69	62	6	(	(	PUNCT
njb-69	62	7	30	30	NUM
njb-69	62	8	µg	µg	X
njb-69	62	9	)	)	PUNCT
njb-69	62	10	(	(	PUNCT
njb-69	62	11	zoi	zoi	NOUN
njb-69	62	12	≤25	≤25	PROPN
njb-69	62	13	mm	mm	PROPN
njb-69	62	14	)	)	PUNCT
njb-69	62	15	and/or	and/or	CCONJ
njb-69	62	16	ceftazidime	ceftazidime	PROPN
njb-69	62	17	(	(	PUNCT
njb-69	62	18	30	30	NUM
njb-69	62	19	µg	µg	X
njb-69	62	20	)	)	PUNCT
njb-69	62	21	(	(	PUNCT
njb-69	62	22	zoi	zoi	VERB
njb-69	62	23	≤22	≤22	PROPN
njb-69	62	24	mm	mm	INTJ
njb-69	62	25	)	)	PUNCT
njb-69	62	26	and/or	and/or	CCONJ
njb-69	62	27	cefpodoxime	cefpodoxime	NOUN
njb-69	62	28	(	(	PUNCT
njb-69	62	29	10	10	NUM
njb-69	62	30	µg	µg	X
njb-69	62	31	)	)	PUNCT
njb-69	62	32	(	(	PUNCT
njb-69	62	33	zoi	zoi	NOUN
njb-69	62	34	≤17	≤17	X
njb-69	62	35	mm	mm	PROPN
njb-69	62	36	)	)	PUNCT
njb-69	62	37	and/or	and/or	CCONJ
njb-69	62	38	cefotaxime	cefotaxime	NOUN
njb-69	62	39	(	(	PUNCT
njb-69	62	40	30	30	NUM
njb-69	62	41	µg	µg	X
njb-69	62	42	)	)	PUNCT
njb-69	62	43	(	(	PUNCT
njb-69	62	44	zoi	zoi	VERB
njb-69	62	45	≤27	≤27	PROPN
njb-69	62	46	mm	mm	NOUN
njb-69	62	47	)	)	PUNCT
njb-69	62	48	were	be	AUX
njb-69	62	49	screened	screen	VERB
njb-69	62	50	for	for	ADP
njb-69	62	51	esbl	esbl	PROPN
njb-69	62	52	production	production	NOUN
njb-69	62	53	.	.	PUNCT
njb-69	63	1	combined	combine	VERB
njb-69	63	2	disc	disc	NOUN
njb-69	63	3	(	(	PUNCT
njb-69	63	4	cd	cd	PROPN
njb-69	63	5	)	)	PUNCT
njb-69	63	6	method	method	NOUN
njb-69	63	7	as	as	ADP
njb-69	63	8	a	a	DET
njb-69	63	9	confirmatory	confirmatory	ADJ
njb-69	63	10	test	test	NOUN
njb-69	63	11	for	for	ADP
njb-69	63	12	esbl	esbl	PROPN
njb-69	63	13	:	:	PUNCT
njb-69	64	1	zois	zois	PROPN
njb-69	64	2	of	of	ADP
njb-69	64	3	isolates	isolate	NOUN
njb-69	64	4	against	against	ADP
njb-69	64	5	ceftazidime	ceftazidime	NOUN
njb-69	64	6	disc	disc	NOUN
njb-69	64	7	(	(	PUNCT
njb-69	64	8	30	30	NUM
njb-69	64	9	µg	µg	X
njb-69	64	10	)	)	PUNCT
njb-69	64	11	and	and	CCONJ
njb-69	64	12	cefotaxime	cefotaxime	NOUN
njb-69	64	13	(	(	PUNCT
njb-69	64	14	30	30	NUM
njb-69	64	15	µg	µg	NOUN
njb-69	64	16	)	)	PUNCT
njb-69	64	17	were	be	AUX
njb-69	64	18	compared	compare	VERB
njb-69	64	19	against	against	ADP
njb-69	64	20	zois	zois	NOUN
njb-69	64	21	of	of	ADP
njb-69	64	22	isolates	isolate	NOUN
njb-69	64	23	against	against	ADP
njb-69	64	24	ceftazidime	ceftazidime	NOUN
njb-69	64	25	disc	disc	NOUN
njb-69	64	26	(	(	PUNCT
njb-69	64	27	30	30	NUM
njb-69	64	28	µg	µg	X
njb-69	64	29	)	)	PUNCT
njb-69	64	30	containing	contain	VERB
njb-69	64	31	clavulanic	clavulanic	ADJ
njb-69	64	32	acid	acid	NOUN
njb-69	64	33	(	(	PUNCT
njb-69	64	34	10	10	NUM
njb-69	64	35	µg	µg	X
njb-69	64	36	)	)	PUNCT
njb-69	64	37	and	and	CCONJ
njb-69	64	38	cefotaxime	cefotaxime	NOUN
njb-69	64	39	(	(	PUNCT
njb-69	64	40	30	30	NUM
njb-69	64	41	µg	µg	X
njb-69	64	42	)	)	PUNCT
njb-69	64	43	containing	contain	VERB
njb-69	64	44	clavulanic	clavulanic	ADJ
njb-69	64	45	acid	acid	NOUN
njb-69	64	46	(	(	PUNCT
njb-69	64	47	10	10	NUM
njb-69	64	48	µg	µg	X
njb-69	64	49	)	)	PUNCT
njb-69	64	50	when	when	SCONJ
njb-69	64	51	placed	place	VERB
njb-69	64	52	25	25	NUM
njb-69	64	53	mm	mm	NOUN
njb-69	64	54	apart	apart	ADV
njb-69	64	55	(	(	PUNCT
njb-69	64	56	center	center	NOUN
njb-69	64	57	to	to	ADP
njb-69	64	58	center	center	NOUN
njb-69	64	59	)	)	PUNCT
njb-69	64	60	.	.	PUNCT
njb-69	65	1	the	the	DET
njb-69	65	2	isolates	isolate	NOUN
njb-69	65	3	showing	show	VERB
njb-69	65	4	the	the	DET
njb-69	65	5	difference	difference	NOUN
njb-69	65	6	of	of	ADP
njb-69	65	7	5	5	NUM
njb-69	65	8	mm	mm	NOUN
njb-69	65	9	or	or	CCONJ
njb-69	65	10	more	more	ADJ
njb-69	65	11	between	between	ADP
njb-69	65	12	either	either	PRON
njb-69	65	13	of	of	ADP
njb-69	65	14	the	the	DET
njb-69	65	15	two	two	NUM
njb-69	65	16	zois	zois	NOUN
njb-69	65	17	of	of	ADP
njb-69	65	18	the	the	DET
njb-69	65	19	disc	disc	NOUN
njb-69	65	20	and	and	CCONJ
njb-69	65	21	clavulanate	clavulanate	NOUN
njb-69	65	22	added	add	VERB
njb-69	65	23	disc	disc	NOUN
njb-69	65	24	was	be	AUX
njb-69	65	25	confirmed	confirm	VERB
njb-69	65	26	positive	positive	ADJ
njb-69	65	27	for	for	ADP
njb-69	65	28	esbl	esbl	PROPN
njb-69	65	29	production	production	NOUN
njb-69	65	30	.	.	PUNCT
njb-69	66	1	klebsiella	klebsiella	PROPN
njb-69	66	2	pneumoniae	pneumoniae	PROPN
njb-69	66	3	atcc	atcc	PROPN
njb-69	66	4	700603	700603	NUM
njb-69	66	5	(	(	PUNCT
njb-69	66	6	esbl	esbl	PROPN
njb-69	66	7	positive	positive	ADJ
njb-69	66	8	)	)	PUNCT
njb-69	66	9	was	be	AUX
njb-69	66	10	used	use	VERB
njb-69	66	11	as	as	ADP
njb-69	66	12	control	control	NOUN
njb-69	66	13	strains	strain	NOUN
njb-69	66	14	.	.	PUNCT
njb-69	67	1	nepal	nepal	ADJ
njb-69	67	2	journal	journal	PROPN
njb-69	67	3	of	of	ADP
njb-69	67	4	biotechnology	biotechnology	NOUN
njb-69	67	5	.	.	PUNCT
njb-69	68	1	d	d	X
njb-69	68	2	e	e	PROPN
njb-69	68	3	c	c	PROPN
njb-69	68	4	.	.	PUNCT
njb-69	69	1	2	2	NUM
njb-69	69	2	0	0	NUM
njb-69	69	3	1	1	NUM
njb-69	69	4	9	9	NUM
njb-69	69	5	vol	vol	NOUN
njb-69	69	6	.	.	PUNCT
njb-69	70	1	7	7	NUM
njb-69	70	2	,	,	PUNCT
njb-69	70	3	no	no	NOUN
njb-69	70	4	.	.	NOUN
njb-69	70	5	1	1	NUM
njb-69	70	6	:	:	SYM
njb-69	70	7	74	74	NUM
njb-69	70	8	-	-	SYM
njb-69	70	9	81	81	NUM
njb-69	70	10	maharjan	maharjan	NOUN
njb-69	70	11	et	et	PROPN
njb-69	70	12	al	al	PROPN
njb-69	70	13	.	.	PROPN
njb-69	71	1	2019	2019	NUM
njb-69	72	1	©	©	ADP
njb-69	72	2	njb	njb	PROPN
njb-69	72	3	,	,	PUNCT
njb-69	72	4	biotechnology	biotechnology	NOUN
njb-69	72	5	society	society	NOUN
njb-69	72	6	of	of	ADP
njb-69	72	7	nepal	nepal	ADJ
njb-69	72	8	76	76	NUM
njb-69	72	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-69	72	10	.	.	PUNCT
njb-69	72	11	table	table	PROPN
njb-69	72	12	1	1	NUM
njb-69	72	13	.	.	PUNCT
njb-69	72	14	sample	sample	NOUN
njb-69	72	15	and	and	CCONJ
njb-69	72	16	significant	significant	ADJ
njb-69	72	17	growth	growth	NOUN
njb-69	72	18	pattern	pattern	NOUN
njb-69	72	19	total	total	ADJ
njb-69	72	20	samples	sample	NOUN
njb-69	72	21	culture	culture	VERB
njb-69	72	22	positive	positive	ADJ
njb-69	72	23	gram	gram	ADJ
njb-69	72	24	-	-	PUNCT
njb-69	72	25	negative	negative	ADJ
njb-69	72	26	bacteria	bacteria	NOUN
njb-69	72	27	gram	gram	NOUN
njb-69	72	28	-	-	PUNCT
njb-69	72	29	positive	positive	ADJ
njb-69	72	30	bacteria	bacteria	NOUN
njb-69	72	31	gender	gender	NOUN
njb-69	72	32	(	(	PUNCT
njb-69	72	33	m	m	NOUN
njb-69	72	34	:	:	PUNCT
njb-69	72	35	f	f	X
njb-69	72	36	ratio=1.45:1	ratio=1.45:1	NUM
njb-69	72	37	)	)	PUNCT
njb-69	73	1	male	male	NOUN
njb-69	73	2	357	357	NUM
njb-69	73	3	(	(	PUNCT
njb-69	73	4	59.1	59.1	NUM
njb-69	73	5	%	%	NOUN
njb-69	73	6	)	)	PUNCT
njb-69	73	7	174	174	NUM
njb-69	73	8	(	(	PUNCT
njb-69	73	9	61.7	61.7	NUM
njb-69	73	10	%	%	NOUN
njb-69	73	11	)	)	PUNCT
njb-69	73	12	143	143	NUM
njb-69	73	13	(	(	PUNCT
njb-69	73	14	62.4	62.4	NUM
njb-69	73	15	%	%	NOUN
njb-69	73	16	)	)	PUNCT
njb-69	73	17	31	31	NUM
njb-69	73	18	(	(	PUNCT
njb-69	73	19	58.5	58.5	NUM
njb-69	73	20	%	%	NOUN
njb-69	73	21	)	)	PUNCT
njb-69	73	22	female	female	ADJ
njb-69	73	23	247	247	NUM
njb-69	73	24	(	(	PUNCT
njb-69	73	25	40.9	40.9	NUM
njb-69	73	26	%	%	NOUN
njb-69	73	27	)	)	PUNCT
njb-69	73	28	108	108	NUM
njb-69	73	29	(	(	PUNCT
njb-69	73	30	38.3	38.3	NUM
njb-69	73	31	%	%	NOUN
njb-69	73	32	)	)	PUNCT
njb-69	73	33	86	86	NUM
njb-69	73	34	(	(	PUNCT
njb-69	73	35	37.6	37.6	NUM
njb-69	73	36	%	%	NOUN
njb-69	73	37	)	)	PUNCT
njb-69	73	38	22	22	NUM
njb-69	73	39	(	(	PUNCT
njb-69	73	40	41.5	41.5	NUM
njb-69	73	41	%	%	NOUN
njb-69	73	42	)	)	PUNCT
njb-69	73	43	departments	department	NOUN
njb-69	73	44	of	of	ADP
njb-69	73	45	patients	patient	NOUN
njb-69	73	46	inpatients	inpatient	NOUN
njb-69	73	47	471	471	NUM
njb-69	73	48	(	(	PUNCT
njb-69	73	49	78	78	NUM
njb-69	73	50	%	%	NOUN
njb-69	73	51	)	)	PUNCT
njb-69	73	52	180	180	NUM
njb-69	73	53	(	(	PUNCT
njb-69	73	54	63.8	63.8	NUM
njb-69	73	55	%	%	NOUN
njb-69	73	56	)	)	PUNCT
njb-69	73	57	157	157	NUM
njb-69	73	58	(	(	PUNCT
njb-69	73	59	68.6	68.6	NUM
njb-69	73	60	%	%	NOUN
njb-69	73	61	)	)	PUNCT
njb-69	73	62	23	23	NUM
njb-69	73	63	(	(	PUNCT
njb-69	73	64	76.7	76.7	NUM
njb-69	73	65	%	%	NOUN
njb-69	73	66	)	)	PUNCT
njb-69	73	67	outpatients	outpatient	NOUN
njb-69	73	68	133	133	NUM
njb-69	73	69	(	(	PUNCT
njb-69	73	70	22	22	NUM
njb-69	73	71	%	%	NOUN
njb-69	73	72	)	)	PUNCT
njb-69	73	73	102	102	NUM
njb-69	73	74	(	(	PUNCT
njb-69	73	75	36.2	36.2	NUM
njb-69	73	76	%	%	NOUN
njb-69	73	77	)	)	PUNCT
njb-69	73	78	72	72	NUM
njb-69	73	79	(	(	PUNCT
njb-69	73	80	31.4	31.4	NUM
njb-69	73	81	%	%	NOUN
njb-69	73	82	)	)	PUNCT
njb-69	73	83	30	30	NUM
njb-69	73	84	(	(	PUNCT
njb-69	73	85	56.6	56.6	NUM
njb-69	73	86	%	%	NOUN
njb-69	73	87	)	)	PUNCT
njb-69	73	88	age	age	NOUN
njb-69	73	89	groups	group	NOUN
njb-69	73	90	(	(	PUNCT
njb-69	73	91	years	year	NOUN
njb-69	73	92	):	):	PUNCT
njb-69	73	93	infants	infant	NOUN
njb-69	73	94	and	and	CCONJ
njb-69	73	95	children	child	NOUN
njb-69	73	96	,	,	PUNCT
njb-69	73	97	adolescents	adolescent	NOUN
njb-69	73	98	,	,	PUNCT
njb-69	73	99	adults	adult	NOUN
njb-69	73	100	,	,	PUNCT
njb-69	73	101	elders	elder	NOUN
njb-69	73	102	≤9	≤9	PROPN
njb-69	73	103	19	19	NUM
njb-69	73	104	(	(	PUNCT
njb-69	73	105	3.2	3.2	NUM
njb-69	73	106	%	%	NOUN
njb-69	73	107	)	)	PUNCT
njb-69	73	108	3	3	NUM
njb-69	73	109	(	(	PUNCT
njb-69	73	110	1.1	1.1	NUM
njb-69	73	111	%	%	NOUN
njb-69	73	112	)	)	PUNCT
njb-69	73	113	2	2	NUM
njb-69	73	114	(	(	PUNCT
njb-69	73	115	0.9	0.9	NUM
njb-69	73	116	%	%	NOUN
njb-69	73	117	)	)	PUNCT
njb-69	73	118	1	1	NUM
njb-69	73	119	(	(	PUNCT
njb-69	73	120	1.9	1.9	NUM
njb-69	73	121	%	%	NOUN
njb-69	73	122	)	)	PUNCT
njb-69	73	123	10	10	NUM
njb-69	73	124	-	-	SYM
njb-69	73	125	19	19	NUM
njb-69	73	126	56	56	NUM
njb-69	73	127	(	(	PUNCT
njb-69	73	128	9.3	9.3	NUM
njb-69	73	129	%	%	NOUN
njb-69	73	130	)	)	PUNCT
njb-69	73	131	29	29	NUM
njb-69	73	132	(	(	PUNCT
njb-69	73	133	10.3	10.3	NUM
njb-69	73	134	%	%	NOUN
njb-69	73	135	)	)	PUNCT
njb-69	73	136	26	26	NUM
njb-69	73	137	(	(	PUNCT
njb-69	73	138	11.4	11.4	NUM
njb-69	73	139	%	%	NOUN
njb-69	73	140	)	)	PUNCT
njb-69	73	141	3	3	NUM
njb-69	73	142	(	(	PUNCT
njb-69	73	143	5.7	5.7	NUM
njb-69	73	144	%	%	NOUN
njb-69	73	145	)	)	PUNCT
njb-69	73	146	20	20	NUM
njb-69	73	147	-	-	SYM
njb-69	73	148	59	59	NUM
njb-69	73	149	313	313	NUM
njb-69	73	150	(	(	PUNCT
njb-69	73	151	51.8	51.8	NUM
njb-69	73	152	%	%	NOUN
njb-69	73	153	)	)	PUNCT
njb-69	73	154	129	129	NUM
njb-69	73	155	(	(	PUNCT
njb-69	73	156	45.7	45.7	NUM
njb-69	73	157	%	%	NOUN
njb-69	73	158	)	)	PUNCT
njb-69	73	159	99	99	NUM
njb-69	73	160	(	(	PUNCT
njb-69	73	161	43.2	43.2	NUM
njb-69	73	162	%	%	NOUN
njb-69	73	163	)	)	PUNCT
njb-69	73	164	30	30	NUM
njb-69	73	165	(	(	PUNCT
njb-69	73	166	56.6	56.6	NUM
njb-69	73	167	%	%	NOUN
njb-69	73	168	)	)	PUNCT
njb-69	73	169	≥60	≥60	NUM
njb-69	73	170	216	216	NUM
njb-69	73	171	(	(	PUNCT
njb-69	73	172	35.8	35.8	NUM
njb-69	73	173	%	%	NOUN
njb-69	73	174	)	)	PUNCT
njb-69	73	175	121	121	NUM
njb-69	73	176	(	(	PUNCT
njb-69	73	177	42.9	42.9	NUM
njb-69	73	178	%	%	NOUN
njb-69	73	179	)	)	PUNCT
njb-69	73	180	102	102	NUM
njb-69	73	181	(	(	PUNCT
njb-69	73	182	44.5	44.5	NUM
njb-69	73	183	%	%	NOUN
njb-69	73	184	)	)	PUNCT
njb-69	73	185	19	19	NUM
njb-69	73	186	(	(	PUNCT
njb-69	73	187	35.8	35.8	NUM
njb-69	73	188	%	%	NOUN
njb-69	73	189	)	)	PUNCT
njb-69	73	190	total	total	ADJ
njb-69	73	191	604	604	NUM
njb-69	73	192	(	(	PUNCT
njb-69	73	193	100	100	NUM
njb-69	73	194	%	%	NOUN
njb-69	73	195	)	)	PUNCT
njb-69	73	196	282	282	NUM
njb-69	73	197	(	(	PUNCT
njb-69	73	198	100	100	NUM
njb-69	73	199	%	%	NOUN
njb-69	73	200	)	)	PUNCT
njb-69	73	201	229	229	NUM
njb-69	74	1	(	(	PUNCT
njb-69	74	2	100	100	NUM
njb-69	74	3	%	%	NOUN
njb-69	74	4	)	)	PUNCT
njb-69	74	5	53	53	NUM
njb-69	74	6	(	(	PUNCT
njb-69	74	7	100	100	NUM
njb-69	74	8	%	%	NOUN
njb-69	74	9	)	)	PUNCT
njb-69	74	10	detection	detection	NOUN
njb-69	74	11	of	of	ADP
njb-69	74	12	metallo	metallo	ADJ
njb-69	74	13	-	-	PUNCT
njb-69	74	14	beta	beta	NOUN
njb-69	74	15	-	-	PUNCT
njb-69	74	16	lactamase	lactamase	NOUN
njb-69	74	17	producing	produce	VERB
njb-69	74	18	strain	strain	NOUN
njb-69	74	19	since	since	SCONJ
njb-69	74	20	during	during	ADP
njb-69	74	21	the	the	DET
njb-69	74	22	study	study	NOUN
njb-69	74	23	no	no	DET
njb-69	74	24	standard	standard	ADJ
njb-69	74	25	protocol	protocol	NOUN
njb-69	74	26	was	be	AUX
njb-69	74	27	available	available	ADJ
njb-69	74	28	for	for	ADP
njb-69	74	29	the	the	DET
njb-69	74	30	detection	detection	NOUN
njb-69	74	31	of	of	ADP
njb-69	74	32	mbl	mbl	PROPN
njb-69	74	33	,	,	PUNCT
njb-69	74	34	mbl	mbl	NOUN
njb-69	74	35	producing	produce	VERB
njb-69	74	36	isolates	isolate	NOUN
njb-69	74	37	were	be	AUX
njb-69	74	38	identified	identify	VERB
njb-69	74	39	by	by	ADP
njb-69	74	40	the	the	DET
njb-69	74	41	commonly	commonly	ADV
njb-69	74	42	used	use	VERB
njb-69	74	43	phenotypic	phenotypic	ADJ
njb-69	74	44	method	method	NOUN
njb-69	74	45	.	.	PUNCT
njb-69	75	1	screening	screen	VERB
njb-69	75	2	test	test	NOUN
njb-69	75	3	for	for	ADP
njb-69	75	4	mbl	mbl	NOUN
njb-69	75	5	:	:	PUNCT
njb-69	75	6	isolates	isolate	VERB
njb-69	75	7	exhibiting	exhibit	VERB
njb-69	75	8	resistance	resistance	NOUN
njb-69	75	9	against	against	ADP
njb-69	75	10	ceftazidime	ceftazidime	NOUN
njb-69	75	11	(	(	PUNCT
njb-69	75	12	30	30	NUM
njb-69	75	13	µg	µg	X
njb-69	75	14	)	)	PUNCT
njb-69	75	15	(	(	PUNCT
njb-69	75	16	zoi<18	zoi<18	NUM
njb-69	75	17	mm	mm	X
njb-69	75	18	)	)	PUNCT
njb-69	75	19	were	be	AUX
njb-69	75	20	screened	screen	VERB
njb-69	75	21	for	for	ADP
njb-69	75	22	mbl	mbl	NOUN
njb-69	75	23	production	production	NOUN
njb-69	75	24	.	.	PUNCT
njb-69	76	1	the	the	DET
njb-69	76	2	resistance	resistance	NOUN
njb-69	76	3	against	against	ADP
njb-69	76	4	imipenem	imipenem	PROPN
njb-69	76	5	(	(	PUNCT
njb-69	76	6	10μg	10μg	PROPN
njb-69	76	7	)	)	PUNCT
njb-69	76	8	and/or	and/or	CCONJ
njb-69	76	9	meropenem	meropenem	PROPN
njb-69	76	10	(	(	PUNCT
njb-69	76	11	10μg	10μg	PROPN
njb-69	76	12	)	)	PUNCT
njb-69	76	13	was	be	AUX
njb-69	76	14	not	not	PART
njb-69	76	15	used	use	VERB
njb-69	76	16	as	as	ADP
njb-69	76	17	a	a	DET
njb-69	76	18	screening	screening	NOUN
njb-69	76	19	tool	tool	NOUN
njb-69	76	20	so	so	SCONJ
njb-69	76	21	as	as	SCONJ
njb-69	76	22	to	to	PART
njb-69	76	23	avoid	avoid	VERB
njb-69	76	24	missing	miss	VERB
njb-69	76	25	the	the	DET
njb-69	76	26	detection	detection	NOUN
njb-69	76	27	of	of	ADP
njb-69	76	28	hidden	hide	VERB
njb-69	76	29	mbl	mbl	NOUN
njb-69	76	30	in	in	ADP
njb-69	76	31	bacteria	bacteria	NOUN
njb-69	76	32	.	.	PUNCT
njb-69	77	1	bacterial	bacterial	ADJ
njb-69	77	2	suspension	suspension	NOUN
njb-69	77	3	equivalent	equivalent	ADJ
njb-69	77	4	to	to	ADP
njb-69	77	5	1:10	1:10	NUM
njb-69	77	6	dilution	dilution	NOUN
njb-69	77	7	of	of	ADP
njb-69	77	8	0.5	0.5	NUM
njb-69	77	9	mcfarland	mcfarland	NOUN
njb-69	77	10	was	be	AUX
njb-69	77	11	used	use	VERB
njb-69	77	12	for	for	ADP
njb-69	77	13	lawn	lawn	NOUN
njb-69	77	14	culture	culture	NOUN
njb-69	77	15	in	in	ADP
njb-69	77	16	mueller	mueller	NOUN
njb-69	77	17	-	-	PUNCT
njb-69	77	18	hinton	hinton	PROPN
njb-69	77	19	agar	agar	NOUN
njb-69	77	20	before	before	ADP
njb-69	77	21	incorporating	incorporate	VERB
njb-69	77	22	antibiotic	antibiotic	ADJ
njb-69	77	23	discs	disc	NOUN
njb-69	77	24	[	[	X
njb-69	77	25	12	12	NUM
njb-69	77	26	]	]	PUNCT
njb-69	77	27	.	.	PUNCT
njb-69	78	1	combined	combine	VERB
njb-69	78	2	disc	disc	NOUN
njb-69	78	3	(	(	PUNCT
njb-69	78	4	cd	cd	PROPN
njb-69	78	5	)	)	PUNCT
njb-69	78	6	method	method	NOUN
njb-69	78	7	as	as	ADP
njb-69	78	8	a	a	DET
njb-69	78	9	confirmatory	confirmatory	ADJ
njb-69	78	10	test	test	NOUN
njb-69	78	11	for	for	ADP
njb-69	78	12	mbl	mbl	PROPN
njb-69	78	13	:	:	PUNCT
njb-69	78	14	zoi	zoi	PROPN
njb-69	78	15	of	of	ADP
njb-69	78	16	isolate	isolate	VERB
njb-69	78	17	against	against	ADP
njb-69	78	18	imipenem	imipenem	PROPN
njb-69	78	19	disc	disc	NOUN
njb-69	78	20	(	(	PUNCT
njb-69	78	21	10	10	NUM
njb-69	78	22	µg	µg	NOUN
njb-69	78	23	)	)	PUNCT
njb-69	78	24	was	be	AUX
njb-69	78	25	compared	compare	VERB
njb-69	78	26	against	against	ADP
njb-69	78	27	zoi	zoi	NOUN
njb-69	78	28	of	of	ADP
njb-69	78	29	isolates	isolate	NOUN
njb-69	78	30	against	against	ADP
njb-69	78	31	imipenem	imipenem	PROPN
njb-69	78	32	disc	disc	NOUN
njb-69	78	33	(	(	PUNCT
njb-69	78	34	10	10	NUM
njb-69	78	35	µg	µg	X
njb-69	78	36	)	)	PUNCT
njb-69	78	37	containing	contain	VERB
njb-69	78	38	292	292	NUM
njb-69	78	39	µg	µg	NOUN
njb-69	78	40	(	(	PUNCT
njb-69	78	41	10µl	10µl	NOUN
njb-69	78	42	of	of	ADP
njb-69	78	43	0.1	0.1	NUM
njb-69	78	44	m	m	NUM
njb-69	78	45	)	)	PUNCT
njb-69	78	46	ethylenediamine	ethylenediamine	NOUN
njb-69	78	47	-	-	PUNCT
njb-69	78	48	tetraacetic	tetraacetic	ADJ
njb-69	78	49	acid	acid	NOUN
njb-69	78	50	(	(	PUNCT
njb-69	78	51	edta	edta	X
njb-69	78	52	)	)	PUNCT
njb-69	78	53	when	when	SCONJ
njb-69	78	54	placed	place	VERB
njb-69	78	55	25	25	NUM
njb-69	78	56	mm	mm	NOUN
njb-69	78	57	apart	apart	ADV
njb-69	78	58	(	(	PUNCT
njb-69	78	59	center	center	NOUN
njb-69	78	60	to	to	ADP
njb-69	78	61	center	center	NOUN
njb-69	78	62	)	)	PUNCT
njb-69	78	63	.	.	PUNCT
njb-69	79	1	the	the	DET
njb-69	79	2	isolates	isolate	NOUN
njb-69	79	3	showing	show	VERB
njb-69	79	4	difference	difference	NOUN
njb-69	79	5	of	of	ADP
njb-69	79	6	4	4	NUM
njb-69	79	7	mm	mm	NOUN
njb-69	79	8	or	or	CCONJ
njb-69	79	9	more	more	ADJ
njb-69	79	10	between	between	ADP
njb-69	79	11	two	two	NUM
njb-69	79	12	zois	zois	NOUN
njb-69	79	13	was	be	AUX
njb-69	79	14	confirmed	confirm	VERB
njb-69	79	15	positive	positive	ADJ
njb-69	79	16	for	for	ADP
njb-69	79	17	mbl	mbl	NOUN
njb-69	79	18	production	production	NOUN
njb-69	80	1	[	[	PUNCT
njb-69	80	2	12	12	NUM
njb-69	80	3	,	,	PUNCT
njb-69	80	4	13	13	NUM
njb-69	80	5	]	]	PUNCT
njb-69	80	6	.	.	PUNCT
njb-69	81	1	p.	p.	PROPN
njb-69	81	2	aeruginosa	aeruginosa	PROPN
njb-69	81	3	atcc	atcc	PROPN
njb-69	81	4	27853	27853	NUM
njb-69	81	5	(	(	PUNCT
njb-69	81	6	mbl	mbl	NOUN
njb-69	81	7	negative	negative	NOUN
njb-69	81	8	)	)	PUNCT
njb-69	81	9	and	and	CCONJ
njb-69	81	10	p.	p.	PROPN
njb-69	81	11	aeruginosa	aeruginosa	PROPN
njb-69	81	12	pa	pa	PROPN
njb-69	81	13	105663	105663	NUM
njb-69	81	14	(	(	PUNCT
njb-69	81	15	mbl	mbl	PROPN
njb-69	81	16	positive	positive	NOUN
njb-69	81	17	)	)	PUNCT
njb-69	81	18	was	be	AUX
njb-69	81	19	used	use	VERB
njb-69	81	20	as	as	ADP
njb-69	81	21	control	control	NOUN
njb-69	81	22	strains	strain	NOUN
njb-69	81	23	.	.	PUNCT
njb-69	82	1	results	result	VERB
njb-69	82	2	distribution	distribution	NOUN
njb-69	82	3	of	of	ADP
njb-69	82	4	samples	sample	NOUN
njb-69	82	5	and	and	CCONJ
njb-69	82	6	isolates	isolate	NOUN
njb-69	82	7	of	of	ADP
njb-69	82	8	604	604	NUM
njb-69	82	9	samples	sample	NOUN
njb-69	82	10	,	,	PUNCT
njb-69	82	11	only	only	ADV
njb-69	82	12	282	282	NUM
njb-69	82	13	(	(	PUNCT
njb-69	82	14	46.7	46.7	NUM
njb-69	82	15	%	%	NOUN
njb-69	82	16	)	)	PUNCT
njb-69	82	17	were	be	AUX
njb-69	82	18	culture	culture	NOUN
njb-69	82	19	positive	positive	ADJ
njb-69	82	20	.	.	PUNCT
njb-69	83	1	higher	high	ADJ
njb-69	83	2	number	number	NOUN
njb-69	83	3	of	of	ADP
njb-69	83	4	samples	sample	NOUN
njb-69	83	5	from	from	ADP
njb-69	83	6	males	male	NOUN
njb-69	83	7	were	be	AUX
njb-69	83	8	culture	culture	NOUN
njb-69	83	9	positive	positive	ADJ
njb-69	83	10	174	174	NUM
njb-69	83	11	(	(	PUNCT
njb-69	83	12	61.7	61.7	NUM
njb-69	83	13	%	%	NOUN
njb-69	83	14	)	)	PUNCT
njb-69	83	15	.	.	PUNCT
njb-69	84	1	similarly	similarly	ADV
njb-69	84	2	,	,	PUNCT
njb-69	84	3	a	a	DET
njb-69	84	4	higher	high	ADJ
njb-69	84	5	number	number	NOUN
njb-69	84	6	of	of	ADP
njb-69	84	7	samples	sample	NOUN
njb-69	84	8	from	from	ADP
njb-69	84	9	the	the	DET
njb-69	84	10	inpatient	inpatient	NOUN
njb-69	84	11	department	department	NOUN
njb-69	84	12	were	be	AUX
njb-69	84	13	culture	culture	NOUN
njb-69	84	14	positive	positive	ADJ
njb-69	84	15	,	,	PUNCT
njb-69	84	16	180	180	NUM
njb-69	84	17	(	(	PUNCT
njb-69	84	18	63.8	63.8	NUM
njb-69	84	19	%	%	NOUN
njb-69	84	20	)	)	PUNCT
njb-69	84	21	.	.	PUNCT
njb-69	85	1	culture	culture	NOUN
njb-69	85	2	positivity	positivity	NOUN
njb-69	85	3	increased	increase	VERB
njb-69	85	4	with	with	ADP
njb-69	85	5	the	the	DET
njb-69	85	6	age	age	NOUN
njb-69	85	7	of	of	ADP
njb-69	85	8	patients	patient	NOUN
njb-69	85	9	.	.	PUNCT
njb-69	86	1	among	among	ADP
njb-69	86	2	282	282	NUM
njb-69	86	3	culture	culture	NOUN
njb-69	86	4	positive	positive	ADJ
njb-69	86	5	,	,	PUNCT
njb-69	86	6	229	229	NUM
njb-69	86	7	(	(	PUNCT
njb-69	86	8	81.2	81.2	NUM
njb-69	86	9	%	%	NOUN
njb-69	86	10	)	)	PUNCT
njb-69	86	11	were	be	AUX
njb-69	86	12	gram	gram	ADJ
njb-69	86	13	-	-	PUNCT
njb-69	86	14	negative	negative	ADJ
njb-69	86	15	bacteria	bacteria	NOUN
njb-69	86	16	(	(	PUNCT
njb-69	86	17	table	table	NOUN
njb-69	86	18	1	1	NUM
njb-69	86	19	)	)	PUNCT
njb-69	86	20	.	.	PUNCT
njb-69	87	1	eight	eight	NUM
njb-69	87	2	different	different	ADJ
njb-69	87	3	species	specie	NOUN
njb-69	87	4	of	of	ADP
njb-69	87	5	gram	gram	ADJ
njb-69	87	6	-	-	PUNCT
njb-69	87	7	negative	negative	ADJ
njb-69	87	8	bacteria	bacteria	NOUN
njb-69	87	9	were	be	AUX
njb-69	87	10	identified	identify	VERB
njb-69	87	11	.	.	PUNCT
njb-69	88	1	among	among	ADP
njb-69	88	2	these	these	PRON
njb-69	88	3	,	,	PUNCT
njb-69	88	4	e.	e.	PROPN
njb-69	88	5	coli	coli	PROPN
njb-69	88	6	were	be	AUX
njb-69	88	7	the	the	DET
njb-69	88	8	predominant	predominant	NOUN
njb-69	88	9	,	,	PUNCT
njb-69	88	10	78	78	NUM
njb-69	88	11	(	(	PUNCT
njb-69	88	12	34.1	34.1	NUM
njb-69	88	13	%	%	NOUN
njb-69	88	14	)	)	PUNCT
njb-69	88	15	.	.	PUNCT
njb-69	89	1	e.	e.	PROPN
njb-69	89	2	coli	coli	PROPN
njb-69	89	3	was	be	AUX
njb-69	89	4	also	also	ADV
njb-69	89	5	predominant	predominant	ADJ
njb-69	89	6	in	in	ADP
njb-69	89	7	urine	urine	NOUN
njb-69	89	8	samples	sample	NOUN
njb-69	89	9	,	,	PUNCT
njb-69	89	10	61(55.0	61(55.0	NUM
njb-69	89	11	%	%	NOUN
njb-69	89	12	)	)	PUNCT
njb-69	89	13	(	(	PUNCT
njb-69	89	14	table	table	NOUN
njb-69	89	15	2	2	NUM
njb-69	89	16	)	)	PUNCT
njb-69	89	17	.	.	PUNCT
njb-69	90	1	nepal	nepal	ADJ
njb-69	90	2	journal	journal	PROPN
njb-69	90	3	of	of	ADP
njb-69	90	4	biotechnology	biotechnology	NOUN
njb-69	90	5	.	.	PUNCT
njb-69	91	1	d	d	X
njb-69	91	2	e	e	PROPN
njb-69	91	3	c	c	PROPN
njb-69	91	4	.	.	PUNCT
njb-69	92	1	2	2	NUM
njb-69	92	2	0	0	NUM
njb-69	92	3	1	1	NUM
njb-69	92	4	9	9	NUM
njb-69	92	5	vol	vol	NOUN
njb-69	92	6	.	.	PUNCT
njb-69	93	1	7	7	NUM
njb-69	93	2	,	,	PUNCT
njb-69	93	3	no	no	NOUN
njb-69	93	4	.	.	NOUN
njb-69	93	5	1	1	NUM
njb-69	93	6	:	:	SYM
njb-69	93	7	74	74	NUM
njb-69	93	8	-	-	SYM
njb-69	93	9	81	81	NUM
njb-69	93	10	maharjan	maharjan	NOUN
njb-69	93	11	et	et	PROPN
njb-69	93	12	al	al	PROPN
njb-69	93	13	.	.	PROPN
njb-69	94	1	2019	2019	NUM
njb-69	95	1	©	©	ADP
njb-69	95	2	njb	njb	PROPN
njb-69	95	3	,	,	PUNCT
njb-69	95	4	biotechnology	biotechnology	NOUN
njb-69	95	5	society	society	NOUN
njb-69	95	6	of	of	ADP
njb-69	95	7	nepal	nepal	ADJ
njb-69	95	8	77	77	NUM
njb-69	95	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	95	10	.	.	PUNCT
njb-69	96	1	antibiotic	antibiotic	ADJ
njb-69	96	2	susceptibility	susceptibility	NOUN
njb-69	96	3	of	of	ADP
njb-69	96	4	gramnegative	gramnegative	ADJ
njb-69	96	5	bacteria	bacteria	NOUN
njb-69	96	6	of	of	ADP
njb-69	96	7	229	229	NUM
njb-69	96	8	gram	gram	ADJ
njb-69	96	9	-	-	PUNCT
njb-69	96	10	negative	negative	ADJ
njb-69	96	11	bacteria	bacteria	NOUN
njb-69	96	12	,	,	PUNCT
njb-69	96	13	e.	e.	PROPN
njb-69	96	14	coli	coli	PROPN
njb-69	96	15	showed	show	VERB
njb-69	96	16	higher	high	ADJ
njb-69	96	17	resistance	resistance	NOUN
njb-69	96	18	against	against	ADP
njb-69	96	19	ampicillin	ampicillin	NOUN
njb-69	96	20	,	,	PUNCT
njb-69	96	21	cefpodoxime	cefpodoxime	NOUN
njb-69	96	22	,	,	PUNCT
njb-69	96	23	ceftriaxone	ceftriaxone	PROPN
njb-69	96	24	,	,	PUNCT
njb-69	96	25	and	and	CCONJ
njb-69	96	26	cefixime	cefixime	NOUN
njb-69	96	27	,	,	PUNCT
njb-69	96	28	while	while	SCONJ
njb-69	96	29	imipenem	imipenem	PROPN
njb-69	96	30	and	and	CCONJ
njb-69	96	31	chloramphenicol	chloramphenicol	NOUN
njb-69	96	32	were	be	AUX
njb-69	96	33	found	find	VERB
njb-69	96	34	effective	effective	ADJ
njb-69	96	35	.	.	PUNCT
njb-69	97	1	p.	p.	PROPN
njb-69	97	2	aeruginosa	aeruginosa	PROPN
njb-69	97	3	showed	show	VERB
njb-69	97	4	higher	high	ADJ
njb-69	97	5	resistance	resistance	NOUN
njb-69	97	6	against	against	ADP
njb-69	97	7	cefixime	cefixime	NOUN
njb-69	97	8	and	and	CCONJ
njb-69	97	9	cefpodoxime	cefpodoxime	NOUN
njb-69	97	10	,	,	PUNCT
njb-69	97	11	while	while	SCONJ
njb-69	97	12	imipenem	imipenem	PROPN
njb-69	97	13	was	be	AUX
njb-69	97	14	found	find	VERB
njb-69	97	15	effective	effective	ADJ
njb-69	97	16	.	.	PUNCT
njb-69	98	1	similarly	similarly	ADV
njb-69	98	2	,	,	PUNCT
njb-69	98	3	other	other	ADJ
njb-69	98	4	gram	gram	ADJ
njb-69	98	5	-	-	PUNCT
njb-69	98	6	negative	negative	ADJ
njb-69	98	7	bacteria	bacteria	NOUN
njb-69	98	8	showed	show	VERB
njb-69	98	9	higher	high	ADJ
njb-69	98	10	resistance	resistance	NOUN
njb-69	98	11	against	against	ADP
njb-69	98	12	ampicillin	ampicillin	NOUN
njb-69	98	13	,	,	PUNCT
njb-69	98	14	cefpodoxime	cefpodoxime	NOUN
njb-69	98	15	,	,	PUNCT
njb-69	98	16	and	and	CCONJ
njb-69	98	17	ceftriaxone	ceftriaxone	PROPN
njb-69	98	18	,	,	PUNCT
njb-69	98	19	while	while	SCONJ
njb-69	98	20	imipenem	imipenem	PROPN
njb-69	98	21	was	be	AUX
njb-69	98	22	found	find	VERB
njb-69	98	23	fairly	fairly	ADV
njb-69	98	24	effective	effective	ADJ
njb-69	98	25	(	(	PUNCT
njb-69	98	26	table	table	NOUN
njb-69	98	27	3	3	NUM
njb-69	98	28	)	)	PUNCT
njb-69	98	29	.	.	PUNCT
njb-69	99	1	distribution	distribution	NOUN
njb-69	99	2	of	of	ADP
njb-69	99	3	beta	beta	NOUN
njb-69	99	4	-	-	PUNCT
njb-69	99	5	lactamase	lactamase	NOUN
njb-69	99	6	producers	producer	NOUN
njb-69	99	7	of	of	ADP
njb-69	99	8	229	229	NUM
njb-69	99	9	gram	gram	ADJ
njb-69	99	10	-	-	PUNCT
njb-69	99	11	negative	negative	ADJ
njb-69	99	12	bacteria	bacteria	NOUN
njb-69	99	13	,	,	PUNCT
njb-69	99	14	200	200	NUM
njb-69	99	15	(	(	PUNCT
njb-69	99	16	87.3	87.3	NUM
njb-69	99	17	%	%	NOUN
njb-69	99	18	)	)	PUNCT
njb-69	99	19	were	be	AUX
njb-69	99	20	found	find	VERB
njb-69	99	21	mdr	mdr	PROPN
njb-69	99	22	.	.	PROPN
njb-69	100	1	of	of	ADP
njb-69	100	2	these	these	DET
njb-69	100	3	bacteria	bacteria	NOUN
njb-69	100	4	,	,	PUNCT
njb-69	100	5	67	67	NUM
njb-69	100	6	(	(	PUNCT
njb-69	100	7	29.3	29.3	NUM
njb-69	100	8	%	%	NOUN
njb-69	100	9	)	)	PUNCT
njb-69	101	1	were	be	AUX
njb-69	101	2	esbl	esbl	NOUN
njb-69	101	3	producers	producer	NOUN
njb-69	101	4	and	and	CCONJ
njb-69	101	5	16	16	NUM
njb-69	101	6	(	(	PUNCT
njb-69	101	7	7.0	7.0	NUM
njb-69	101	8	%	%	NOUN
njb-69	101	9	)	)	PUNCT
njb-69	101	10	were	be	AUX
njb-69	101	11	mbl	mbl	NOUN
njb-69	101	12	producers	producer	NOUN
njb-69	101	13	.	.	PUNCT
njb-69	102	1	esbl	esbl	PROPN
njb-69	102	2	production	production	NOUN
njb-69	102	3	was	be	AUX
njb-69	102	4	higher	high	ADJ
njb-69	102	5	among	among	ADP
njb-69	102	6	sputum	sputum	NOUN
njb-69	102	7	isolates	isolate	VERB
njb-69	102	8	i.e.	i.e.	X
njb-69	102	9	35	35	NUM
njb-69	102	10	(	(	PUNCT
njb-69	102	11	52.2	52.2	NUM
njb-69	102	12	%	%	NOUN
njb-69	102	13	)	)	PUNCT
njb-69	102	14	and	and	CCONJ
njb-69	102	15	mbl	mbl	NOUN
njb-69	102	16	production	production	NOUN
njb-69	102	17	was	be	AUX
njb-69	102	18	higher	high	ADJ
njb-69	102	19	among	among	ADP
njb-69	102	20	urine	urine	NOUN
njb-69	102	21	isolates	isolate	VERB
njb-69	102	22	i.e.	i.e.	X
njb-69	102	23	8	8	NUM
njb-69	102	24	(	(	PUNCT
njb-69	102	25	50	50	NUM
njb-69	102	26	%	%	NOUN
njb-69	102	27	)	)	PUNCT
njb-69	102	28	(	(	PUNCT
njb-69	102	29	table	table	NOUN
njb-69	102	30	4).distribution	4).distribution	NUM
njb-69	102	31	of	of	ADP
njb-69	102	32	betalactamase	betalactamase	PROPN
njb-69	102	33	production	production	NOUN
njb-69	102	34	among	among	ADP
njb-69	102	35	gram	gram	ADJ
njb-69	102	36	-	-	PUNCT
njb-69	102	37	negative	negative	ADJ
njb-69	102	38	bacteria	bacteria	NOUN
njb-69	102	39	of	of	ADP
njb-69	102	40	229	229	NUM
njb-69	102	41	gram	gram	ADJ
njb-69	102	42	-	-	PUNCT
njb-69	102	43	negative	negative	ADJ
njb-69	102	44	bacteria	bacteria	NOUN
njb-69	102	45	,	,	PUNCT
njb-69	102	46	mdr	mdr	PROPN
njb-69	102	47	was	be	AUX
njb-69	102	48	found	find	VERB
njb-69	102	49	higher	high	ADJ
njb-69	102	50	among	among	ADP
njb-69	102	51	klebsiella	klebsiella	PROPN
njb-69	102	52	spp	spp	PROPN
njb-69	102	53	.	.	PUNCT
njb-69	102	54	isolates	isolate	NOUN
njb-69	102	55	.	.	PUNCT
njb-69	103	1	esbl	esbl	PROPN
njb-69	103	2	production	production	NOUN
njb-69	103	3	was	be	AUX
njb-69	103	4	higher	high	ADJ
njb-69	103	5	among	among	ADP
njb-69	103	6	k.	k.	NOUN
njb-69	103	7	pneumoniae	pneumoniae	NOUN
njb-69	103	8	25	25	NUM
njb-69	103	9	(	(	PUNCT
njb-69	103	10	37.3	37.3	NUM
njb-69	103	11	%	%	NOUN
njb-69	103	12	)	)	PUNCT
njb-69	103	13	,	,	PUNCT
njb-69	103	14	e.	e.	PROPN
njb-69	103	15	coli	coli	PROPN
njb-69	103	16	16	16	NUM
njb-69	103	17	(	(	PUNCT
njb-69	103	18	23.9	23.9	NUM
njb-69	103	19	%	%	NOUN
njb-69	103	20	)	)	PUNCT
njb-69	103	21	and	and	CCONJ
njb-69	103	22	p.	p.	PROPN
njb-69	103	23	aeruginosa	aeruginosa	PROPN
njb-69	103	24	16	16	NUM
njb-69	103	25	(	(	PUNCT
njb-69	103	26	23.9	23.9	NUM
njb-69	103	27	%	%	NOUN
njb-69	103	28	)	)	PUNCT
njb-69	103	29	.	.	PUNCT
njb-69	104	1	similarly	similarly	ADV
njb-69	104	2	,	,	PUNCT
njb-69	104	3	mbl	mbl	NOUN
njb-69	104	4	production	production	NOUN
njb-69	104	5	was	be	AUX
njb-69	104	6	higher	high	ADJ
njb-69	104	7	among	among	ADP
njb-69	104	8	p.	p.	PROPN
njb-69	104	9	aeruginosa	aeruginosa	PROPN
njb-69	104	10	9	9	NUM
njb-69	104	11	(	(	PUNCT
njb-69	104	12	56.3	56.3	NUM
njb-69	104	13	%	%	NOUN
njb-69	104	14	)	)	PUNCT
njb-69	104	15	and	and	CCONJ
njb-69	104	16	e.	e.	PROPN
njb-69	104	17	coli	coli	PROPN
njb-69	104	18	3	3	NUM
njb-69	104	19	(	(	PUNCT
njb-69	104	20	18.8	18.8	NUM
njb-69	104	21	%	%	NOUN
njb-69	104	22	)	)	PUNCT
njb-69	104	23	(	(	PUNCT
njb-69	104	24	table	table	NOUN
njb-69	104	25	5	5	NUM
njb-69	104	26	)	)	PUNCT
njb-69	104	27	.	.	PUNCT
njb-69	105	1	discussion	discussion	NOUN
njb-69	105	2	rise	rise	NOUN
njb-69	105	3	of	of	ADP
njb-69	105	4	beta	beta	NOUN
njb-69	105	5	-	-	PUNCT
njb-69	105	6	lactamases	lactamase	NOUN
njb-69	105	7	among	among	ADP
njb-69	105	8	pathogens	pathogen	NOUN
njb-69	105	9	has	have	AUX
njb-69	105	10	now	now	ADV
njb-69	105	11	been	be	AUX
njb-69	105	12	a	a	DET
njb-69	105	13	prime	prime	ADJ
njb-69	105	14	threat	threat	NOUN
njb-69	105	15	to	to	ADP
njb-69	105	16	global	global	ADJ
njb-69	105	17	health	health	NOUN
njb-69	105	18	.	.	PUNCT
njb-69	106	1	betalactamase	betalactamase	PROPN
njb-69	106	2	production	production	NOUN
njb-69	106	3	has	have	AUX
njb-69	106	4	been	be	AUX
njb-69	106	5	reported	report	VERB
njb-69	106	6	in	in	ADP
njb-69	106	7	p.	p.	PROPN
njb-69	106	8	aeruginosa	aeruginosa	PROPN
njb-69	106	9	,	,	PUNCT
njb-69	106	10	acinetobacter	acinetobacter	PROPN
njb-69	106	11	spp	spp	PROPN
njb-69	106	12	.	.	PUNCT
njb-69	107	1	and	and	CCONJ
njb-69	107	2	enterobacteriaceae	enterobacteriaceae	PROPN
njb-69	107	3	[	[	X
njb-69	107	4	14	14	NUM
njb-69	107	5	]	]	PUNCT
njb-69	107	6	.	.	PUNCT
njb-69	108	1	the	the	DET
njb-69	108	2	evidence	evidence	NOUN
njb-69	108	3	has	have	AUX
njb-69	108	4	shown	show	VERB
njb-69	108	5	that	that	SCONJ
njb-69	108	6	abr	abr	PROPN
njb-69	108	7	has	have	VERB
njb-69	108	8	a	a	DET
njb-69	108	9	significant	significant	ADJ
njb-69	108	10	adverse	adverse	ADJ
njb-69	108	11	impact	impact	NOUN
njb-69	108	12	on	on	ADP
njb-69	108	13	clinical	clinical	ADJ
njb-69	108	14	outcomes	outcome	NOUN
njb-69	108	15	and	and	CCONJ
njb-69	108	16	increases	increase	VERB
njb-69	108	17	costs	cost	NOUN
njb-69	108	18	due	due	ADP
njb-69	108	19	to	to	ADP
njb-69	108	20	the	the	DET
njb-69	108	21	consumption	consumption	NOUN
njb-69	108	22	of	of	ADP
njb-69	108	23	health	health	NOUN
njb-69	108	24	care	care	NOUN
njb-69	108	25	resources	resource	NOUN
njb-69	109	1	[	[	X
njb-69	109	2	15	15	NUM
njb-69	109	3	]	]	PUNCT
njb-69	109	4	.	.	X
njb-69	110	1	of	of	ADP
njb-69	110	2	229	229	NUM
njb-69	110	3	gram	gram	ADJ
njb-69	110	4	-	-	PUNCT
njb-69	110	5	negative	negative	ADJ
njb-69	110	6	bacteria	bacteria	NOUN
njb-69	110	7	,	,	PUNCT
njb-69	110	8	29.3	29.3	NUM
njb-69	110	9	%	%	NOUN
njb-69	110	10	were	be	AUX
njb-69	110	11	found	find	VERB
njb-69	110	12	esbl	esbl	PROPN
njb-69	110	13	producers	producer	NOUN
njb-69	110	14	.	.	PUNCT
njb-69	111	1	similar	similar	ADJ
njb-69	111	2	results	result	NOUN
njb-69	111	3	were	be	AUX
njb-69	111	4	reported	report	VERB
njb-69	111	5	by	by	ADP
njb-69	111	6	previous	previous	ADJ
njb-69	111	7	studies	study	NOUN
njb-69	111	8	as	as	ADP
njb-69	111	9	25	25	NUM
njb-69	111	10	%	%	NOUN
njb-69	111	11	in	in	ADP
njb-69	111	12	2013	2013	NUM
njb-69	111	13	[	[	PUNCT
njb-69	111	14	16	16	NUM
njb-69	111	15	]	]	PUNCT
njb-69	111	16	,	,	PUNCT
njb-69	111	17	25.8	25.8	NUM
njb-69	111	18	%	%	NOUN
njb-69	111	19	in	in	ADP
njb-69	111	20	2014	2014	NUM
njb-69	111	21	[	[	PUNCT
njb-69	111	22	17	17	NUM
njb-69	111	23	]	]	PUNCT
njb-69	111	24	,	,	PUNCT
njb-69	111	25	24	24	NUM
njb-69	111	26	%	%	NOUN
njb-69	111	27	in	in	ADP
njb-69	111	28	2015	2015	NUM
njb-69	112	1	[	[	PUNCT
njb-69	112	2	18	18	NUM
njb-69	112	3	]	]	PUNCT
njb-69	112	4	,	,	PUNCT
njb-69	112	5	26.9	26.9	NUM
njb-69	112	6	%	%	NOUN
njb-69	112	7	in	in	ADP
njb-69	112	8	2015	2015	NUM
njb-69	112	9	[	[	PUNCT
njb-69	112	10	19	19	NUM
njb-69	112	11	]	]	PUNCT
njb-69	112	12	and	and	CCONJ
njb-69	112	13	34.5	34.5	NUM
njb-69	112	14	%	%	NOUN
njb-69	112	15	in	in	ADP
njb-69	112	16	2017	2017	NUM
njb-69	112	17	[	[	PUNCT
njb-69	112	18	20	20	NUM
njb-69	112	19	]	]	PUNCT
njb-69	112	20	.	.	PUNCT
njb-69	113	1	esbl	esbl	PROPN
njb-69	113	2	producers	producer	NOUN
njb-69	113	3	are	be	AUX
njb-69	113	4	increasingly	increasingly	ADV
njb-69	113	5	disseminating	disseminate	VERB
njb-69	113	6	in	in	ADP
njb-69	113	7	nepal	nepal	ADJ
njb-69	113	8	,	,	PUNCT
njb-69	113	9	0.6	0.6	NUM
njb-69	113	10	%	%	NOUN
njb-69	113	11	in	in	ADP
njb-69	113	12	2006	2006	NUM
njb-69	113	13	to	to	ADP
njb-69	113	14	40	40	NUM
njb-69	113	15	%	%	NOUN
njb-69	113	16	in	in	ADP
njb-69	113	17	2017	2017	NUM
njb-69	113	18	[	[	PUNCT
njb-69	113	19	5	5	NUM
njb-69	113	20	,	,	PUNCT
njb-69	113	21	16	16	NUM
njb-69	113	22	-	-	SYM
njb-69	113	23	22	22	NUM
njb-69	113	24	]	]	PUNCT
njb-69	113	25	.	.	PUNCT
njb-69	114	1	esbl	esbl	PROPN
njb-69	114	2	production	production	NOUN
njb-69	114	3	was	be	AUX
njb-69	114	4	higher	high	ADJ
njb-69	114	5	among	among	ADP
njb-69	114	6	k.	k.	NOUN
njb-69	114	7	pneumoniae	pneumoniae	NOUN
njb-69	114	8	(	(	PUNCT
njb-69	114	9	37.3	37.3	NUM
njb-69	114	10	%	%	NOUN
njb-69	114	11	)	)	PUNCT
njb-69	114	12	,	,	PUNCT
njb-69	114	13	e.	e.	PROPN
njb-69	114	14	coli	coli	PROPN
njb-69	114	15	(	(	PUNCT
njb-69	114	16	23.9	23.9	NUM
njb-69	114	17	%	%	NOUN
njb-69	114	18	)	)	PUNCT
njb-69	114	19	and	and	CCONJ
njb-69	114	20	p.	p.	PROPN
njb-69	114	21	aeruginosa	aeruginosa	PROPN
njb-69	114	22	(	(	PUNCT
njb-69	114	23	23.9	23.9	NUM
njb-69	114	24	%	%	NOUN
njb-69	114	25	)	)	PUNCT
njb-69	114	26	.	.	PUNCT
njb-69	115	1	table	table	NOUN
njb-69	115	2	2	2	NUM
njb-69	115	3	:	:	PUNCT
njb-69	115	4	distribution	distribution	NOUN
njb-69	115	5	of	of	ADP
njb-69	115	6	gram	gram	ADJ
njb-69	115	7	-	-	PUNCT
njb-69	115	8	negative	negative	ADJ
njb-69	115	9	bacteria	bacteria	NOUN
njb-69	115	10	in	in	ADP
njb-69	115	11	different	different	ADJ
njb-69	115	12	clinical	clinical	ADJ
njb-69	115	13	samples	sample	NOUN
njb-69	115	14	bacteria	bacteria	NOUN
njb-69	115	15	sample	sample	VERB
njb-69	115	16	total	total	ADJ
njb-69	115	17	urine	urine	NOUN
njb-69	115	18	blood	blood	NOUN
njb-69	115	19	sputum	sputum	NOUN
njb-69	115	20	body	body	NOUN
njb-69	115	21	fluid	fluid	NOUN
njb-69	115	22	acb	acb	CCONJ
njb-69	115	23	*	*	NUM
njb-69	115	24	2	2	NUM
njb-69	115	25	(	(	PUNCT
njb-69	115	26	1.8	1.8	NUM
njb-69	115	27	%	%	NOUN
njb-69	115	28	)	)	PUNCT
njb-69	115	29	0	0	NUM
njb-69	115	30	(	(	PUNCT
njb-69	115	31	0	0	NUM
njb-69	115	32	%	%	NOUN
njb-69	115	33	)	)	PUNCT
njb-69	115	34	4	4	NUM
njb-69	115	35	(	(	PUNCT
njb-69	115	36	5.5	5.5	NUM
njb-69	115	37	%	%	NOUN
njb-69	115	38	)	)	PUNCT
njb-69	115	39	2	2	NUM
njb-69	115	40	(	(	PUNCT
njb-69	115	41	4.9	4.9	NUM
njb-69	115	42	%	%	NOUN
njb-69	115	43	)	)	PUNCT
njb-69	115	44	8	8	NUM
njb-69	115	45	(	(	PUNCT
njb-69	115	46	3.5	3.5	NUM
njb-69	115	47	%	%	NOUN
njb-69	115	48	)	)	PUNCT
njb-69	115	49	citrobacter	citrobacter	NOUN
njb-69	115	50	spp	spp	PROPN
njb-69	115	51	.	.	PROPN
njb-69	115	52	1	1	NUM
njb-69	115	53	(	(	PUNCT
njb-69	115	54	0.9	0.9	NUM
njb-69	115	55	%	%	NOUN
njb-69	115	56	)	)	PUNCT
njb-69	115	57	0	0	NUM
njb-69	115	58	(	(	PUNCT
njb-69	115	59	0	0	NUM
njb-69	115	60	%	%	NOUN
njb-69	115	61	)	)	PUNCT
njb-69	115	62	0	0	NUM
njb-69	116	1	(	(	PUNCT
njb-69	116	2	0.0	0.0	NUM
njb-69	116	3	%	%	NOUN
njb-69	116	4	)	)	PUNCT
njb-69	116	5	0	0	NUM
njb-69	117	1	(	(	PUNCT
njb-69	117	2	0.0	0.0	NUM
njb-69	117	3	%	%	NOUN
njb-69	117	4	)	)	PUNCT
njb-69	117	5	1	1	NUM
njb-69	117	6	(	(	PUNCT
njb-69	117	7	0.4	0.4	NUM
njb-69	117	8	%	%	NOUN
njb-69	117	9	)	)	PUNCT
njb-69	117	10	e.	e.	PROPN
njb-69	117	11	coli	coli	PROPN
njb-69	117	12	61	61	NUM
njb-69	117	13	(	(	PUNCT
njb-69	117	14	55.0	55.0	NUM
njb-69	117	15	%	%	NOUN
njb-69	117	16	)	)	PUNCT
njb-69	117	17	0	0	NUM
njb-69	117	18	(	(	PUNCT
njb-69	117	19	0	0	NUM
njb-69	117	20	%	%	NOUN
njb-69	117	21	)	)	PUNCT
njb-69	117	22	9	9	NUM
njb-69	117	23	(	(	PUNCT
njb-69	117	24	12.3	12.3	NUM
njb-69	117	25	%	%	NOUN
njb-69	117	26	)	)	PUNCT
njb-69	117	27	8	8	NUM
njb-69	117	28	(	(	PUNCT
njb-69	117	29	19.5	19.5	NUM
njb-69	117	30	%	%	NOUN
njb-69	117	31	)	)	PUNCT
njb-69	117	32	78	78	NUM
njb-69	117	33	(	(	PUNCT
njb-69	117	34	34.1	34.1	NUM
njb-69	117	35	%	%	NOUN
njb-69	117	36	)	)	PUNCT
njb-69	117	37	k.	k.	NOUN
njb-69	117	38	pneumoniae	pneumoniae	NOUN
njb-69	117	39	16	16	NUM
njb-69	117	40	(	(	PUNCT
njb-69	117	41	14.4	14.4	NUM
njb-69	117	42	%	%	NOUN
njb-69	117	43	)	)	PUNCT
njb-69	117	44	0	0	NUM
njb-69	117	45	(	(	PUNCT
njb-69	117	46	0	0	NUM
njb-69	117	47	%	%	NOUN
njb-69	117	48	)	)	PUNCT
njb-69	117	49	33	33	NUM
njb-69	117	50	(	(	PUNCT
njb-69	117	51	45.2	45.2	NUM
njb-69	117	52	%	%	NOUN
njb-69	117	53	)	)	PUNCT
njb-69	117	54	22	22	NUM
njb-69	117	55	(	(	PUNCT
njb-69	117	56	53.7	53.7	NUM
njb-69	117	57	%	%	NOUN
njb-69	117	58	)	)	PUNCT
njb-69	117	59	71	71	NUM
njb-69	117	60	(	(	PUNCT
njb-69	117	61	31.0	31.0	NUM
njb-69	117	62	%	%	NOUN
njb-69	117	63	)	)	PUNCT
njb-69	117	64	k.	k.	PROPN
njb-69	117	65	oxytoca	oxytoca	PROPN
njb-69	117	66	15	15	NUM
njb-69	117	67	(	(	PUNCT
njb-69	117	68	13.5	13.5	NUM
njb-69	117	69	%	%	NOUN
njb-69	117	70	)	)	PUNCT
njb-69	117	71	0	0	NUM
njb-69	117	72	(	(	PUNCT
njb-69	117	73	0	0	NUM
njb-69	117	74	%	%	NOUN
njb-69	117	75	)	)	PUNCT
njb-69	117	76	6	6	NUM
njb-69	117	77	(	(	PUNCT
njb-69	117	78	8.2	8.2	NUM
njb-69	117	79	%	%	NOUN
njb-69	117	80	)	)	PUNCT
njb-69	117	81	1	1	NUM
njb-69	117	82	(	(	PUNCT
njb-69	117	83	2.4	2.4	NUM
njb-69	117	84	%	%	NOUN
njb-69	117	85	)	)	PUNCT
njb-69	117	86	22	22	NUM
njb-69	117	87	(	(	PUNCT
njb-69	117	88	9.6	9.6	NUM
njb-69	117	89	%	%	NOUN
njb-69	117	90	)	)	PUNCT
njb-69	118	1	p.	p.	PROPN
njb-69	118	2	aeruginosa	aeruginosa	PROPN
njb-69	118	3	12	12	NUM
njb-69	118	4	(	(	PUNCT
njb-69	118	5	10.8	10.8	NUM
njb-69	118	6	%	%	NOUN
njb-69	118	7	)	)	PUNCT
njb-69	118	8	2	2	NUM
njb-69	118	9	(	(	PUNCT
njb-69	118	10	50	50	NUM
njb-69	118	11	%	%	NOUN
njb-69	118	12	)	)	PUNCT
njb-69	118	13	20	20	NUM
njb-69	118	14	(	(	PUNCT
njb-69	118	15	27.4	27.4	NUM
njb-69	118	16	%	%	NOUN
njb-69	118	17	)	)	PUNCT
njb-69	118	18	7	7	NUM
njb-69	118	19	(	(	PUNCT
njb-69	118	20	17.1	17.1	NUM
njb-69	118	21	%	%	NOUN
njb-69	118	22	)	)	PUNCT
njb-69	118	23	41	41	NUM
njb-69	118	24	(	(	PUNCT
njb-69	118	25	17.9	17.9	NUM
njb-69	118	26	%	%	NOUN
njb-69	118	27	)	)	PUNCT
njb-69	118	28	proteus	proteus	NOUN
njb-69	118	29	spp	spp	PROPN
njb-69	118	30	.	.	PROPN
njb-69	118	31	4	4	NUM
njb-69	118	32	(	(	PUNCT
njb-69	118	33	3.6	3.6	NUM
njb-69	118	34	%	%	NOUN
njb-69	118	35	)	)	PUNCT
njb-69	118	36	0	0	NUM
njb-69	118	37	(	(	PUNCT
njb-69	118	38	0	0	NUM
njb-69	118	39	%	%	NOUN
njb-69	118	40	)	)	PUNCT
njb-69	118	41	1	1	NUM
njb-69	118	42	(	(	PUNCT
njb-69	118	43	1.4	1.4	NUM
njb-69	118	44	%	%	NOUN
njb-69	118	45	)	)	PUNCT
njb-69	118	46	1	1	NUM
njb-69	118	47	(	(	PUNCT
njb-69	118	48	2.4	2.4	NUM
njb-69	118	49	%	%	NOUN
njb-69	118	50	)	)	PUNCT
njb-69	118	51	6	6	NUM
njb-69	118	52	(	(	PUNCT
njb-69	118	53	2.6	2.6	NUM
njb-69	118	54	%	%	NOUN
njb-69	118	55	)	)	PUNCT
njb-69	118	56	salmonella	salmonella	NOUN
njb-69	118	57	spp	spp	PROPN
njb-69	118	58	.	.	PROPN
njb-69	118	59	0	0	PUNCT
njb-69	119	1	(	(	PUNCT
njb-69	119	2	0.0	0.0	NUM
njb-69	119	3	%	%	NOUN
njb-69	119	4	)	)	PUNCT
njb-69	119	5	2	2	NUM
njb-69	119	6	(	(	PUNCT
njb-69	119	7	50	50	NUM
njb-69	119	8	%	%	NOUN
njb-69	119	9	)	)	PUNCT
njb-69	119	10	0	0	NUM
njb-69	120	1	(	(	PUNCT
njb-69	120	2	0.0	0.0	NUM
njb-69	120	3	%	%	NOUN
njb-69	120	4	)	)	PUNCT
njb-69	120	5	0	0	NUM
njb-69	121	1	(	(	PUNCT
njb-69	121	2	0.0	0.0	NUM
njb-69	121	3	%	%	NOUN
njb-69	121	4	)	)	PUNCT
njb-69	121	5	2	2	NUM
njb-69	121	6	(	(	PUNCT
njb-69	121	7	0.9	0.9	NUM
njb-69	121	8	%	%	NOUN
njb-69	121	9	)	)	PUNCT
njb-69	121	10	total	total	ADJ
njb-69	121	11	111	111	NUM
njb-69	121	12	(	(	PUNCT
njb-69	121	13	100	100	NUM
njb-69	121	14	%	%	NOUN
njb-69	121	15	)	)	PUNCT
njb-69	121	16	4	4	NUM
njb-69	121	17	(	(	PUNCT
njb-69	121	18	100	100	NUM
njb-69	121	19	%	%	NOUN
njb-69	121	20	)	)	PUNCT
njb-69	121	21	73	73	NUM
njb-69	121	22	(	(	PUNCT
njb-69	121	23	100	100	NUM
njb-69	121	24	%	%	NOUN
njb-69	121	25	)	)	PUNCT
njb-69	121	26	41	41	NUM
njb-69	121	27	(	(	PUNCT
njb-69	121	28	100	100	NUM
njb-69	121	29	%	%	NOUN
njb-69	121	30	)	)	PUNCT
njb-69	121	31	229(100	229(100	NUM
njb-69	121	32	%	%	NOUN
njb-69	121	33	)	)	PUNCT
njb-69	121	34	*	*	PUNCT
njb-69	121	35	acinetobacter	acinetobacter	ADJ
njb-69	121	36	calcoaceticus	calcoaceticus	ADJ
njb-69	121	37	-	-	PUNCT
njb-69	121	38	baumannii	baumannii	ADJ
njb-69	121	39	complex	complex	ADJ
njb-69	121	40	nepal	nepal	ADJ
njb-69	121	41	journal	journal	NOUN
njb-69	121	42	of	of	ADP
njb-69	121	43	biotechnology	biotechnology	NOUN
njb-69	121	44	.	.	PUNCT
njb-69	122	1	d	d	X
njb-69	122	2	e	e	PROPN
njb-69	122	3	c	c	PROPN
njb-69	122	4	.	.	PUNCT
njb-69	123	1	2	2	NUM
njb-69	123	2	0	0	NUM
njb-69	123	3	1	1	NUM
njb-69	123	4	9	9	NUM
njb-69	123	5	vol	vol	NOUN
njb-69	123	6	.	.	PUNCT
njb-69	124	1	7	7	NUM
njb-69	124	2	,	,	PUNCT
njb-69	124	3	no	no	NOUN
njb-69	124	4	.	.	NOUN
njb-69	124	5	1	1	NUM
njb-69	124	6	:	:	SYM
njb-69	124	7	74	74	NUM
njb-69	124	8	-	-	SYM
njb-69	124	9	81	81	NUM
njb-69	124	10	maharjan	maharjan	NOUN
njb-69	124	11	et	et	PROPN
njb-69	124	12	al	al	PROPN
njb-69	124	13	.	.	PROPN
njb-69	125	1	2019	2019	NUM
njb-69	126	1	©	©	ADP
njb-69	126	2	njb	njb	PROPN
njb-69	126	3	,	,	PUNCT
njb-69	126	4	biotechnology	biotechnology	NOUN
njb-69	126	5	society	society	NOUN
njb-69	126	6	of	of	ADP
njb-69	126	7	nepal	nepal	ADJ
njb-69	126	8	78	78	NUM
njb-69	126	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	126	10	.	.	PUNCT
njb-69	127	1	similar	similar	ADJ
njb-69	127	2	results	result	NOUN
njb-69	127	3	were	be	AUX
njb-69	127	4	reported	report	VERB
njb-69	127	5	in	in	ADP
njb-69	127	6	e.	e.	PROPN
njb-69	127	7	coli	coli	PROPN
njb-69	127	8	as	as	ADP
njb-69	127	9	25.8	25.8	NUM
njb-69	127	10	%	%	NOUN
njb-69	127	11	by	by	ADP
njb-69	127	12	pokhrel	pokhrel	PROPN
njb-69	127	13	et	et	PROPN
njb-69	127	14	al	al	PROPN
njb-69	127	15	in	in	ADP
njb-69	127	16	2014	2014	NUM
njb-69	128	1	[	[	PUNCT
njb-69	128	2	17	17	NUM
njb-69	128	3	]	]	PUNCT
njb-69	128	4	,	,	PUNCT
njb-69	128	5	22.4	22.4	NUM
njb-69	128	6	%	%	NOUN
njb-69	128	7	by	by	ADP
njb-69	128	8	raut	raut	PROPN
njb-69	128	9	et	et	PROPN
njb-69	128	10	al	al	PROPN
njb-69	128	11	in	in	ADP
njb-69	128	12	2015	2015	NUM
njb-69	129	1	[	[	PUNCT
njb-69	129	2	23	23	NUM
njb-69	129	3	]	]	PUNCT
njb-69	129	4	,	,	PUNCT
njb-69	129	5	26.9	26.9	NUM
njb-69	129	6	%	%	NOUN
njb-69	129	7	yadav	yadav	NOUN
njb-69	129	8	et	et	PROPN
njb-69	129	9	al	al	PROPN
njb-69	129	10	in	in	ADP
njb-69	129	11	2015	2015	NUM
njb-69	130	1	[	[	PUNCT
njb-69	130	2	19	19	NUM
njb-69	130	3	]	]	PUNCT
njb-69	130	4	.	.	PUNCT
njb-69	131	1	similarly	similarly	ADV
njb-69	131	2	,	,	PUNCT
njb-69	131	3	comparable	comparable	ADJ
njb-69	131	4	results	result	NOUN
njb-69	131	5	were	be	AUX
njb-69	131	6	reported	report	VERB
njb-69	131	7	in	in	ADP
njb-69	131	8	k.	k.	NOUN
njb-69	131	9	pneumoniae	pneumoniae	NOUN
njb-69	131	10	as	as	ADP
njb-69	131	11	22.4	22.4	NUM
njb-69	131	12	%	%	NOUN
njb-69	131	13	by	by	ADP
njb-69	131	14	raut	raut	PROPN
njb-69	131	15	et	et	PROPN
njb-69	131	16	al	al	PROPN
njb-69	131	17	in	in	ADP
njb-69	131	18	2015	2015	NUM
njb-69	132	1	[	[	PUNCT
njb-69	132	2	23	23	NUM
njb-69	132	3	]	]	PUNCT
njb-69	132	4	and	and	CCONJ
njb-69	132	5	43.3	43.3	NUM
njb-69	132	6	%	%	NOUN
njb-69	132	7	nepal	nepal	NOUN
njb-69	132	8	et	et	PROPN
njb-69	132	9	al	al	PROPN
njb-69	132	10	in	in	ADP
njb-69	132	11	2017	2017	NUM
njb-69	132	12	[	[	PUNCT
njb-69	132	13	22	22	NUM
njb-69	132	14	]	]	PUNCT
njb-69	132	15	.	.	PUNCT
njb-69	133	1	esbl	esbl	PROPN
njb-69	133	2	production	production	NOUN
njb-69	133	3	was	be	AUX
njb-69	133	4	higher	high	ADJ
njb-69	133	5	among	among	ADP
njb-69	133	6	sputum	sputum	NOUN
njb-69	133	7	isolates	isolate	VERB
njb-69	133	8	i.e.	i.e.	X
njb-69	133	9	35	35	NUM
njb-69	133	10	(	(	PUNCT
njb-69	133	11	52.2	52.2	NUM
njb-69	133	12	%	%	NOUN
njb-69	133	13	)	)	PUNCT
njb-69	133	14	.	.	PUNCT
njb-69	134	1	of	of	ADP
njb-69	134	2	229	229	NUM
njb-69	134	3	gram	gram	ADJ
njb-69	134	4	-	-	PUNCT
njb-69	134	5	negative	negative	ADJ
njb-69	134	6	bacteria	bacteria	NOUN
njb-69	134	7	,	,	PUNCT
njb-69	134	8	7	7	NUM
njb-69	134	9	%	%	NOUN
njb-69	134	10	were	be	AUX
njb-69	134	11	found	find	VERB
njb-69	134	12	mbl	mbl	NOUN
njb-69	134	13	producers	producer	NOUN
njb-69	134	14	.	.	PUNCT
njb-69	135	1	similar	similar	ADJ
njb-69	135	2	results	result	NOUN
njb-69	135	3	were	be	AUX
njb-69	135	4	reported	report	VERB
njb-69	135	5	by	by	ADP
njb-69	135	6	previous	previous	ADJ
njb-69	135	7	studies	study	NOUN
njb-69	135	8	as	as	ADP
njb-69	135	9	7.1	7.1	NUM
njb-69	135	10	%	%	NOUN
njb-69	135	11	khanal	khanal	NOUN
njb-69	135	12	et	et	PROPN
njb-69	135	13	al	al	PROPN
njb-69	135	14	in	in	ADP
njb-69	135	15	2013	2013	NUM
njb-69	136	1	[	[	PUNCT
njb-69	136	2	16	16	NUM
njb-69	136	3	]	]	PUNCT
njb-69	136	4	,	,	PUNCT
njb-69	136	5	3.2	3.2	NUM
njb-69	136	6	%	%	NOUN
njb-69	136	7	pokhrel	pokhrel	NOUN
njb-69	136	8	et	et	PROPN
njb-69	136	9	al	al	PROPN
njb-69	136	10	in	in	ADP
njb-69	136	11	2014	2014	NUM
njb-69	136	12	[	[	PUNCT
njb-69	136	13	17	17	NUM
njb-69	136	14	]	]	PUNCT
njb-69	136	15	and	and	CCONJ
njb-69	136	16	4	4	NUM
njb-69	136	17	%	%	NOUN
njb-69	136	18	nepal	nepal	NOUN
njb-69	136	19	et	et	NOUN
njb-69	136	20	al	al	PROPN
njb-69	136	21	in	in	ADP
njb-69	136	22	2017	2017	NUM
njb-69	137	1	[	[	PUNCT
njb-69	137	2	20	20	NUM
njb-69	137	3	]	]	PUNCT
njb-69	137	4	.	.	PUNCT
njb-69	138	1	but	but	CCONJ
njb-69	138	2	a	a	DET
njb-69	138	3	lower	low	ADJ
njb-69	138	4	rate	rate	NOUN
njb-69	138	5	of	of	ADP
njb-69	138	6	1.3	1.3	NUM
njb-69	138	7	%	%	NOUN
njb-69	138	8	was	be	AUX
njb-69	138	9	reported	report	VERB
njb-69	138	10	by	by	ADP
njb-69	138	11	mishra	mishra	PROPN
njb-69	138	12	et	et	PROPN
njb-69	138	13	al	al	PROPN
njb-69	138	14	in	in	ADP
njb-69	138	15	2012	2012	NUM
njb-69	139	1	[	[	PUNCT
njb-69	139	2	12	12	NUM
njb-69	139	3	]	]	PUNCT
njb-69	139	4	and	and	CCONJ
njb-69	139	5	a	a	DET
njb-69	139	6	higher	high	ADJ
njb-69	139	7	rate	rate	NOUN
njb-69	139	8	of	of	ADP
njb-69	139	9	15	15	NUM
njb-69	139	10	%	%	NOUN
njb-69	139	11	was	be	AUX
njb-69	139	12	reported	report	VERB
njb-69	139	13	ansari	ansari	PROPN
njb-69	139	14	et	et	PROPN
njb-69	139	15	al	al	PROPN
njb-69	139	16	in	in	ADP
njb-69	139	17	2015	2015	NUM
njb-69	140	1	[	[	PUNCT
njb-69	140	2	18	18	NUM
njb-69	140	3	]	]	PUNCT
njb-69	140	4	.	.	PUNCT
njb-69	141	1	mbl	mbl	PROPN
njb-69	141	2	producers	producer	NOUN
njb-69	141	3	are	be	AUX
njb-69	141	4	increasingly	increasingly	ADV
njb-69	141	5	disseminating	disseminate	VERB
njb-69	141	6	in	in	ADP
njb-69	141	7	nepal	nepal	ADJ
njb-69	141	8	[	[	ADP
njb-69	141	9	12	12	NUM
njb-69	141	10	,	,	PUNCT
njb-69	141	11	16	16	NUM
njb-69	141	12	-	-	SYM
njb-69	141	13	18	18	NUM
njb-69	141	14	,	,	PUNCT
njb-69	141	15	20	20	NUM
njb-69	141	16	]	]	PUNCT
njb-69	141	17	.	.	PUNCT
njb-69	142	1	mbl	mbl	NOUN
njb-69	142	2	production	production	NOUN
njb-69	142	3	was	be	AUX
njb-69	142	4	higher	high	ADJ
njb-69	142	5	among	among	ADP
njb-69	142	6	p.	p.	PROPN
njb-69	142	7	aeruginosa	aeruginosa	PROPN
njb-69	142	8	isolates	isolate	NOUN
njb-69	142	9	,	,	PUNCT
njb-69	142	10	56.3	56.3	NUM
njb-69	142	11	%	%	NOUN
njb-69	142	12	.	.	PUNCT
njb-69	143	1	besides	besides	SCONJ
njb-69	143	2	p.	p.	PROPN
njb-69	143	3	aeruginosa	aeruginosa	PROPN
njb-69	143	4	and	and	CCONJ
njb-69	143	5	acinetobacter	acinetobacter	ADJ
njb-69	143	6	spp	spp	PROPN
njb-69	143	7	.	.	PROPN
njb-69	143	8	,	,	PUNCT
njb-69	143	9	mbl	mbl	NOUN
njb-69	143	10	production	production	NOUN
njb-69	143	11	was	be	AUX
njb-69	143	12	also	also	ADV
njb-69	143	13	found	find	VERB
njb-69	143	14	in	in	ADP
njb-69	143	15	e.	e.	PROPN
njb-69	143	16	coli	coli	PROPN
njb-69	143	17	and	and	CCONJ
njb-69	143	18	k.	k.	NOUN
njb-69	143	19	pneumoniae	pneumoniae	NOUN
njb-69	143	20	as	as	ADV
njb-69	143	21	well	well	ADV
njb-69	143	22	.	.	PUNCT
njb-69	144	1	mbl	mbl	PROPN
njb-69	144	2	in	in	ADP
njb-69	144	3	enterobacteriaceae	enterobacteriaceae	PROPN
njb-69	144	4	was	be	AUX
njb-69	144	5	reported	report	VERB
njb-69	144	6	by	by	ADP
njb-69	144	7	similar	similar	ADJ
njb-69	144	8	studies	study	NOUN
njb-69	144	9	reported	report	VERB
njb-69	144	10	[	[	X
njb-69	144	11	16	16	NUM
njb-69	144	12	-	-	SYM
njb-69	144	13	18	18	NUM
njb-69	144	14	,	,	PUNCT
njb-69	144	15	20	20	NUM
njb-69	144	16	]	]	PUNCT
njb-69	144	17	.	.	PUNCT
njb-69	145	1	however	however	ADV
njb-69	145	2	,	,	PUNCT
njb-69	145	3	this	this	DET
njb-69	145	4	contrast	contrast	NOUN
njb-69	145	5	with	with	ADP
njb-69	145	6	the	the	DET
njb-69	145	7	result	result	NOUN
njb-69	145	8	of	of	ADP
njb-69	145	9	similar	similar	ADJ
njb-69	145	10	previous	previous	ADJ
njb-69	145	11	studies	study	NOUN
njb-69	145	12	[	[	X
njb-69	145	13	12	12	NUM
njb-69	145	14	]	]	PUNCT
njb-69	145	15	which	which	PRON
njb-69	145	16	reported	report	VERB
njb-69	145	17	mbl	mbl	NOUN
njb-69	145	18	production	production	NOUN
njb-69	145	19	only	only	ADV
njb-69	145	20	in	in	ADP
njb-69	145	21	p.	p.	PROPN
njb-69	145	22	aeruginosa	aeruginosa	PROPN
njb-69	145	23	and	and	CCONJ
njb-69	145	24	acinetobacter	acinetobacter	PROPN
njb-69	145	25	spp	spp	PROPN
njb-69	145	26	.	.	PUNCT
njb-69	146	1	mbl	mbl	PROPN
njb-69	146	2	production	production	NOUN
njb-69	146	3	was	be	AUX
njb-69	146	4	higher	high	ADJ
njb-69	146	5	among	among	ADP
njb-69	146	6	urine	urine	NOUN
njb-69	146	7	isolates	isolate	VERB
njb-69	146	8	i.e.	i.e.	ADV
njb-69	146	9	50	50	NUM
njb-69	146	10	%	%	NOUN
njb-69	146	11	of	of	ADP
njb-69	146	12	total	total	ADJ
njb-69	146	13	mbl	mbl	NOUN
njb-69	146	14	producers	producer	NOUN
njb-69	146	15	.	.	PUNCT
njb-69	147	1	genotypic	genotypic	NOUN
njb-69	147	2	methods	method	NOUN
njb-69	147	3	are	be	AUX
njb-69	147	4	considered	consider	VERB
njb-69	147	5	superior	superior	ADJ
njb-69	147	6	tools	tool	NOUN
njb-69	147	7	for	for	ADP
njb-69	147	8	surveillance	surveillance	NOUN
njb-69	147	9	of	of	ADP
njb-69	147	10	such	such	ADJ
njb-69	147	11	esbl	esbl	NOUN
njb-69	147	12	and	and	CCONJ
njb-69	147	13	mbl	mbl	NOUN
njb-69	147	14	producers	producer	NOUN
njb-69	147	15	.	.	PUNCT
njb-69	148	1	but	but	CCONJ
njb-69	148	2	the	the	DET
njb-69	148	3	evolution	evolution	NOUN
njb-69	148	4	of	of	ADP
njb-69	148	5	newer	new	ADJ
njb-69	148	6	betatable	betatable	ADJ
njb-69	148	7	3	3	NUM
njb-69	148	8	:	:	PUNCT
njb-69	148	9	antibiotic	antibiotic	ADJ
njb-69	148	10	susceptibility	susceptibility	NOUN
njb-69	148	11	of	of	ADP
njb-69	148	12	gram	gram	ADJ
njb-69	148	13	-	-	PUNCT
njb-69	148	14	negative	negative	ADJ
njb-69	148	15	bacteria	bacteria	NOUN
njb-69	148	16	antibiotics	antibiotic	NOUN
njb-69	148	17	e.	e.	PROPN
njb-69	148	18	coli	coli	PROPN
njb-69	148	19	(	(	PUNCT
njb-69	148	20	n=78	n=78	PROPN
njb-69	148	21	)	)	PUNCT
njb-69	148	22	(	(	PUNCT
njb-69	148	23	%	%	INTJ
njb-69	148	24	)	)	PUNCT
njb-69	148	25	p.	p.	PROPN
njb-69	148	26	aeruginosa	aeruginosa	PROPN
njb-69	148	27	(	(	PUNCT
njb-69	148	28	n=41	n=41	PROPN
njb-69	148	29	)	)	PUNCT
njb-69	148	30	(	(	PUNCT
njb-69	148	31	%	%	INTJ
njb-69	148	32	)	)	PUNCT
njb-69	148	33	other	other	ADJ
njb-69	148	34	gnb	gnb	ADJ
njb-69	148	35	(	(	PUNCT
njb-69	148	36	n=110	n=110	PROPN
njb-69	148	37	)	)	PUNCT
njb-69	149	1	(	(	PUNCT
njb-69	149	2	%	%	INTJ
njb-69	149	3	)	)	PUNCT
njb-69	149	4	s	s	VERB
njb-69	149	5	i	i	PRON
njb-69	150	1	r	r	NOUN
njb-69	151	1	s	s	NOUN
njb-69	152	1	i	i	PRON
njb-69	153	1	r	r	NOUN
njb-69	154	1	s	s	NOUN
njb-69	154	2	i	i	PRON
njb-69	154	3	r	r	NOUN
njb-69	154	4	amikacin	amikacin	PROPN
njb-69	154	5	30.8	30.8	NUM
njb-69	154	6	14.1	14.1	NUM
njb-69	154	7	55.1	55.1	NUM
njb-69	154	8	58.5	58.5	NUM
njb-69	154	9	17.1	17.1	NUM
njb-69	154	10	24.4	24.4	NUM
njb-69	154	11	39.1	39.1	NUM
njb-69	154	12	11.8	11.8	NUM
njb-69	154	13	49.1	49.1	NUM
njb-69	154	14	ampicillin	ampicillin	NOUN
njb-69	154	15	5.1	5.1	NUM
njb-69	154	16	0.0	0.0	NUM
njb-69	154	17	94.9	94.9	NUM
njb-69	154	18	12.2	12.2	NUM
njb-69	155	1	0.0	0.0	NUM
njb-69	155	2	87.8	87.8	NUM
njb-69	155	3	4.5	4.5	NUM
njb-69	155	4	0.9	0.9	NUM
njb-69	155	5	94.5	94.5	NUM
njb-69	155	6	aztreonam	aztreonam	NOUN
njb-69	155	7	10.3	10.3	NUM
njb-69	155	8	15.4	15.4	NUM
njb-69	155	9	74.4	74.4	NUM
njb-69	155	10	34.1	34.1	NUM
njb-69	155	11	19.5	19.5	NUM
njb-69	155	12	46.3	46.3	NUM
njb-69	155	13	20.0	20.0	NUM
njb-69	155	14	10.0	10.0	NUM
njb-69	155	15	70.0	70.0	NUM
njb-69	155	16	ceftriaxone	ceftriaxone	NOUN
njb-69	155	17	5.1	5.1	NUM
njb-69	155	18	2.6	2.6	NUM
njb-69	155	19	92.3	92.3	NUM
njb-69	155	20	19.5	19.5	NUM
njb-69	155	21	0.0	0.0	NUM
njb-69	155	22	80.5	80.5	NUM
njb-69	155	23	5.5	5.5	NUM
njb-69	155	24	0.9	0.9	NUM
njb-69	155	25	93.6	93.6	NUM
njb-69	155	26	cefixime	cefixime	NOUN
njb-69	155	27	2.6	2.6	NUM
njb-69	155	28	5.1	5.1	NUM
njb-69	155	29	92.3	92.3	NUM
njb-69	155	30	2.4	2.4	NUM
njb-69	155	31	0.0	0.0	NUM
njb-69	155	32	97.6	97.6	NUM
njb-69	155	33	8.2	8.2	NUM
njb-69	155	34	0.0	0.0	NUM
njb-69	155	35	91.8	91.8	NUM
njb-69	155	36	cefotaxime	cefotaxime	NOUN
njb-69	155	37	3.8	3.8	NUM
njb-69	155	38	7.7	7.7	NUM
njb-69	155	39	88.5	88.5	NUM
njb-69	155	40	17.1	17.1	NUM
njb-69	155	41	2.4	2.4	NUM
njb-69	155	42	80.5	80.5	NUM
njb-69	155	43	10.0	10.0	NUM
njb-69	155	44	0.9	0.9	NUM
njb-69	155	45	89.1	89.1	NUM
njb-69	155	46	cefpodoxime	cefpodoxime	NOUN
njb-69	155	47	5.1	5.1	NUM
njb-69	155	48	0.0	0.0	NUM
njb-69	155	49	94.9	94.9	NUM
njb-69	155	50	12.2	12.2	NUM
njb-69	155	51	0.0	0.0	NUM
njb-69	155	52	87.8	87.8	NUM
njb-69	155	53	5.5	5.5	NUM
njb-69	155	54	0.0	0.0	NUM
njb-69	155	55	94.5	94.5	NUM
njb-69	155	56	ceftazidime	ceftazidime	NOUN
njb-69	155	57	9.0	9.0	NUM
njb-69	155	58	2.6	2.6	NUM
njb-69	155	59	88.5	88.5	NUM
njb-69	155	60	17.1	17.1	NUM
njb-69	155	61	4.9	4.9	NUM
njb-69	155	62	78.0	78.0	NUM
njb-69	155	63	10.0	10.0	NUM
njb-69	155	64	0.9	0.9	NUM
njb-69	155	65	89.1	89.1	NUM
njb-69	155	66	ciprofloxacin	ciprofloxacin	NOUN
njb-69	155	67	14.1	14.1	NUM
njb-69	155	68	1.3	1.3	NUM
njb-69	155	69	84.6	84.6	NUM
njb-69	155	70	19.5	19.5	NUM
njb-69	155	71	2.4	2.4	NUM
njb-69	155	72	78.0	78.0	NUM
njb-69	155	73	11.8	11.8	NUM
njb-69	155	74	0.0	0.0	NUM
njb-69	155	75	88.2	88.2	NUM
njb-69	155	76	chloramphenicol	chloramphenicol	NOUN
njb-69	155	77	38.5	38.5	NUM
njb-69	155	78	9.0	9.0	NUM
njb-69	155	79	52.6	52.6	NUM
njb-69	155	80	58.5	58.5	NUM
njb-69	155	81	17.1	17.1	NUM
njb-69	155	82	24.4	24.4	NUM
njb-69	155	83	30.9	30.9	NUM
njb-69	155	84	18.2	18.2	NUM
njb-69	155	85	50.9	50.9	NUM
njb-69	155	86	co	co	NOUN
njb-69	155	87	-	-	NOUN
njb-69	155	88	trimoxazole	trimoxazole	NOUN
njb-69	155	89	11.5	11.5	NUM
njb-69	155	90	2.6	2.6	NUM
njb-69	155	91	85.9	85.9	NUM
njb-69	155	92	14.6	14.6	NUM
njb-69	155	93	0.0	0.0	NUM
njb-69	155	94	85.4	85.4	NUM
njb-69	155	95	11.8	11.8	NUM
njb-69	155	96	2.7	2.7	NUM
njb-69	155	97	85.5	85.5	NUM
njb-69	155	98	gentamicin	gentamicin	VERB
njb-69	155	99	21.8	21.8	NUM
njb-69	155	100	5.1	5.1	NUM
njb-69	155	101	73.1	73.1	NUM
njb-69	155	102	41.5	41.5	NUM
njb-69	155	103	4.9	4.9	NUM
njb-69	155	104	53.7	53.7	NUM
njb-69	155	105	20.9	20.9	NUM
njb-69	155	106	2.7	2.7	NUM
njb-69	155	107	76.4	76.4	NUM
njb-69	155	108	imipenem	imipenem	PROPN
njb-69	155	109	39.7	39.7	NUM
njb-69	155	110	15.4	15.4	NUM
njb-69	155	111	44.9	44.9	NUM
njb-69	155	112	78.0	78.0	NUM
njb-69	155	113	0.0	0.0	NUM
njb-69	155	114	22.0	22.0	NUM
njb-69	155	115	56.4	56.4	NUM
njb-69	155	116	4.5	4.5	NUM
njb-69	155	117	39.1	39.1	NUM
njb-69	155	118	nitrofurantoin	nitrofurantoin	NOUN
njb-69	155	119	18.0	18.0	NUM
njb-69	155	120	4.9	4.9	NUM
njb-69	155	121	77.1	77.1	NUM
njb-69	156	1	nt	not	PART
njb-69	156	2	nt	not	PART
njb-69	156	3	nt	not	PART
njb-69	156	4	nt	not	PART
njb-69	156	5	nt	not	PART
njb-69	156	6	nt	not	PART
njb-69	156	7	norfloxacin	norfloxacin	VERB
njb-69	156	8	12.8	12.8	NUM
njb-69	156	9	1.3	1.3	NUM
njb-69	156	10	85.9	85.9	NUM
njb-69	156	11	9.8	9.8	NUM
njb-69	156	12	4.9	4.9	NUM
njb-69	156	13	85.4	85.4	NUM
njb-69	156	14	13.6	13.6	NUM
njb-69	156	15	0.0	0.0	NUM
njb-69	156	16	86.4	86.4	NUM
njb-69	156	17	piperacillin/	piperacillin/	NOUN
njb-69	156	18	tazobactam	tazobactam	NOUN
njb-69	156	19	nt	not	PART
njb-69	156	20	nt	not	PART
njb-69	156	21	nt	not	PART
njb-69	156	22	63.4	63.4	NUM
njb-69	156	23	9.8	9.8	NUM
njb-69	156	24	26.8	26.8	NUM
njb-69	156	25	nt	not	PART
njb-69	156	26	nt	not	PART
njb-69	156	27	nt	not	PART
njb-69	156	28	*	*	PUNCT
njb-69	156	29	gnb	gnb	ADJ
njb-69	156	30	=	=	VERB
njb-69	156	31	gram	gram	ADJ
njb-69	156	32	-	-	PUNCT
njb-69	156	33	negative	negative	ADJ
njb-69	156	34	bacteria	bacteria	NOUN
njb-69	156	35	,	,	PUNCT
njb-69	156	36	s	s	NOUN
njb-69	156	37	=	=	NOUN
njb-69	156	38	sensitive	sensitive	ADJ
njb-69	156	39	,	,	PUNCT
njb-69	156	40	i	i	PRON
njb-69	156	41	=	=	NOUN
njb-69	156	42	intermediate	intermediate	ADJ
njb-69	156	43	,	,	PUNCT
njb-69	156	44	r	r	NOUN
njb-69	156	45	=	=	NOUN
njb-69	156	46	resistance	resistance	NOUN
njb-69	156	47	,	,	PUNCT
njb-69	156	48	nt	not	PART
njb-69	156	49	=	=	PROPN
njb-69	156	50	not	not	PART
njb-69	156	51	tested	test	VERB
njb-69	156	52	nepal	nepal	ADJ
njb-69	156	53	journal	journal	NOUN
njb-69	156	54	of	of	ADP
njb-69	156	55	biotechnology	biotechnology	NOUN
njb-69	156	56	.	.	PUNCT
njb-69	157	1	d	d	X
njb-69	157	2	e	e	PROPN
njb-69	157	3	c	c	PROPN
njb-69	157	4	.	.	PUNCT
njb-69	158	1	2	2	NUM
njb-69	158	2	0	0	NUM
njb-69	158	3	1	1	NUM
njb-69	158	4	9	9	NUM
njb-69	158	5	vol	vol	NOUN
njb-69	158	6	.	.	PUNCT
njb-69	159	1	7	7	NUM
njb-69	159	2	,	,	PUNCT
njb-69	159	3	no	no	NOUN
njb-69	159	4	.	.	NOUN
njb-69	159	5	1	1	NUM
njb-69	159	6	:	:	SYM
njb-69	159	7	74	74	NUM
njb-69	159	8	-	-	SYM
njb-69	159	9	81	81	NUM
njb-69	159	10	maharjan	maharjan	NOUN
njb-69	159	11	et	et	PROPN
njb-69	159	12	al	al	PROPN
njb-69	159	13	.	.	PROPN
njb-69	160	1	2019	2019	NUM
njb-69	161	1	©	©	ADP
njb-69	161	2	njb	njb	PROPN
njb-69	161	3	,	,	PUNCT
njb-69	161	4	biotechnology	biotechnology	NOUN
njb-69	161	5	society	society	NOUN
njb-69	161	6	of	of	ADP
njb-69	161	7	nepal	nepal	ADJ
njb-69	161	8	79	79	NUM
njb-69	161	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	161	10	.	.	PUNCT
njb-69	162	1	lactamase	lactamase	NOUN
njb-69	162	2	genes	gene	NOUN
njb-69	162	3	would	would	AUX
njb-69	162	4	make	make	VERB
njb-69	162	5	use	use	NOUN
njb-69	162	6	of	of	ADP
njb-69	162	7	such	such	ADJ
njb-69	162	8	tools	tool	NOUN
njb-69	162	9	tough	tough	ADJ
njb-69	162	10	,	,	PUNCT
njb-69	162	11	owing	owe	VERB
njb-69	162	12	to	to	ADP
njb-69	162	13	the	the	DET
njb-69	162	14	lack	lack	NOUN
njb-69	162	15	of	of	ADP
njb-69	162	16	primers	primer	NOUN
njb-69	162	17	.	.	PUNCT
njb-69	163	1	moreover	moreover	ADV
njb-69	163	2	,	,	PUNCT
njb-69	163	3	using	use	VERB
njb-69	163	4	such	such	ADJ
njb-69	163	5	expensive	expensive	ADJ
njb-69	163	6	tools	tool	NOUN
njb-69	163	7	in	in	ADP
njb-69	163	8	resource	resource	NOUN
njb-69	163	9	lacking	lack	VERB
njb-69	163	10	settings	setting	NOUN
njb-69	163	11	,	,	PUNCT
njb-69	163	12	like	like	ADP
njb-69	163	13	nepal	nepal	ADJ
njb-69	163	14	,	,	PUNCT
njb-69	163	15	would	would	AUX
njb-69	163	16	be	be	AUX
njb-69	163	17	a	a	DET
njb-69	163	18	fairy	fairy	NOUN
njb-69	163	19	tale	tale	NOUN
njb-69	163	20	scenario	scenario	NOUN
njb-69	163	21	.	.	PUNCT
njb-69	164	1	a	a	DET
njb-69	164	2	combined	combine	VERB
njb-69	164	3	disc	disc	NOUN
njb-69	164	4	phenotypic	phenotypic	ADJ
njb-69	164	5	method	method	NOUN
njb-69	164	6	using	use	VERB
njb-69	164	7	imipenem	imipenem	PROPN
njb-69	164	8	and	and	CCONJ
njb-69	164	9	edta	edta	NOUN
njb-69	164	10	for	for	ADP
njb-69	164	11	mbl	mbl	PROPN
njb-69	164	12	,	,	PUNCT
njb-69	164	13	ceftazidime	ceftazidime	PROPN
njb-69	164	14	/	/	SYM
njb-69	164	15	clavulanate	clavulanate	NOUN
njb-69	164	16	or	or	CCONJ
njb-69	164	17	cefotaxime	cefotaxime	NOUN
njb-69	164	18	/clavulanate	/clavulanate	NOUN
njb-69	164	19	for	for	ADP
njb-69	164	20	esbl	esbl	PROPN
njb-69	164	21	offers	offer	VERB
njb-69	164	22	a	a	DET
njb-69	164	23	cheaper	cheap	ADJ
njb-69	164	24	alternative	alternative	NOUN
njb-69	164	25	.	.	PUNCT
njb-69	165	1	also	also	ADV
njb-69	165	2	,	,	PUNCT
njb-69	165	3	phenotypic	phenotypic	ADJ
njb-69	165	4	method	method	NOUN
njb-69	165	5	proves	prove	VERB
njb-69	165	6	not	not	PART
njb-69	165	7	only	only	ADV
njb-69	165	8	the	the	DET
njb-69	165	9	presence	presence	NOUN
njb-69	165	10	of	of	ADP
njb-69	165	11	beta	beta	NOUN
njb-69	165	12	-	-	PUNCT
njb-69	165	13	lactamases	lactamase	NOUN
njb-69	165	14	producing	produce	VERB
njb-69	165	15	genes	gene	NOUN
njb-69	165	16	but	but	CCONJ
njb-69	165	17	also	also	ADV
njb-69	165	18	their	their	PRON
njb-69	165	19	expression	expression	NOUN
njb-69	165	20	.	.	PUNCT
njb-69	166	1	this	this	DET
njb-69	166	2	method	method	NOUN
njb-69	166	3	has	have	AUX
njb-69	166	4	been	be	AUX
njb-69	166	5	reported	report	VERB
njb-69	166	6	to	to	PART
njb-69	166	7	have	have	VERB
njb-69	166	8	a	a	DET
njb-69	166	9	sensitivity	sensitivity	NOUN
njb-69	166	10	of	of	ADP
njb-69	166	11	100	100	NUM
njb-69	166	12	%	%	NOUN
njb-69	166	13	and	and	CCONJ
njb-69	166	14	specificity	specificity	NOUN
njb-69	166	15	of	of	ADP
njb-69	166	16	98	98	NUM
njb-69	166	17	%	%	NOUN
njb-69	166	18	,	,	PUNCT
njb-69	166	19	thus	thus	ADV
njb-69	166	20	reliable	reliable	ADJ
njb-69	167	1	[	[	ADP
njb-69	167	2	12	12	NUM
njb-69	167	3	,	,	PUNCT
njb-69	167	4	24	24	NUM
njb-69	167	5	]	]	PUNCT
njb-69	167	6	.	.	X
njb-69	168	1	of	of	ADP
njb-69	168	2	229	229	NUM
njb-69	168	3	gram	gram	ADJ
njb-69	168	4	-	-	PUNCT
njb-69	168	5	negative	negative	ADJ
njb-69	168	6	bacteria	bacteria	NOUN
njb-69	168	7	,	,	PUNCT
njb-69	168	8	e.	e.	PROPN
njb-69	168	9	coli	coli	PROPN
njb-69	168	10	showed	show	VERB
njb-69	168	11	higher	high	ADJ
njb-69	168	12	resistance	resistance	NOUN
njb-69	168	13	against	against	ADP
njb-69	168	14	ampicillin	ampicillin	NOUN
njb-69	168	15	,	,	PUNCT
njb-69	168	16	cefpodoxime	cefpodoxime	NOUN
njb-69	168	17	,	,	PUNCT
njb-69	168	18	ceftriaxone	ceftriaxone	PROPN
njb-69	168	19	,	,	PUNCT
njb-69	168	20	and	and	CCONJ
njb-69	168	21	cefixime	cefixime	NOUN
njb-69	168	22	while	while	SCONJ
njb-69	168	23	imipenem	imipenem	PROPN
njb-69	168	24	and	and	CCONJ
njb-69	168	25	chloramphenicol	chloramphenicol	NOUN
njb-69	168	26	were	be	AUX
njb-69	168	27	found	find	VERB
njb-69	168	28	effective	effective	ADJ
njb-69	168	29	.	.	PUNCT
njb-69	169	1	p.	p.	PROPN
njb-69	169	2	aeruginosa	aeruginosa	PROPN
njb-69	169	3	showed	show	VERB
njb-69	169	4	higher	high	ADJ
njb-69	169	5	resistance	resistance	NOUN
njb-69	169	6	against	against	ADP
njb-69	169	7	cefixime	cefixime	NOUN
njb-69	169	8	and	and	CCONJ
njb-69	169	9	cefpodoxime	cefpodoxime	NOUN
njb-69	169	10	while	while	SCONJ
njb-69	169	11	imipenem	imipenem	PROPN
njb-69	169	12	was	be	AUX
njb-69	169	13	found	find	VERB
njb-69	169	14	effective	effective	ADJ
njb-69	169	15	.	.	PUNCT
njb-69	170	1	similarly	similarly	ADV
njb-69	170	2	,	,	PUNCT
njb-69	170	3	other	other	ADJ
njb-69	170	4	gram	gram	ADJ
njb-69	170	5	-	-	PUNCT
njb-69	170	6	negative	negative	ADJ
njb-69	170	7	bacteria	bacteria	NOUN
njb-69	170	8	showed	show	VERB
njb-69	170	9	higher	high	ADJ
njb-69	170	10	resistance	resistance	NOUN
njb-69	170	11	against	against	ADP
njb-69	170	12	ampicillin	ampicillin	NOUN
njb-69	170	13	,	,	PUNCT
njb-69	170	14	cefpodoxime	cefpodoxime	NOUN
njb-69	170	15	,	,	PUNCT
njb-69	170	16	and	and	CCONJ
njb-69	170	17	ceftriaxone	ceftriaxone	NOUN
njb-69	170	18	while	while	SCONJ
njb-69	170	19	imipenem	imipenem	PROPN
njb-69	170	20	was	be	AUX
njb-69	170	21	found	find	VERB
njb-69	170	22	fairly	fairly	ADV
njb-69	170	23	effective	effective	ADJ
njb-69	170	24	.	.	PUNCT
njb-69	171	1	imipenem	imipenem	PROPN
njb-69	171	2	was	be	AUX
njb-69	171	3	found	find	VERB
njb-69	171	4	as	as	ADP
njb-69	171	5	an	an	DET
njb-69	171	6	effective	effective	ADJ
njb-69	171	7	drug	drug	NOUN
njb-69	171	8	against	against	ADP
njb-69	171	9	most	most	ADJ
njb-69	171	10	of	of	ADP
njb-69	171	11	the	the	DET
njb-69	171	12	tested	test	VERB
njb-69	171	13	gram	gram	ADJ
njb-69	171	14	-	-	PUNCT
njb-69	171	15	negative	negative	ADJ
njb-69	171	16	isolates	isolate	NOUN
njb-69	171	17	.	.	PUNCT
njb-69	172	1	this	this	DET
njb-69	172	2	concords	concord	NOUN
njb-69	172	3	with	with	ADP
njb-69	172	4	similar	similar	ADJ
njb-69	172	5	reports	report	NOUN
njb-69	172	6	which	which	PRON
njb-69	172	7	reported	report	VERB
njb-69	172	8	imipenem	imipenem	PROPN
njb-69	172	9	as	as	ADP
njb-69	172	10	the	the	DET
njb-69	172	11	most	most	ADV
njb-69	172	12	sensitive	sensitive	ADJ
njb-69	172	13	drug	drug	NOUN
njb-69	172	14	[	[	PUNCT
njb-69	172	15	25	25	NUM
njb-69	172	16	,	,	PUNCT
njb-69	172	17	26	26	NUM
njb-69	172	18	]	]	PUNCT
njb-69	172	19	.	.	PUNCT
njb-69	173	1	as	as	ADP
njb-69	173	2	per	per	ADP
njb-69	173	3	the	the	DET
njb-69	173	4	expert	expert	ADJ
njb-69	173	5	consensus	consensus	NOUN
njb-69	173	6	,	,	PUNCT
njb-69	173	7	isolates	isolate	VERB
njb-69	173	8	resistant	resistant	ADJ
njb-69	173	9	to	to	ADP
njb-69	173	10	two	two	NUM
njb-69	173	11	or	or	CCONJ
njb-69	173	12	more	more	ADJ
njb-69	173	13	classes	class	NOUN
njb-69	173	14	of	of	ADP
njb-69	173	15	antibiotics	antibiotic	NOUN
njb-69	173	16	are	be	AUX
njb-69	173	17	considered	consider	VERB
njb-69	173	18	mdr	mdr	NOUN
njb-69	173	19	strains	strain	VERB
njb-69	173	20	[	[	X
njb-69	173	21	27	27	NUM
njb-69	173	22	]	]	SYM
njb-69	173	23	.	.	X
njb-69	173	24	of	of	ADP
njb-69	173	25	229	229	NUM
njb-69	173	26	gram	gram	ADJ
njb-69	173	27	-	-	PUNCT
njb-69	173	28	negative	negative	ADJ
njb-69	173	29	bacteria	bacteria	NOUN
njb-69	173	30	,	,	PUNCT
njb-69	173	31	87.3	87.3	NUM
njb-69	173	32	%	%	NOUN
njb-69	173	33	of	of	ADP
njb-69	173	34	the	the	DET
njb-69	173	35	isolates	isolate	NOUN
njb-69	173	36	were	be	AUX
njb-69	173	37	found	find	VERB
njb-69	173	38	mdr	mdr	NOUN
njb-69	173	39	strains	strain	NOUN
njb-69	173	40	.	.	PUNCT
njb-69	174	1	mdr	mdr	PROPN
njb-69	174	2	was	be	AUX
njb-69	174	3	found	find	VERB
njb-69	174	4	higher	high	ADJ
njb-69	174	5	among	among	ADP
njb-69	174	6	klebsiella	klebsiella	PROPN
njb-69	174	7	spp	spp	PROPN
njb-69	174	8	.	.	PUNCT
njb-69	175	1	isolates	isolate	VERB
njb-69	175	2	(	(	PUNCT
njb-69	175	3	93.5	93.5	NUM
njb-69	175	4	%	%	NOUN
njb-69	175	5	)	)	PUNCT
njb-69	175	6	.	.	PUNCT
njb-69	176	1	similarly	similarly	ADV
njb-69	176	2	,	,	PUNCT
njb-69	176	3	87.8	87.8	NUM
njb-69	176	4	%	%	NOUN
njb-69	176	5	of	of	ADP
njb-69	176	6	p.	p.	PROPN
njb-69	176	7	aeruginosa	aeruginosa	PROPN
njb-69	176	8	and	and	CCONJ
njb-69	176	9	50	50	NUM
njb-69	176	10	%	%	NOUN
njb-69	176	11	of	of	ADP
njb-69	176	12	acinetobacter	acinetobacter	PROPN
njb-69	176	13	spp	spp	PROPN
njb-69	176	14	.	.	PUNCT
njb-69	177	1	isolates	isolate	NOUN
njb-69	177	2	were	be	AUX
njb-69	177	3	found	find	VERB
njb-69	177	4	mdr	mdr	NOUN
njb-69	177	5	strains	strain	NOUN
njb-69	177	6	.	.	PUNCT
njb-69	178	1	some	some	DET
njb-69	178	2	studies	study	NOUN
njb-69	178	3	reported	report	VERB
njb-69	178	4	higher	high	ADJ
njb-69	178	5	mdr	mdr	NOUN
njb-69	178	6	in	in	ADP
njb-69	178	7	these	these	DET
njb-69	178	8	bacteria	bacteria	NOUN
njb-69	178	9	[	[	PUNCT
njb-69	178	10	16	16	NUM
njb-69	178	11	,	,	PUNCT
njb-69	178	12	18	18	NUM
njb-69	178	13	,	,	PUNCT
njb-69	178	14	20	20	NUM
njb-69	178	15	]	]	PUNCT
njb-69	178	16	.	.	PUNCT
njb-69	179	1	in	in	ADP
njb-69	179	2	our	our	PRON
njb-69	179	3	study	study	NOUN
njb-69	179	4	,	,	PUNCT
njb-69	179	5	nearly	nearly	ADV
njb-69	179	6	all	all	PRON
njb-69	179	7	esbl	esbl	NOUN
njb-69	179	8	and	and	CCONJ
njb-69	179	9	mbl	mbl	NOUN
njb-69	179	10	producers	producer	NOUN
njb-69	179	11	were	be	AUX
njb-69	179	12	mdr	mdr	NOUN
njb-69	179	13	strains	strain	NOUN
njb-69	179	14	.	.	PUNCT
njb-69	180	1	this	this	PRON
njb-69	180	2	limits	limit	VERB
njb-69	180	3	physicians	physician	NOUN
njb-69	180	4	with	with	ADP
njb-69	180	5	therapeutics	therapeutic	NOUN
njb-69	180	6	for	for	ADP
njb-69	180	7	the	the	DET
njb-69	180	8	management	management	NOUN
njb-69	180	9	of	of	ADP
njb-69	180	10	infections	infection	NOUN
njb-69	180	11	.	.	PUNCT
njb-69	181	1	such	such	ADJ
njb-69	181	2	esbl	esbl	NOUN
njb-69	181	3	producing	produce	VERB
njb-69	181	4	strains	strain	NOUN
njb-69	181	5	can	can	AUX
njb-69	181	6	be	be	AUX
njb-69	181	7	inhibited	inhibit	VERB
njb-69	181	8	by	by	ADP
njb-69	181	9	the	the	DET
njb-69	181	10	use	use	NOUN
njb-69	181	11	of	of	ADP
njb-69	181	12	beta	beta	NOUN
njb-69	181	13	-	-	PUNCT
njb-69	181	14	lacatamase	lacatamase	ADJ
njb-69	181	15	inhibitors	inhibitor	NOUN
njb-69	181	16	like	like	ADP
njb-69	181	17	clavulanate	clavulanate	NOUN
njb-69	181	18	,	,	PUNCT
njb-69	181	19	but	but	CCONJ
njb-69	181	20	mbl	mbl	NOUN
njb-69	181	21	producers	producer	NOUN
njb-69	181	22	are	be	AUX
njb-69	181	23	resistance	resistance	NOUN
njb-69	181	24	to	to	ADP
njb-69	181	25	these	these	DET
njb-69	181	26	inhibitors	inhibitor	NOUN
njb-69	181	27	and	and	CCONJ
njb-69	181	28	mbl	mbl	NOUN
njb-69	181	29	inhibitors	inhibitor	NOUN
njb-69	181	30	are	be	AUX
njb-69	181	31	yet	yet	ADV
njb-69	181	32	to	to	PART
njb-69	181	33	be	be	AUX
njb-69	181	34	trialed	triale	VERB
njb-69	181	35	in	in	ADP
njb-69	181	36	human	human	NOUN
njb-69	181	37	.	.	PUNCT
njb-69	182	1	the	the	DET
njb-69	182	2	reserve	reserve	PROPN
njb-69	182	3	drug	drug	PROPN
njb-69	182	4	for	for	ADP
njb-69	182	5	mdr	mdr	PROPN
njb-69	182	6	gramnegative	gramnegative	ADJ
njb-69	182	7	bacteria	bacteria	NOUN
njb-69	182	8	is	be	AUX
njb-69	182	9	emptied	empty	VERB
njb-69	182	10	with	with	ADP
njb-69	182	11	the	the	DET
njb-69	182	12	evolution	evolution	NOUN
njb-69	182	13	of	of	ADP
njb-69	182	14	newer	new	ADJ
njb-69	182	15	beta	beta	NOUN
njb-69	182	16	-	-	PUNCT
njb-69	182	17	lactamases	lactamase	NOUN
njb-69	182	18	.	.	PUNCT
njb-69	183	1	colistin	colistin	PROPN
njb-69	183	2	has	have	AUX
njb-69	183	3	always	always	ADV
njb-69	183	4	been	be	AUX
njb-69	183	5	the	the	DET
njb-69	183	6	ultimate	ultimate	ADJ
njb-69	183	7	weapon	weapon	NOUN
njb-69	183	8	in	in	ADP
njb-69	183	9	the	the	DET
njb-69	183	10	fight	fight	NOUN
njb-69	183	11	against	against	ADP
njb-69	183	12	mdr	mdr	PROPN
njb-69	183	13	superbugs	superbugs	PROPN
njb-69	183	14	in	in	ADP
njb-69	183	15	case	case	NOUN
njb-69	183	16	all	all	DET
njb-69	183	17	other	other	ADJ
njb-69	183	18	therapeutic	therapeutic	ADJ
njb-69	183	19	options	option	NOUN
njb-69	183	20	fail	fail	VERB
njb-69	183	21	.	.	PUNCT
njb-69	184	1	however	however	ADV
njb-69	184	2	,	,	PUNCT
njb-69	184	3	resistance	resistance	NOUN
njb-69	184	4	against	against	ADP
njb-69	184	5	colistin	colistin	PROPN
njb-69	184	6	has	have	AUX
njb-69	184	7	been	be	AUX
njb-69	184	8	reported	report	VERB
njb-69	184	9	in	in	ADP
njb-69	184	10	recent	recent	ADJ
njb-69	184	11	times	time	NOUN
njb-69	184	12	,	,	PUNCT
njb-69	184	13	rendering	render	VERB
njb-69	184	14	our	our	PRON
njb-69	184	15	drug	drug	NOUN
njb-69	184	16	arsenal	arsenal	NOUN
njb-69	184	17	completely	completely	ADV
njb-69	184	18	empty	empty	ADJ
njb-69	184	19	for	for	ADP
njb-69	184	20	such	such	ADJ
njb-69	184	21	superbugs	superbug	NOUN
njb-69	184	22	[	[	PUNCT
njb-69	184	23	28	28	NUM
njb-69	184	24	-	-	SYM
njb-69	184	25	30	30	NUM
njb-69	184	26	]	]	PUNCT
njb-69	184	27	.	.	PUNCT
njb-69	185	1	abr	abr	PROPN
njb-69	185	2	is	be	AUX
njb-69	185	3	a	a	DET
njb-69	185	4	crisis	crisis	NOUN
njb-69	185	5	that	that	PRON
njb-69	185	6	must	must	AUX
njb-69	185	7	be	be	AUX
njb-69	185	8	managed	manage	VERB
njb-69	185	9	with	with	ADP
njb-69	185	10	the	the	DET
njb-69	185	11	utmost	utmost	ADJ
njb-69	185	12	urgency	urgency	NOUN
njb-69	185	13	to	to	PART
njb-69	185	14	contain	contain	VERB
njb-69	185	15	it	it	PRON
njb-69	185	16	.	.	PUNCT
njb-69	186	1	such	such	ADJ
njb-69	186	2	surveillance	surveillance	NOUN
njb-69	186	3	that	that	PRON
njb-69	186	4	generates	generate	VERB
njb-69	186	5	updated	update	VERB
njb-69	186	6	data	datum	NOUN
njb-69	186	7	is	be	AUX
njb-69	186	8	required	require	VERB
njb-69	186	9	for	for	ADP
njb-69	186	10	the	the	DET
njb-69	186	11	implementation	implementation	NOUN
njb-69	186	12	of	of	ADP
njb-69	186	13	sound	sound	NOUN
njb-69	186	14	strategies	strategy	NOUN
njb-69	186	15	and	and	CCONJ
njb-69	186	16	public	public	ADJ
njb-69	186	17	health	health	NOUN
njb-69	186	18	actions	action	NOUN
njb-69	186	19	to	to	PART
njb-69	186	20	contain	contain	VERB
njb-69	186	21	abr	abr	PROPN
njb-69	186	22	.	.	PUNCT
njb-69	187	1	abr	abr	PROPN
njb-69	187	2	requires	require	VERB
njb-69	187	3	concerted	concert	VERB
njb-69	187	4	cross	cross	ADJ
njb-69	187	5	-	-	ADJ
njb-69	187	6	sectional	sectional	ADJ
njb-69	187	7	action	action	NOUN
njb-69	187	8	by	by	ADP
njb-69	187	9	governments	government	NOUN
njb-69	187	10	table	table	NOUN
njb-69	187	11	5	5	NUM
njb-69	187	12	.	.	PUNCT
njb-69	188	1	distribution	distribution	NOUN
njb-69	188	2	of	of	ADP
njb-69	188	3	gram	gram	NOUN
njb-69	188	4	-	-	PUNCT
njb-69	188	5	negative	negative	ADJ
njb-69	188	6	isolates	isolate	NOUN
njb-69	188	7	producing	produce	VERB
njb-69	188	8	esbl	esbl	NOUN
njb-69	188	9	and	and	CCONJ
njb-69	188	10	mbl	mbl	PROPN
njb-69	188	11	bacteria	bacteria	NOUN
njb-69	188	12	total	total	NOUN
njb-69	188	13	isolates	isolate	NOUN
njb-69	188	14	mdr	mdr	PROPN
njb-69	188	15	bacteria	bacteria	NOUN
njb-69	188	16	esbl	esbl	PROPN
njb-69	188	17	producers	producer	NOUN
njb-69	189	1	mbl	mbl	NOUN
njb-69	189	2	producers	producer	NOUN
njb-69	189	3	acb	acb	VERB
njb-69	189	4	*	*	NUM
njb-69	189	5	8	8	NUM
njb-69	189	6	4	4	NUM
njb-69	189	7	4	4	NUM
njb-69	189	8	(	(	PUNCT
njb-69	189	9	6.0	6.0	NUM
njb-69	189	10	%	%	NOUN
njb-69	189	11	)	)	PUNCT
njb-69	189	12	2	2	NUM
njb-69	189	13	(	(	PUNCT
njb-69	189	14	12.5	12.5	NUM
njb-69	189	15	%	%	NOUN
njb-69	189	16	)	)	PUNCT
njb-69	189	17	citrobacter	citrobacter	NOUN
njb-69	189	18	spp	spp	PROPN
njb-69	189	19	.	.	PROPN
njb-69	190	1	1	1	NUM
njb-69	190	2	1	1	NUM
njb-69	190	3	0	0	NUM
njb-69	190	4	(	(	PUNCT
njb-69	190	5	0.0	0.0	NUM
njb-69	190	6	%	%	NOUN
njb-69	190	7	)	)	PUNCT
njb-69	190	8	0	0	NUM
njb-69	191	1	(	(	PUNCT
njb-69	191	2	0.0	0.0	NUM
njb-69	191	3	%	%	NOUN
njb-69	191	4	)	)	PUNCT
njb-69	191	5	e.	e.	PROPN
njb-69	191	6	coli	coli	NOUN
njb-69	191	7	78	78	NUM
njb-69	191	8	65	65	NUM
njb-69	191	9	16	16	NUM
njb-69	191	10	(	(	PUNCT
njb-69	191	11	23.9	23.9	NUM
njb-69	191	12	%	%	NOUN
njb-69	191	13	)	)	PUNCT
njb-69	191	14	3	3	NUM
njb-69	191	15	(	(	PUNCT
njb-69	191	16	18.8	18.8	NUM
njb-69	191	17	%	%	NOUN
njb-69	191	18	)	)	PUNCT
njb-69	192	1	k.	k.	PROPN
njb-69	192	2	oxytoca	oxytoca	PROPN
njb-69	192	3	22	22	NUM
njb-69	192	4	21	21	NUM
njb-69	192	5	5	5	NUM
njb-69	192	6	(	(	PUNCT
njb-69	192	7	7.5	7.5	NUM
njb-69	192	8	%	%	NOUN
njb-69	192	9	)	)	PUNCT
njb-69	192	10	0	0	NUM
njb-69	193	1	(	(	PUNCT
njb-69	193	2	0.0	0.0	NUM
njb-69	193	3	%	%	NOUN
njb-69	193	4	)	)	PUNCT
njb-69	193	5	k.	k.	NOUN
njb-69	193	6	pneumoniae	pneumoniae	NOUN
njb-69	193	7	71	71	NUM
njb-69	193	8	66	66	NUM
njb-69	193	9	25	25	NUM
njb-69	193	10	(	(	PUNCT
njb-69	193	11	37.3	37.3	NUM
njb-69	193	12	%	%	NOUN
njb-69	193	13	)	)	PUNCT
njb-69	193	14	2	2	NUM
njb-69	193	15	(	(	PUNCT
njb-69	193	16	12.5	12.5	NUM
njb-69	193	17	%	%	NOUN
njb-69	193	18	)	)	PUNCT
njb-69	194	1	p.	p.	NOUN
njb-69	194	2	aeruginosa	aeruginosa	PROPN
njb-69	195	1	41	41	NUM
njb-69	195	2	36	36	NUM
njb-69	195	3	16	16	NUM
njb-69	195	4	(	(	PUNCT
njb-69	195	5	23.9	23.9	NUM
njb-69	195	6	%	%	NOUN
njb-69	195	7	)	)	PUNCT
njb-69	195	8	9	9	NUM
njb-69	195	9	(	(	PUNCT
njb-69	195	10	56.3	56.3	NUM
njb-69	195	11	%	%	NOUN
njb-69	195	12	)	)	PUNCT
njb-69	195	13	proteus	proteus	NOUN
njb-69	195	14	spp	spp	PROPN
njb-69	195	15	.	.	PROPN
njb-69	196	1	6	6	NUM
njb-69	196	2	6	6	NUM
njb-69	196	3	0	0	NUM
njb-69	196	4	(	(	PUNCT
njb-69	196	5	0.0	0.0	NUM
njb-69	196	6	%	%	NOUN
njb-69	196	7	)	)	PUNCT
njb-69	196	8	0	0	NUM
njb-69	197	1	(	(	PUNCT
njb-69	197	2	0.0	0.0	NUM
njb-69	197	3	%	%	NOUN
njb-69	197	4	)	)	PUNCT
njb-69	197	5	salmonella	salmonella	NOUN
njb-69	197	6	spp	spp	PROPN
njb-69	197	7	.	.	PROPN
njb-69	198	1	2	2	NUM
njb-69	198	2	1	1	NUM
njb-69	198	3	1	1	NUM
njb-69	198	4	(	(	PUNCT
njb-69	198	5	1.5	1.5	NUM
njb-69	198	6	%	%	NOUN
njb-69	198	7	)	)	PUNCT
njb-69	198	8	0	0	NUM
njb-69	199	1	(	(	PUNCT
njb-69	199	2	0.0	0.0	NUM
njb-69	199	3	%	%	NOUN
njb-69	199	4	)	)	PUNCT
njb-69	199	5	total	total	ADJ
njb-69	199	6	229	229	NUM
njb-69	199	7	200	200	NUM
njb-69	199	8	(	(	PUNCT
njb-69	199	9	100	100	NUM
njb-69	199	10	%	%	NOUN
njb-69	199	11	)	)	PUNCT
njb-69	199	12	67	67	NUM
njb-69	199	13	(	(	PUNCT
njb-69	199	14	100	100	NUM
njb-69	199	15	%	%	NOUN
njb-69	199	16	)	)	PUNCT
njb-69	199	17	16	16	NUM
njb-69	199	18	(	(	PUNCT
njb-69	199	19	100	100	NUM
njb-69	199	20	%	%	NOUN
njb-69	199	21	)	)	PUNCT
njb-69	199	22	*	*	PUNCT
njb-69	199	23	acinetobacter	acinetobacter	ADJ
njb-69	199	24	calcoaceticus	calcoaceticus	ADJ
njb-69	199	25	-	-	PUNCT
njb-69	199	26	baumannii	baumannii	ADJ
njb-69	199	27	complex	complex	ADJ
njb-69	199	28	nepal	nepal	ADJ
njb-69	199	29	journal	journal	NOUN
njb-69	199	30	of	of	ADP
njb-69	199	31	biotechnology	biotechnology	NOUN
njb-69	199	32	.	.	PUNCT
njb-69	200	1	d	d	X
njb-69	200	2	e	e	PROPN
njb-69	200	3	c	c	PROPN
njb-69	200	4	.	.	PUNCT
njb-69	201	1	2	2	NUM
njb-69	201	2	0	0	NUM
njb-69	201	3	1	1	NUM
njb-69	201	4	9	9	NUM
njb-69	201	5	vol	vol	NOUN
njb-69	201	6	.	.	PUNCT
njb-69	202	1	7	7	NUM
njb-69	202	2	,	,	PUNCT
njb-69	202	3	no	no	NOUN
njb-69	202	4	.	.	NOUN
njb-69	202	5	1	1	NUM
njb-69	202	6	:	:	SYM
njb-69	202	7	74	74	NUM
njb-69	202	8	-	-	SYM
njb-69	202	9	81	81	NUM
njb-69	202	10	maharjan	maharjan	NOUN
njb-69	202	11	et	et	PROPN
njb-69	202	12	al	al	PROPN
njb-69	202	13	.	.	PROPN
njb-69	203	1	2019	2019	NUM
njb-69	204	1	©	©	ADP
njb-69	204	2	njb	njb	PROPN
njb-69	204	3	,	,	PUNCT
njb-69	204	4	biotechnology	biotechnology	NOUN
njb-69	204	5	society	society	NOUN
njb-69	204	6	of	of	ADP
njb-69	204	7	nepal	nepal	ADJ
njb-69	204	8	80	80	NUM
njb-69	204	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	204	10	.	.	PUNCT
njb-69	204	11	and	and	CCONJ
njb-69	204	12	society	society	NOUN
njb-69	204	13	as	as	ADP
njb-69	204	14	a	a	DET
njb-69	204	15	whole	whole	NOUN
njb-69	204	16	.	.	PUNCT
njb-69	205	1	currently	currently	ADV
njb-69	205	2	,	,	PUNCT
njb-69	205	3	‘	'	PUNCT
njb-69	205	4	the	the	DET
njb-69	205	5	global	global	ADJ
njb-69	205	6	action	action	NOUN
njb-69	205	7	plan	plan	NOUN
njb-69	205	8	on	on	ADP
njb-69	205	9	antimicrobial	antimicrobial	ADJ
njb-69	205	10	resistance-2015	resistance-2015	PROPN
njb-69	205	11	’	'	PUNCT
njb-69	205	12	,	,	PUNCT
njb-69	205	13	as	as	SCONJ
njb-69	205	14	formulated	formulate	VERB
njb-69	205	15	by	by	ADP
njb-69	205	16	who	who	PRON
njb-69	205	17	[	[	PUNCT
njb-69	205	18	31	31	NUM
njb-69	205	19	]	]	PUNCT
njb-69	205	20	,	,	PUNCT
njb-69	205	21	must	must	AUX
njb-69	205	22	be	be	AUX
njb-69	205	23	implemented	implement	VERB
njb-69	205	24	as	as	SCONJ
njb-69	205	25	envisioned	envision	VERB
njb-69	205	26	to	to	PART
njb-69	205	27	tackle	tackle	VERB
njb-69	205	28	the	the	DET
njb-69	205	29	abr	abr	NOUN
njb-69	205	30	.	.	PUNCT
njb-69	206	1	conclusion	conclusion	NOUN
njb-69	206	2	the	the	DET
njb-69	206	3	findings	finding	NOUN
njb-69	206	4	suggest	suggest	VERB
njb-69	206	5	higher	high	ADJ
njb-69	206	6	mdr	mdr	PROPN
njb-69	206	7	,	,	PUNCT
njb-69	206	8	esbl	esbl	PROPN
njb-69	206	9	,	,	PUNCT
njb-69	206	10	and	and	CCONJ
njb-69	206	11	mbl	mbl	VERB
njb-69	206	12	not	not	PART
njb-69	206	13	only	only	ADV
njb-69	206	14	among	among	ADP
njb-69	206	15	p.	p.	PROPN
njb-69	206	16	aeruginosa	aeruginosa	PROPN
njb-69	206	17	and	and	CCONJ
njb-69	206	18	acinetobacter	acinetobacter	ADJ
njb-69	206	19	spp	spp	PROPN
njb-69	206	20	.	.	PUNCT
njb-69	207	1	but	but	CCONJ
njb-69	207	2	also	also	ADV
njb-69	207	3	among	among	ADP
njb-69	207	4	enterobacteriaceae	enterobacteriaceae	PROPN
njb-69	207	5	family	family	NOUN
njb-69	207	6	,	,	PUNCT
njb-69	207	7	including	include	VERB
njb-69	207	8	e.	e.	PROPN
njb-69	207	9	coli	coli	PROPN
njb-69	207	10	and	and	CCONJ
njb-69	207	11	k.	k.	NOUN
njb-69	207	12	pneumoniae	pneumoniae	NOUN
njb-69	207	13	.	.	PUNCT
njb-69	208	1	imipenem	imipenem	PROPN
njb-69	208	2	showed	show	VERB
njb-69	208	3	promising	promising	ADJ
njb-69	208	4	sensitivity	sensitivity	NOUN
njb-69	208	5	against	against	ADP
njb-69	208	6	most	most	ADJ
njb-69	208	7	of	of	ADP
njb-69	208	8	the	the	DET
njb-69	208	9	gram	gram	ADJ
njb-69	208	10	-	-	PUNCT
njb-69	208	11	negative	negative	ADJ
njb-69	208	12	isolates	isolate	NOUN
njb-69	208	13	,	,	PUNCT
njb-69	208	14	thus	thus	ADV
njb-69	208	15	it	it	PRON
njb-69	208	16	can	can	AUX
njb-69	208	17	be	be	AUX
njb-69	208	18	the	the	DET
njb-69	208	19	antibiotic	antibiotic	NOUN
njb-69	208	20	of	of	ADP
njb-69	208	21	choice	choice	NOUN
njb-69	208	22	for	for	ADP
njb-69	208	23	management	management	NOUN
njb-69	208	24	of	of	ADP
njb-69	208	25	such	such	ADJ
njb-69	208	26	infections	infection	NOUN
njb-69	208	27	.	.	PUNCT
njb-69	209	1	evolving	evolve	VERB
njb-69	209	2	betalactamases	betalactamase	NOUN
njb-69	209	3	against	against	ADP
njb-69	209	4	newer	new	ADJ
njb-69	209	5	generation	generation	NOUN
njb-69	209	6	betalactams	betalactam	NOUN
njb-69	209	7	have	have	AUX
njb-69	209	8	posed	pose	VERB
njb-69	209	9	a	a	DET
njb-69	209	10	serious	serious	ADJ
njb-69	209	11	threat	threat	NOUN
njb-69	209	12	to	to	ADP
njb-69	209	13	public	public	ADJ
njb-69	209	14	health	health	NOUN
njb-69	209	15	.	.	PUNCT
njb-69	210	1	only	only	ADV
njb-69	210	2	the	the	DET
njb-69	210	3	continuous	continuous	ADJ
njb-69	210	4	monitoring	monitoring	NOUN
njb-69	210	5	,	,	PUNCT
njb-69	210	6	surveillance	surveillance	NOUN
njb-69	210	7	,	,	PUNCT
njb-69	210	8	early	early	ADJ
njb-69	210	9	detection	detection	NOUN
njb-69	210	10	,	,	PUNCT
njb-69	210	11	and	and	CCONJ
njb-69	210	12	infection	infection	NOUN
njb-69	210	13	control	control	NOUN
njb-69	210	14	practices	practice	NOUN
njb-69	210	15	can	can	AUX
njb-69	210	16	ensure	ensure	VERB
njb-69	210	17	the	the	DET
njb-69	210	18	effective	effective	ADJ
njb-69	210	19	management	management	NOUN
njb-69	210	20	of	of	ADP
njb-69	210	21	such	such	ADJ
njb-69	210	22	resistant	resistant	ADJ
njb-69	210	23	strains	strain	NOUN
njb-69	210	24	.	.	PUNCT
njb-69	211	1	conflict	conflict	NOUN
njb-69	211	2	of	of	ADP
njb-69	211	3	interest	interest	NOUN
njb-69	211	4	the	the	DET
njb-69	211	5	authors	author	NOUN
njb-69	211	6	declare	declare	VERB
njb-69	211	7	no	no	DET
njb-69	211	8	conflict	conflict	NOUN
njb-69	211	9	of	of	ADP
njb-69	211	10	interest	interest	NOUN
njb-69	211	11	.	.	PUNCT
njb-69	212	1	acknowledgments	acknowledgment	VERB
njb-69	212	2	we	we	PRON
njb-69	212	3	acknowledge	acknowledge	VERB
njb-69	212	4	asst	asst	NOUN
njb-69	212	5	.	.	PUNCT
njb-69	213	1	prof	prof	PROPN
njb-69	213	2	.	.	PUNCT
njb-69	213	3	archana	archana	PROPN
njb-69	213	4	katuwal	katuwal	PROPN
njb-69	213	5	and	and	CCONJ
njb-69	213	6	dr	dr	PROPN
njb-69	213	7	.	.	PROPN
njb-69	213	8	ranga	ranga	PROPN
njb-69	213	9	bahadur	bahadur	PROPN
njb-69	213	10	basnet	basnet	PROPN
njb-69	213	11	for	for	ADP
njb-69	213	12	supervising	supervise	VERB
njb-69	213	13	this	this	DET
njb-69	213	14	study	study	NOUN
njb-69	213	15	and	and	CCONJ
njb-69	213	16	providing	provide	VERB
njb-69	213	17	the	the	DET
njb-69	213	18	methodology	methodology	NOUN
njb-69	213	19	for	for	ADP
njb-69	213	20	the	the	DET
njb-69	213	21	study	study	NOUN
njb-69	213	22	.	.	PUNCT
njb-69	214	1	consent	consent	NOUN
njb-69	214	2	to	to	PART
njb-69	214	3	publish	publish	VERB
njb-69	214	4	not	not	PART
njb-69	214	5	applicable	applicable	ADJ
njb-69	214	6	ethical	ethical	ADJ
njb-69	214	7	approval	approval	NOUN
njb-69	214	8	and	and	CCONJ
njb-69	214	9	consent	consent	NOUN
njb-69	214	10	to	to	ADP
njb-69	214	11	the	the	DET
njb-69	214	12	participant	participant	NOUN
njb-69	214	13	no	no	DET
njb-69	214	14	patient	patient	NOUN
njb-69	214	15	-	-	PUNCT
njb-69	214	16	related	relate	VERB
njb-69	214	17	data	datum	NOUN
njb-69	214	18	were	be	AUX
njb-69	214	19	collected	collect	VERB
njb-69	214	20	and	and	CCONJ
njb-69	214	21	thus	thus	ADV
njb-69	214	22	ethical	ethical	ADJ
njb-69	214	23	approval	approval	NOUN
njb-69	214	24	was	be	AUX
njb-69	214	25	not	not	PART
njb-69	214	26	required	require	VERB
njb-69	214	27	.	.	PUNCT
njb-69	215	1	the	the	DET
njb-69	215	2	study	study	NOUN
njb-69	215	3	was	be	AUX
njb-69	215	4	a	a	DET
njb-69	215	5	laboratory	laboratory	NOUN
njb-69	215	6	-	-	PUNCT
njb-69	215	7	based	base	VERB
njb-69	215	8	study	study	NOUN
njb-69	215	9	and	and	CCONJ
njb-69	215	10	a	a	DET
njb-69	215	11	part	part	NOUN
njb-69	215	12	of	of	ADP
njb-69	215	13	the	the	DET
njb-69	215	14	study	study	NOUN
njb-69	215	15	was	be	AUX
njb-69	215	16	a	a	DET
njb-69	215	17	routine	routine	ADJ
njb-69	215	18	patient	patient	NOUN
njb-69	215	19	care	care	NOUN
njb-69	215	20	investigation	investigation	NOUN
njb-69	215	21	.	.	PUNCT
njb-69	216	1	oral	oral	ADJ
njb-69	216	2	informed	inform	VERB
njb-69	216	3	consent	consent	NOUN
njb-69	216	4	was	be	AUX
njb-69	216	5	taken	take	VERB
njb-69	216	6	from	from	ADP
njb-69	216	7	all	all	DET
njb-69	216	8	patients	patient	NOUN
njb-69	216	9	or	or	CCONJ
njb-69	216	10	from	from	ADP
njb-69	216	11	a	a	DET
njb-69	216	12	guardian	guardian	NOUN
njb-69	216	13	on	on	ADP
njb-69	216	14	behalf	behalf	NOUN
njb-69	216	15	of	of	ADP
njb-69	216	16	the	the	DET
njb-69	216	17	patients	patient	NOUN
njb-69	216	18	.	.	PUNCT
njb-69	217	1	availability	availability	NOUN
njb-69	217	2	of	of	ADP
njb-69	217	3	data	datum	NOUN
njb-69	217	4	and	and	CCONJ
njb-69	217	5	materials	material	NOUN
njb-69	217	6	all	all	DET
njb-69	217	7	data	datum	NOUN
njb-69	217	8	generated	generate	VERB
njb-69	217	9	or	or	CCONJ
njb-69	217	10	analyzed	analyze	VERB
njb-69	217	11	during	during	ADP
njb-69	217	12	this	this	DET
njb-69	217	13	study	study	NOUN
njb-69	217	14	are	be	AUX
njb-69	217	15	included	include	VERB
njb-69	217	16	in	in	ADP
njb-69	217	17	the	the	DET
njb-69	217	18	article	article	NOUN
njb-69	217	19	.	.	PUNCT
njb-69	218	1	raw	raw	ADJ
njb-69	218	2	data	datum	NOUN
njb-69	218	3	can	can	AUX
njb-69	218	4	be	be	AUX
njb-69	218	5	made	make	VERB
njb-69	218	6	available	available	ADJ
njb-69	218	7	upon	upon	SCONJ
njb-69	218	8	request	request	NOUN
njb-69	218	9	to	to	ADP
njb-69	218	10	the	the	DET
njb-69	218	11	corresponding	correspond	VERB
njb-69	218	12	author	author	NOUN
njb-69	218	13	.	.	PUNCT
njb-69	219	1	funding	fund	VERB
njb-69	219	2	none	none	NOUN
njb-69	219	3	authors	author	NOUN
njb-69	219	4	’	’	PART
njb-69	219	5	contributions	contribution	NOUN
njb-69	219	6	all	all	DET
njb-69	219	7	authors	author	NOUN
njb-69	219	8	made	make	VERB
njb-69	219	9	substantial	substantial	ADJ
njb-69	219	10	contributions	contribution	NOUN
njb-69	219	11	to	to	ADP
njb-69	219	12	the	the	DET
njb-69	219	13	study	study	NOUN
njb-69	219	14	.	.	PUNCT
njb-69	220	1	em	em	INTJ
njb-69	220	2	,	,	PUNCT
njb-69	220	3	ds	ds	PROPN
njb-69	220	4	and	and	CCONJ
njb-69	220	5	ps	ps	PROPN
njb-69	220	6	conceived	conceive	VERB
njb-69	220	7	and	and	CCONJ
njb-69	220	8	designed	design	VERB
njb-69	220	9	the	the	DET
njb-69	220	10	study	study	NOUN
njb-69	220	11	.	.	PUNCT
njb-69	221	1	em	em	PRON
njb-69	221	2	and	and	CCONJ
njb-69	221	3	ps	ps	PROPN
njb-69	221	4	collected	collect	VERB
njb-69	221	5	sample	sample	NOUN
njb-69	221	6	,	,	PUNCT
njb-69	221	7	investigated	investigate	VERB
njb-69	221	8	and	and	CCONJ
njb-69	221	9	recorded	record	VERB
njb-69	221	10	the	the	DET
njb-69	221	11	laboratory	laboratory	NOUN
njb-69	221	12	findings	finding	NOUN
njb-69	221	13	at	at	ADP
njb-69	221	14	the	the	DET
njb-69	221	15	hospital	hospital	NOUN
njb-69	221	16	.	.	PUNCT
njb-69	222	1	ds	ds	INTJ
njb-69	222	2	,	,	PUNCT
njb-69	222	3	bb	bb	PROPN
njb-69	222	4	and	and	CCONJ
njb-69	222	5	bpb	bpb	PROPN
njb-69	222	6	curated	curate	VERB
njb-69	222	7	the	the	DET
njb-69	222	8	data	datum	NOUN
njb-69	222	9	and	and	CCONJ
njb-69	222	10	analyzed	analyze	VERB
njb-69	222	11	the	the	DET
njb-69	222	12	data	datum	NOUN
njb-69	222	13	.	.	PUNCT
njb-69	223	1	em	em	PRON
njb-69	223	2	and	and	CCONJ
njb-69	223	3	ds	ds	PROPN
njb-69	223	4	administered	administer	VERB
njb-69	223	5	the	the	DET
njb-69	223	6	project	project	NOUN
njb-69	223	7	,	,	PUNCT
njb-69	223	8	reviewed	review	VERB
njb-69	223	9	literature	literature	NOUN
njb-69	223	10	,	,	PUNCT
njb-69	223	11	and	and	CCONJ
njb-69	223	12	drafted	draft	VERB
njb-69	223	13	the	the	DET
njb-69	223	14	manuscript	manuscript	NOUN
njb-69	223	15	.	.	PUNCT
njb-69	224	1	ds	ds	PROPN
njb-69	224	2	helped	help	VERB
njb-69	224	3	with	with	ADP
njb-69	224	4	critical	critical	ADJ
njb-69	224	5	review	review	NOUN
njb-69	224	6	and	and	CCONJ
njb-69	224	7	revision	revision	NOUN
njb-69	224	8	of	of	ADP
njb-69	224	9	the	the	DET
njb-69	224	10	manuscript	manuscript	NOUN
njb-69	224	11	by	by	ADP
njb-69	224	12	compiling	compile	VERB
njb-69	224	13	,	,	PUNCT
njb-69	224	14	formatting	formatting	NOUN
njb-69	224	15	,	,	PUNCT
njb-69	224	16	editing	edit	VERB
njb-69	224	17	and	and	CCONJ
njb-69	224	18	writing	write	VERB
njb-69	224	19	the	the	DET
njb-69	224	20	final	final	ADJ
njb-69	224	21	version	version	NOUN
njb-69	224	22	of	of	ADP
njb-69	224	23	the	the	DET
njb-69	224	24	manuscript	manuscript	NOUN
njb-69	224	25	.	.	PUNCT
njb-69	225	1	all	all	DET
njb-69	225	2	authors	author	NOUN
njb-69	225	3	read	read	VERB
njb-69	225	4	and	and	CCONJ
njb-69	225	5	approved	approve	VERB
njb-69	225	6	the	the	DET
njb-69	225	7	final	final	ADJ
njb-69	225	8	manuscript	manuscript	NOUN
njb-69	225	9	.	.	PUNCT
njb-69	226	1	references	reference	NOUN
njb-69	226	2	1	1	NUM
njb-69	226	3	.	.	PUNCT
njb-69	227	1	antimicrobial	antimicrobial	ADJ
njb-69	227	2	resistance	resistance	NOUN
njb-69	227	3	[	[	X
njb-69	227	4	https://www	https://www	X
njb-69	227	5	.	.	PUNCT
njb-69	228	1	who.int/en/news-room/fact-sheets/detail	who.int/en/news-room/fact-sheets/detail	PROPN
njb-69	228	2	/antimicrobial	/antimicrobial	ADJ
njb-69	228	3	-	-	NOUN
njb-69	228	4	resistance	resistance	NOUN
njb-69	228	5	]	]	PUNCT
njb-69	228	6	2	2	X
njb-69	228	7	.	.	X
njb-69	229	1	the	the	DET
njb-69	229	2	global	global	ADJ
njb-69	229	3	threat	threat	NOUN
njb-69	229	4	of	of	ADP
njb-69	229	5	antibiotic	antibiotic	ADJ
njb-69	229	6	resistance	resistance	NOUN
njb-69	229	7	[	[	X
njb-69	229	8	https://www.reactgroup.org/antibioticresistance/the-threat/	https://www.reactgroup.org/antibioticresistance/the-threat/	X
njb-69	229	9	]	]	X
njb-69	229	10	3	3	NUM
njb-69	229	11	.	.	PUNCT
njb-69	230	1	philippon	philippon	PROPN
njb-69	230	2	a	a	PRON
njb-69	230	3	,	,	PUNCT
njb-69	230	4	labia	labia	PROPN
njb-69	230	5	r	r	PROPN
njb-69	230	6	,	,	PUNCT
njb-69	230	7	jacoby	jacoby	PROPN
njb-69	230	8	g	g	X
njb-69	230	9	:	:	PUNCT
njb-69	230	10	extendedspectrum	extendedspectrum	PROPN
njb-69	230	11	beta	beta	PROPN
njb-69	230	12	-	-	PUNCT
njb-69	230	13	lactamases	lactamases	PROPN
njb-69	230	14	.	.	PUNCT
njb-69	231	1	antimicrob	antimicrob	PROPN
njb-69	231	2	agents	agents	PROPN
njb-69	231	3	chemother.1989	chemother.1989	PROPN
njb-69	231	4	33(8):1131	33(8):1131	NUM
njb-69	231	5	-	-	SYM
njb-69	231	6	1136	1136	NUM
njb-69	231	7	.	.	PUNCT
njb-69	232	1	4	4	X
njb-69	232	2	.	.	X
njb-69	232	3	knothe	knothe	PROPN
njb-69	232	4	h	h	PROPN
njb-69	232	5	,	,	PUNCT
njb-69	232	6	shah	shah	PROPN
njb-69	232	7	p	p	PROPN
njb-69	232	8	,	,	PUNCT
njb-69	232	9	krcmery	krcmery	PROPN
njb-69	232	10	v	v	PROPN
njb-69	232	11	,	,	PUNCT
njb-69	232	12	antal	antal	PROPN
njb-69	232	13	m	m	PROPN
njb-69	232	14	,	,	PUNCT
njb-69	232	15	mitsuhashi	mitsuhashi	PROPN
njb-69	232	16	s	s	PROPN
njb-69	232	17	:	:	PUNCT
njb-69	232	18	transferable	transferable	ADJ
njb-69	232	19	resistance	resistance	NOUN
njb-69	232	20	to	to	ADP
njb-69	232	21	cefotaxime	cefotaxime	NOUN
njb-69	232	22	,	,	PUNCT
njb-69	232	23	cefoxitin	cefoxitin	NOUN
njb-69	232	24	,	,	PUNCT
njb-69	232	25	cefamandole	cefamandole	NOUN
njb-69	232	26	and	and	CCONJ
njb-69	232	27	cefuroxime	cefuroxime	NOUN
njb-69	232	28	in	in	ADP
njb-69	232	29	clinical	clinical	ADJ
njb-69	232	30	isolates	isolate	NOUN
njb-69	232	31	of	of	ADP
njb-69	232	32	klebsiella	klebsiella	PROPN
njb-69	232	33	pneumoniae	pneumoniae	NOUN
njb-69	232	34	and	and	CCONJ
njb-69	232	35	serratia	serratia	PROPN
njb-69	232	36	marcescens	marcescen	NOUN
njb-69	232	37	.	.	PUNCT
njb-69	233	1	infection	infection	NOUN
njb-69	233	2	.	.	PUNCT
njb-69	234	1	1983	1983	NUM
njb-69	234	2	,	,	PUNCT
njb-69	234	3	11(6):315	11(6):315	PROPN
njb-69	234	4	-	-	PUNCT
njb-69	234	5	317	317	NUM
njb-69	234	6	.	.	NUM
njb-69	234	7	5	5	NUM
njb-69	234	8	.	.	PROPN
njb-69	234	9	pokharel	pokharel	PROPN
njb-69	234	10	bm	bm	PROPN
njb-69	234	11	,	,	PUNCT
njb-69	234	12	koirala	koirala	PROPN
njb-69	234	13	j	j	PROPN
njb-69	234	14	,	,	PUNCT
njb-69	234	15	dahal	dahal	PROPN
njb-69	234	16	rk	rk	PROPN
njb-69	234	17	,	,	PUNCT
njb-69	234	18	mishra	mishra	PROPN
njb-69	234	19	sk	sk	PROPN
njb-69	234	20	,	,	PUNCT
njb-69	234	21	khadga	khadga	PROPN
njb-69	234	22	pk	pk	PROPN
njb-69	234	23	,	,	PUNCT
njb-69	234	24	tuladhar	tuladhar	PROPN
njb-69	234	25	nr	nr	ADP
njb-69	234	26	:	:	PUNCT
njb-69	234	27	multidrugresistant	multidrugresistant	PROPN
njb-69	234	28	and	and	CCONJ
njb-69	234	29	extended	extend	VERB
njb-69	234	30	-	-	PUNCT
njb-69	234	31	spectrum	spectrum	NOUN
njb-69	234	32	betalactamase	betalactamase	NOUN
njb-69	234	33	(	(	PUNCT
njb-69	234	34	esbl)-producing	esbl)-produce	VERB
njb-69	234	35	salmonella	salmonella	PROPN
njb-69	234	36	enterica	enterica	PROPN
njb-69	234	37	(	(	PUNCT
njb-69	234	38	serotypes	serotype	VERB
njb-69	234	39	typhi	typhi	ADV
njb-69	234	40	and	and	CCONJ
njb-69	234	41	paratyphi	paratyphi	PROPN
njb-69	234	42	a	a	X
njb-69	234	43	)	)	PUNCT
njb-69	234	44	from	from	ADP
njb-69	234	45	blood	blood	NOUN
njb-69	234	46	isolates	isolate	NOUN
njb-69	234	47	in	in	ADP
njb-69	234	48	nepal	nepal	NOUN
njb-69	234	49	:	:	PUNCT
njb-69	234	50	surveillance	surveillance	NOUN
njb-69	234	51	of	of	ADP
njb-69	234	52	resistance	resistance	NOUN
njb-69	234	53	and	and	CCONJ
njb-69	234	54	a	a	DET
njb-69	234	55	search	search	NOUN
njb-69	234	56	for	for	ADP
njb-69	234	57	newer	new	ADJ
njb-69	234	58	alternatives	alternative	NOUN
njb-69	234	59	.	.	PUNCT
njb-69	235	1	int	int	PROPN
njb-69	235	2	j	j	PROPN
njb-69	235	3	inf	inf	PROPN
njb-69	235	4	dis	dis	PROPN
njb-69	235	5	.	.	PROPN
njb-69	235	6	2006	2006	NUM
njb-69	236	1	10(6):434	10(6):434	NUM
njb-69	236	2	-	-	PUNCT
njb-69	236	3	438	438	NUM
njb-69	236	4	.	.	NUM
njb-69	237	1	6	6	NUM
njb-69	237	2	.	.	PROPN
njb-69	237	3	walsh	walsh	PROPN
njb-69	237	4	tr	tr	VERB
njb-69	237	5	:	:	PUNCT
njb-69	237	6	emerging	emerge	VERB
njb-69	237	7	carbapenemases	carbapenemase	NOUN
njb-69	237	8	:	:	PUNCT
njb-69	237	9	a	a	DET
njb-69	237	10	global	global	ADJ
njb-69	237	11	perspective	perspective	NOUN
njb-69	237	12	.	.	PUNCT
njb-69	238	1	int	int	PROPN
njb-69	238	2	j	j	PROPN
njb-69	238	3	antimicrob	antimicrob	PROPN
njb-69	238	4	agents	agents	PROPN
njb-69	238	5	.	.	PUNCT
njb-69	239	1	2010	2010	NUM
njb-69	239	2	36	36	NUM
njb-69	239	3	:	:	PUNCT
njb-69	239	4	s8	s8	PROPN
njb-69	239	5	-	-	PUNCT
njb-69	239	6	s14	s14	PROPN
njb-69	239	7	.	.	PUNCT
njb-69	239	8	7	7	NUM
njb-69	239	9	.	.	PUNCT
njb-69	239	10	watanabe	watanabe	PROPN
njb-69	239	11	m	m	PROPN
njb-69	239	12	,	,	PUNCT
njb-69	239	13	iyobe	iyobe	PROPN
njb-69	239	14	s	s	PROPN
njb-69	239	15	,	,	PUNCT
njb-69	239	16	inoue	inoue	PROPN
njb-69	239	17	m	m	PROPN
njb-69	239	18	,	,	PUNCT
njb-69	239	19	mitsuhashi	mitsuhashi	PROPN
njb-69	239	20	s	s	PROPN
njb-69	239	21	:	:	PUNCT
njb-69	239	22	transferable	transferable	PROPN
njb-69	239	23	imipenem	imipenem	PROPN
njb-69	239	24	resistance	resistance	NOUN
njb-69	239	25	in	in	ADP
njb-69	239	26	pseudomonas	pseudomonas	PROPN
njb-69	239	27	aeruginosa	aeruginosa	PROPN
njb-69	239	28	.	.	PUNCT
njb-69	240	1	antimicrob	antimicrob	PROPN
njb-69	240	2	agents	agents	PROPN
njb-69	240	3	chemother	chemother	PROPN
njb-69	240	4	.	.	PUNCT
njb-69	241	1	1991	1991	NUM
njb-69	241	2	35(1):147	35(1):147	NUM
njb-69	241	3	-	-	SYM
njb-69	241	4	151	151	NUM
njb-69	241	5	.	.	NUM
njb-69	241	6	8	8	NUM
njb-69	241	7	.	.	PUNCT
njb-69	242	1	mishra	mishra	PROPN
njb-69	242	2	sk	sk	PROPN
njb-69	242	3	,	,	PUNCT
njb-69	242	4	acharya	acharya	PROPN
njb-69	242	5	j	j	PROPN
njb-69	242	6	,	,	PUNCT
njb-69	242	7	kattel	kattel	PROPN
njb-69	242	8	hp	hp	PROPN
njb-69	242	9	,	,	PUNCT
njb-69	242	10	shah	shah	NOUN
njb-69	242	11	as	as	ADP
njb-69	242	12	,	,	PUNCT
njb-69	242	13	rijal	rijal	ADJ
njb-69	242	14	bp	bp	PROPN
njb-69	242	15	,	,	PUNCT
njb-69	242	16	pokhrel	pokhrel	PROPN
njb-69	242	17	bm	bm	PROPN
njb-69	242	18	:	:	PUNCT
njb-69	242	19	metallo	metallo	PROPN
njb-69	242	20	-	-	PUNCT
njb-69	242	21	beta	beta	NOUN
njb-69	242	22	-	-	PUNCT
njb-69	242	23	lactamase	lactamase	NOUN
njb-69	242	24	producing	produce	VERB
njb-69	242	25	bacterial	bacterial	ADJ
njb-69	242	26	isolates	isolate	NOUN
njb-69	242	27	:	:	PUNCT
njb-69	242	28	first	first	ADJ
njb-69	242	29	report	report	NOUN
njb-69	242	30	from	from	ADP
njb-69	242	31	nepal	nepal	ADJ
njb-69	242	32	.	.	PUNCT
njb-69	243	1	in	in	ADP
njb-69	243	2	.	.	PUNCT
njb-69	244	1	kathmandu	kathmandu	NOUN
njb-69	244	2	:	:	PUNCT
njb-69	244	3	iom	iom	PROPN
njb-69	244	4	souvenir	souvenir	PROPN
njb-69	244	5	2009	2009	NUM
njb-69	244	6	:	:	PUNCT
njb-69	244	7	57	57	NUM
njb-69	244	8	.	.	X
njb-69	244	9	9	9	NUM
njb-69	244	10	.	.	PUNCT
njb-69	245	1	shah	shah	PROPN
njb-69	245	2	aa	aa	PROPN
njb-69	245	3	,	,	PUNCT
njb-69	245	4	hasan	hasan	PROPN
njb-69	245	5	f	f	PROPN
njb-69	245	6	,	,	PUNCT
njb-69	245	7	ahmed	ahmed	PROPN
njb-69	245	8	s	s	PROPN
njb-69	245	9	,	,	PUNCT
njb-69	245	10	hameed	hameed	VERB
njb-69	245	11	a	a	PRON
njb-69	245	12	:	:	PUNCT
njb-69	245	13	characteristics	characteristic	NOUN
njb-69	245	14	,	,	PUNCT
njb-69	245	15	epidemiology	epidemiology	NOUN
njb-69	245	16	and	and	CCONJ
njb-69	245	17	clinical	clinical	ADJ
njb-69	245	18	importance	importance	NOUN
njb-69	245	19	of	of	ADP
njb-69	245	20	emerging	emerge	VERB
njb-69	245	21	strains	strain	NOUN
njb-69	245	22	of	of	ADP
njb-69	245	23	gramnegative	gramnegative	ADJ
njb-69	245	24	bacilli	bacilli	PROPN
njb-69	245	25	producing	produce	VERB
njb-69	245	26	extendedspectrum	extendedspectrum	PROPN
njb-69	245	27	β	β	PROPN
njb-69	245	28	-	-	PUNCT
njb-69	245	29	lactamases	lactamases	PROPN
njb-69	245	30	.	.	PUNCT
njb-69	246	1	res	res	NOUN
njb-69	246	2	microbiol	microbiol	PROPN
njb-69	246	3	.	.	PUNCT
njb-69	247	1	2004	2004	NUM
njb-69	247	2	155(6):409	155(6):409	NUM
njb-69	247	3	-	-	SYM
njb-69	247	4	421	421	NUM
njb-69	247	5	.	.	SYM
njb-69	248	1	10	10	NUM
njb-69	248	2	.	.	PROPN
njb-69	248	3	bauer	bauer	PROPN
njb-69	248	4	aw	aw	PROPN
njb-69	248	5	,	,	PUNCT
njb-69	248	6	kirby	kirby	PROPN
njb-69	248	7	wmm	wmm	PROPN
njb-69	248	8	,	,	PUNCT
njb-69	248	9	sherris	sherris	PROPN
njb-69	248	10	jc	jc	PROPN
njb-69	248	11	,	,	PUNCT
njb-69	248	12	turck	turck	ADV
njb-69	248	13	m	m	NOUN
njb-69	248	14	:	:	PUNCT
njb-69	248	15	antibiotic	antibiotic	ADJ
njb-69	248	16	susceptibility	susceptibility	NOUN
njb-69	248	17	testing	testing	NOUN
njb-69	248	18	by	by	ADP
njb-69	248	19	a	a	DET
njb-69	248	20	nepal	nepal	ADJ
njb-69	248	21	journal	journal	NOUN
njb-69	248	22	of	of	ADP
njb-69	248	23	biotechnology	biotechnology	NOUN
njb-69	248	24	.	.	PUNCT
njb-69	249	1	d	d	X
njb-69	249	2	e	e	PROPN
njb-69	249	3	c	c	PROPN
njb-69	249	4	.	.	PUNCT
njb-69	250	1	2	2	NUM
njb-69	250	2	0	0	NUM
njb-69	250	3	1	1	NUM
njb-69	250	4	9	9	NUM
njb-69	250	5	vol	vol	NOUN
njb-69	250	6	.	.	PUNCT
njb-69	251	1	7	7	NUM
njb-69	251	2	,	,	PUNCT
njb-69	251	3	no	no	NOUN
njb-69	251	4	.	.	NOUN
njb-69	251	5	1	1	NUM
njb-69	251	6	:	:	SYM
njb-69	251	7	74	74	NUM
njb-69	251	8	-	-	SYM
njb-69	251	9	81	81	NUM
njb-69	251	10	maharjan	maharjan	NOUN
njb-69	251	11	et	et	PROPN
njb-69	251	12	al	al	PROPN
njb-69	251	13	.	.	PROPN
njb-69	252	1	2019	2019	NUM
njb-69	253	1	©	©	ADP
njb-69	253	2	njb	njb	PROPN
njb-69	253	3	,	,	PUNCT
njb-69	253	4	biotechnology	biotechnology	NOUN
njb-69	253	5	society	society	NOUN
njb-69	253	6	of	of	ADP
njb-69	253	7	nepal	nepal	ADJ
njb-69	253	8	81	81	NUM
njb-69	253	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-69	253	10	.	.	PUNCT
njb-69	254	1	standardized	standardized	ADJ
njb-69	254	2	single	single	ADJ
njb-69	254	3	disk	disk	NOUN
njb-69	254	4	method	method	NOUN
njb-69	254	5	.	.	PUNCT
njb-69	255	1	am	be	AUX
njb-69	255	2	j	j	PROPN
njb-69	255	3	clin	clin	PROPN
njb-69	255	4	pathol	pathol	PROPN
njb-69	255	5	1966	1966	NUM
njb-69	255	6	45(4):493	45(4):493	PROPN
njb-69	255	7	-	-	SYM
njb-69	255	8	496	496	NUM
njb-69	255	9	.	.	NUM
njb-69	255	10	11	11	NUM
njb-69	255	11	.	.	X
njb-69	255	12	clinical	clinical	ADJ
njb-69	255	13	and	and	CCONJ
njb-69	255	14	laboratory	laboratory	PROPN
njb-69	255	15	standards	standards	PROPN
njb-69	255	16	institute	institute	PROPN
njb-69	255	17	(	(	PUNCT
njb-69	255	18	clsi	clsi	NOUN
njb-69	255	19	):	):	PUNCT
njb-69	255	20	performance	performance	NOUN
njb-69	255	21	standards	standard	NOUN
njb-69	255	22	for	for	ADP
njb-69	255	23	antimicrobial	antimicrobial	ADJ
njb-69	255	24	susceptibility	susceptibility	NOUN
njb-69	255	25	testing	testing	NOUN
njb-69	255	26	,	,	PUNCT
njb-69	255	27	in	in	ADP
njb-69	255	28	twenty	twenty	NUM
njb-69	255	29	-	-	PUNCT
njb-69	255	30	fourth	fourth	ADJ
njb-69	255	31	informational	informational	ADJ
njb-69	255	32	supplement	supplement	NOUN
njb-69	255	33	(	(	PUNCT
njb-69	255	34	m100	m100	PROPN
njb-69	255	35	-	-	PUNCT
njb-69	255	36	s24	s24	NOUN
njb-69	255	37	)	)	PUNCT
njb-69	255	38	.	.	PUNCT
njb-69	256	1	in	in	ADP
njb-69	256	2	.	.	PUNCT
njb-69	257	1	wayne	wayne	PROPN
njb-69	257	2	:	:	PUNCT
njb-69	257	3	clinical	clinical	ADJ
njb-69	257	4	and	and	CCONJ
njb-69	257	5	laboratory	laboratory	PROPN
njb-69	257	6	standards	standards	PROPN
njb-69	257	7	institute	institute	PROPN
njb-69	257	8	;	;	PUNCT
njb-69	257	9	2014	2014	NUM
njb-69	257	10	.	.	PUNCT
njb-69	258	1	12	12	NUM
njb-69	258	2	.	.	PUNCT
njb-69	259	1	mishra	mishra	PROPN
njb-69	259	2	sk	sk	PROPN
njb-69	259	3	,	,	PUNCT
njb-69	259	4	acharya	acharya	PROPN
njb-69	259	5	j	j	PROPN
njb-69	259	6	,	,	PUNCT
njb-69	259	7	kattel	kattel	PROPN
njb-69	259	8	hp	hp	PROPN
njb-69	259	9	,	,	PUNCT
njb-69	259	10	koirala	koirala	PROPN
njb-69	259	11	j	j	PROPN
njb-69	259	12	,	,	PUNCT
njb-69	259	13	rijal	rijal	PROPN
njb-69	259	14	bp	bp	PROPN
njb-69	259	15	,	,	PUNCT
njb-69	259	16	pokhrel	pokhrel	PROPN
njb-69	259	17	bm	bm	PROPN
njb-69	259	18	:	:	PUNCT
njb-69	259	19	metallo	metallo	PROPN
njb-69	259	20	-	-	PUNCT
njb-69	259	21	beta	beta	NOUN
njb-69	259	22	-	-	PUNCT
njb-69	259	23	lactamase	lactamase	NOUN
njb-69	259	24	producing	produce	VERB
njb-69	259	25	gram	gram	ADJ
njb-69	259	26	-	-	PUNCT
njb-69	259	27	negative	negative	ADJ
njb-69	259	28	bacterial	bacterial	ADJ
njb-69	259	29	isolates	isolate	NOUN
njb-69	259	30	.	.	PUNCT
njb-69	260	1	j	j	PROPN
njb-69	260	2	nepal	nepal	PROPN
njb-69	260	3	health	health	PROPN
njb-69	260	4	res	res	PROPN
njb-69	260	5	counc	counc	PROPN
njb-69	260	6	.	.	PUNCT
njb-69	261	1	2012	2012	NUM
njb-69	261	2	10(22):208	10(22):208	NUM
njb-69	261	3	-	-	SYM
njb-69	261	4	213	213	NUM
njb-69	261	5	.	.	NUM
njb-69	261	6	13	13	NUM
njb-69	261	7	.	.	PUNCT
njb-69	262	1	yong	yong	PROPN
njb-69	262	2	d	d	PROPN
njb-69	262	3	,	,	PUNCT
njb-69	262	4	lee	lee	PROPN
njb-69	262	5	k	k	PROPN
njb-69	262	6	,	,	PUNCT
njb-69	262	7	yum	yum	PROPN
njb-69	262	8	jh	jh	PROPN
njb-69	262	9	,	,	PUNCT
njb-69	262	10	shin	shin	PROPN
njb-69	262	11	hb	hb	PROPN
njb-69	262	12	,	,	PUNCT
njb-69	262	13	rossolini	rossolini	PROPN
njb-69	262	14	gm	gm	PROPN
njb-69	262	15	,	,	PUNCT
njb-69	262	16	chong	chong	PROPN
njb-69	262	17	y	y	PROPN
njb-69	262	18	:	:	PUNCT
njb-69	262	19	imipenem	imipenem	PROPN
njb-69	262	20	-	-	PUNCT
njb-69	262	21	edta	edta	NOUN
njb-69	262	22	disk	disk	NOUN
njb-69	262	23	method	method	NOUN
njb-69	262	24	for	for	ADP
njb-69	262	25	differentiation	differentiation	NOUN
njb-69	262	26	of	of	ADP
njb-69	262	27	metallo	metallo	ADJ
njb-69	262	28	-	-	PUNCT
njb-69	262	29	beta	beta	NOUN
njb-69	262	30	-	-	PUNCT
njb-69	262	31	lactamaseproducing	lactamaseproduce	VERB
njb-69	262	32	clinical	clinical	ADJ
njb-69	262	33	isolates	isolate	NOUN
njb-69	262	34	of	of	ADP
njb-69	262	35	pseudomonas	pseudomonas	PROPN
njb-69	262	36	spp	spp	NOUN
njb-69	262	37	.	.	PUNCT
njb-69	263	1	and	and	CCONJ
njb-69	263	2	acinetobacter	acinetobacter	PROPN
njb-69	263	3	spp	spp	PROPN
njb-69	263	4	.	.	PUNCT
njb-69	264	1	j	j	PROPN
njb-69	264	2	clin	clin	PROPN
njb-69	264	3	microbiol	microbiol	PROPN
njb-69	264	4	.	.	PUNCT
njb-69	265	1	2002	2002	NUM
njb-69	265	2	40(10):3798	40(10):3798	NUM
njb-69	265	3	-	-	SYM
njb-69	265	4	3801	3801	NUM
njb-69	265	5	.	.	PUNCT
njb-69	266	1	14	14	NUM
njb-69	266	2	.	.	PUNCT
njb-69	267	1	bonomo	bonomo	PROPN
njb-69	267	2	ra	ra	INTJ
njb-69	267	3	:	:	PUNCT
njb-69	267	4	β	β	PROPN
njb-69	267	5	-	-	PUNCT
njb-69	267	6	lactamases	lactamase	NOUN
njb-69	267	7	:	:	PUNCT
njb-69	267	8	a	a	DET
njb-69	267	9	focus	focus	NOUN
njb-69	267	10	on	on	ADP
njb-69	267	11	current	current	ADJ
njb-69	267	12	challenges	challenge	NOUN
njb-69	267	13	.	.	PUNCT
njb-69	268	1	cold	cold	ADJ
njb-69	268	2	spring	spring	NOUN
njb-69	268	3	harb	harb	PROPN
njb-69	268	4	perspect	perspect	VERB
njb-69	268	5	mede	mede	NOUN
njb-69	268	6	2017	2017	NUM
njb-69	268	7	7(1	7(1	NUM
njb-69	268	8	)	)	PUNCT
njb-69	268	9	.	.	PUNCT
njb-69	269	1	15	15	X
njb-69	269	2	.	.	PUNCT
njb-69	269	3	lakshmi	lakshmi	PROPN
njb-69	269	4	r	r	PROPN
njb-69	269	5	,	,	PUNCT
njb-69	269	6	nusrin	nusrin	PROPN
njb-69	269	7	ks	ks	PROPN
njb-69	269	8	,	,	PUNCT
njb-69	269	9	ann	ann	PROPN
njb-69	269	10	gs	gs	PROPN
njb-69	269	11	,	,	PUNCT
njb-69	269	12	sreelakshmi	sreelakshmi	PROPN
njb-69	269	13	ks	ks	PROPN
njb-69	269	14	:	:	PUNCT
njb-69	269	15	role	role	NOUN
njb-69	269	16	of	of	ADP
njb-69	269	17	beta	beta	NOUN
njb-69	269	18	-	-	PUNCT
njb-69	269	19	lactamases	lactamase	NOUN
njb-69	269	20	in	in	ADP
njb-69	269	21	antibiotic	antibiotic	ADJ
njb-69	269	22	resistance	resistance	NOUN
njb-69	269	23	:	:	PUNCT
njb-69	269	24	a	a	DET
njb-69	269	25	review	review	NOUN
njb-69	269	26	.	.	PUNCT
njb-69	270	1	int	int	PROPN
njb-69	270	2	res	res	PROPN
njb-69	270	3	j	j	PROPN
njb-69	270	4	pharm	pharm	PROPN
njb-69	270	5	.	.	PUNCT
njb-69	271	1	2014	2014	NUM
njb-69	271	2	5(2):37	5(2):37	NUM
njb-69	271	3	-	-	SYM
njb-69	271	4	40	40	NUM
njb-69	271	5	.	.	NUM
njb-69	271	6	16	16	NUM
njb-69	271	7	.	.	PUNCT
njb-69	272	1	khanal	khanal	PROPN
njb-69	272	2	s	s	PROPN
njb-69	272	3	,	,	PUNCT
njb-69	272	4	joshi	joshi	PROPN
njb-69	272	5	dr	dr	PROPN
njb-69	272	6	,	,	PUNCT
njb-69	272	7	bhatta	bhatta	PROPN
njb-69	272	8	dr	dr	PROPN
njb-69	272	9	,	,	PUNCT
njb-69	272	10	devkota	devkota	PROPN
njb-69	272	11	u	u	PROPN
njb-69	272	12	,	,	PUNCT
njb-69	272	13	pokhrel	pokhrel	PROPN
njb-69	272	14	bm	bm	PROPN
njb-69	272	15	:	:	PUNCT
njb-69	272	16	β	β	NOUN
njb-69	272	17	-lactamase	-lactamase	NOUN
njb-69	272	18	-	-	PUNCT
njb-69	272	19	producing	produce	VERB
njb-69	272	20	multidrug	multidrug	NOUN
njb-69	272	21	-	-	PUNCT
njb-69	272	22	resistant	resistant	ADJ
njb-69	272	23	bacterial	bacterial	ADJ
njb-69	272	24	pathogens	pathogen	NOUN
njb-69	272	25	from	from	ADP
njb-69	272	26	tracheal	tracheal	PROPN
njb-69	272	27	aspirates	aspirate	NOUN
njb-69	272	28	of	of	ADP
njb-69	272	29	intensive	intensive	ADJ
njb-69	272	30	care	care	NOUN
njb-69	272	31	unit	unit	NOUN
njb-69	272	32	patients	patient	NOUN
njb-69	272	33	at	at	ADP
njb-69	272	34	national	national	PROPN
njb-69	272	35	institute	institute	PROPN
njb-69	272	36	of	of	ADP
njb-69	272	37	neurological	neurological	ADJ
njb-69	272	38	and	and	CCONJ
njb-69	272	39	allied	allied	ADJ
njb-69	272	40	sciences	science	NOUN
njb-69	272	41	,	,	PUNCT
njb-69	272	42	nepal	nepal	ADJ
njb-69	272	43	.	.	PUNCT
njb-69	273	1	in	in	ADP
njb-69	273	2	:	:	PUNCT
njb-69	273	3	isrn	isrn	PROPN
njb-69	273	4	microbiol	microbiol	PROPN
njb-69	273	5	.	.	PUNCT
njb-69	274	1	2013	2013	NUM
njb-69	274	2	2013	2013	NUM
njb-69	274	3	:	:	PUNCT
njb-69	274	4	847569	847569	NUM
njb-69	274	5	.	.	PUNCT
njb-69	275	1	17	17	NUM
njb-69	275	2	.	.	PUNCT
njb-69	276	1	pokhrel	pokhrel	PROPN
njb-69	276	2	rh	rh	PROPN
njb-69	276	3	,	,	PUNCT
njb-69	276	4	thapa	thapa	PROPN
njb-69	276	5	b	b	PROPN
njb-69	276	6	,	,	PUNCT
njb-69	276	7	kafle	kafle	PROPN
njb-69	276	8	r	r	PROPN
njb-69	276	9	,	,	PUNCT
njb-69	276	10	shah	shah	PROPN
njb-69	276	11	pk	pk	PROPN
njb-69	276	12	,	,	PUNCT
njb-69	276	13	tribuddharat	tribuddharat	PROPN
njb-69	276	14	c	c	NOUN
njb-69	276	15	:	:	PUNCT
njb-69	276	16	co	co	NOUN
njb-69	276	17	-	-	NOUN
njb-69	276	18	existence	existence	NOUN
njb-69	276	19	of	of	ADP
njb-69	276	20	betalactamases	betalactamase	NOUN
njb-69	276	21	in	in	ADP
njb-69	276	22	clinical	clinical	ADJ
njb-69	276	23	isolates	isolate	NOUN
njb-69	276	24	of	of	ADP
njb-69	276	25	escherichia	escherichia	NOUN
njb-69	276	26	coli	coli	NOUN
njb-69	276	27	from	from	ADP
njb-69	276	28	kathmandu	kathmandu	NOUN
njb-69	276	29	,	,	PUNCT
njb-69	276	30	nepal	nepal	ADJ
njb-69	276	31	.	.	PUNCT
njb-69	277	1	bmc	bmc	PROPN
njb-69	277	2	res	res	PROPN
njb-69	277	3	notes	note	NOUN
njb-69	277	4	.	.	PUNCT
njb-69	278	1	2014	2014	NUM
njb-69	278	2	7(1):694	7(1):694	NUM
njb-69	278	3	.	.	PUNCT
njb-69	278	4	18	18	NUM
njb-69	278	5	.	.	PUNCT
njb-69	279	1	ansari	ansari	PROPN
njb-69	279	2	s	s	PROPN
njb-69	279	3	,	,	PUNCT
njb-69	279	4	nepal	nepal	ADJ
njb-69	279	5	hp	hp	PROPN
njb-69	279	6	,	,	PUNCT
njb-69	279	7	gautam	gautam	PROPN
njb-69	279	8	r	r	PROPN
njb-69	279	9	,	,	PUNCT
njb-69	279	10	shrestha	shrestha	PROPN
njb-69	279	11	s	s	PROPN
njb-69	279	12	,	,	PUNCT
njb-69	279	13	neopane	neopane	PROPN
njb-69	279	14	p	p	PROPN
njb-69	279	15	,	,	PUNCT
njb-69	279	16	gurung	gurung	PROPN
njb-69	279	17	g	g	PROPN
njb-69	279	18	,	,	PUNCT
njb-69	279	19	et	et	PROPN
njb-69	279	20	al	al	PROPN
njb-69	279	21	:	:	PUNCT
njb-69	279	22	community	community	NOUN
njb-69	279	23	acquired	acquire	VERB
njb-69	279	24	multi	multi	ADJ
njb-69	279	25	-	-	ADJ
njb-69	279	26	drug	drug	ADJ
njb-69	279	27	resistant	resistant	ADJ
njb-69	279	28	clinical	clinical	ADJ
njb-69	279	29	isolates	isolate	NOUN
njb-69	279	30	of	of	ADP
njb-69	279	31	escherichia	escherichia	NOUN
njb-69	279	32	coli	coli	NOUN
njb-69	279	33	in	in	ADP
njb-69	279	34	a	a	DET
njb-69	279	35	tertiary	tertiary	ADJ
njb-69	279	36	care	care	NOUN
njb-69	279	37	center	center	NOUN
njb-69	279	38	of	of	ADP
njb-69	279	39	nepal	nepal	PROPN
njb-69	279	40	.	.	PUNCT
njb-69	280	1	antimicrob	antimicrob	PROPN
njb-69	280	2	resist	resist	VERB
njb-69	280	3	infect	infect	ADJ
njb-69	280	4	control	control	NOUN
njb-69	280	5	2015	2015	NUM
njb-69	280	6	4(1):15	4(1):15	NUM
njb-69	280	7	.	.	PROPN
njb-69	280	8	19	19	NUM
njb-69	280	9	.	.	PUNCT
njb-69	281	1	yadav	yadav	PROPN
njb-69	281	2	kk	kk	PROPN
njb-69	281	3	,	,	PUNCT
njb-69	281	4	adhikari	adhikari	PROPN
njb-69	281	5	n	n	PROPN
njb-69	281	6	,	,	PUNCT
njb-69	281	7	khadka	khadka	PROPN
njb-69	281	8	r	r	PROPN
njb-69	281	9	,	,	PUNCT
njb-69	281	10	pant	pant	NOUN
njb-69	281	11	ad	ad	NOUN
njb-69	281	12	,	,	PUNCT
njb-69	281	13	shah	shah	PROPN
njb-69	281	14	b	b	PROPN
njb-69	281	15	:	:	PUNCT
njb-69	281	16	multidrug	multidrug	VERB
njb-69	281	17	resistant	resistant	ADJ
njb-69	281	18	enterobacteriaceae	enterobacteriaceae	PROPN
njb-69	281	19	and	and	CCONJ
njb-69	281	20	extended	extend	VERB
njb-69	281	21	spectrum	spectrum	NOUN
njb-69	281	22	β	β	NOUN
njb-69	281	23	-	-	PUNCT
njb-69	281	24	lactamase	lactamase	ADJ
njb-69	281	25	producing	produce	VERB
njb-69	281	26	escherichia	escherichia	NOUN
njb-69	281	27	coli	coli	NOUN
njb-69	281	28	:	:	PUNCT
njb-69	281	29	a	a	DET
njb-69	281	30	cross	cross	ADJ
njb-69	281	31	-	-	ADJ
njb-69	281	32	sectional	sectional	ADJ
njb-69	281	33	study	study	NOUN
njb-69	281	34	in	in	ADP
njb-69	281	35	national	national	ADJ
njb-69	281	36	kidney	kidney	NOUN
njb-69	281	37	center	center	NOUN
njb-69	281	38	,	,	PUNCT
njb-69	281	39	nepal	nepal	ADJ
njb-69	281	40	.	.	PUNCT
njb-69	282	1	antimicrob	antimicrob	PROPN
njb-69	282	2	resist	resist	VERB
njb-69	282	3	infect	infect	ADJ
njb-69	282	4	control	control	NOUN
njb-69	282	5	.	.	PUNCT
njb-69	283	1	2015	2015	NUM
njb-69	283	2	4(1):42	4(1):42	NUM
njb-69	283	3	.	.	PUNCT
njb-69	283	4	20	20	NUM
njb-69	283	5	.	.	PUNCT
njb-69	283	6	nepal	nepal	PROPN
njb-69	283	7	k	k	PROPN
njb-69	283	8	,	,	PUNCT
njb-69	283	9	pant	pant	PROPN
njb-69	283	10	nd	nd	PROPN
njb-69	283	11	,	,	PUNCT
njb-69	283	12	neupane	neupane	PROPN
njb-69	283	13	b	b	PROPN
njb-69	283	14	,	,	PUNCT
njb-69	283	15	belbase	belbase	PROPN
njb-69	283	16	a	a	PROPN
njb-69	283	17	,	,	PUNCT
njb-69	283	18	baidhya	baidhya	PROPN
njb-69	283	19	r	r	PROPN
njb-69	283	20	,	,	PUNCT
njb-69	283	21	shrestha	shrestha	X
njb-69	283	22	rk	rk	PROPN
njb-69	283	23	,	,	PUNCT
njb-69	283	24	et	et	PROPN
njb-69	283	25	al	al	PROPN
njb-69	283	26	:	:	PUNCT
njb-69	283	27	extended	extended	ADJ
njb-69	283	28	spectrum	spectrum	NOUN
njb-69	283	29	beta	beta	NOUN
njb-69	283	30	-	-	PUNCT
njb-69	283	31	lactamase	lactamase	NOUN
njb-69	283	32	and	and	CCONJ
njb-69	283	33	metallo	metallo	NOUN
njb-69	283	34	betalactamase	betalactamase	ADJ
njb-69	283	35	production	production	NOUN
njb-69	283	36	among	among	ADP
njb-69	283	37	escherichia	escherichia	NOUN
njb-69	283	38	coli	coli	NOUN
njb-69	283	39	and	and	CCONJ
njb-69	283	40	klebsiella	klebsiella	PROPN
njb-69	283	41	pneumoniae	pneumoniae	NOUN
njb-69	283	42	isolated	isolate	VERB
njb-69	283	43	from	from	ADP
njb-69	283	44	different	different	ADJ
njb-69	283	45	clinical	clinical	ADJ
njb-69	283	46	samples	sample	NOUN
njb-69	283	47	in	in	ADP
njb-69	283	48	a	a	DET
njb-69	283	49	tertiary	tertiary	ADJ
njb-69	283	50	care	care	NOUN
njb-69	283	51	hospital	hospital	NOUN
njb-69	283	52	in	in	ADP
njb-69	283	53	kathmandu	kathmandu	NOUN
njb-69	283	54	,	,	PUNCT
njb-69	283	55	nepal	nepal	NOUN
njb-69	283	56	.	.	PUNCT
njb-69	284	1	ann	ann	PROPN
njb-69	284	2	clin	clin	PROPN
njb-69	284	3	microbiol	microbiol	PROPN
njb-69	284	4	antimicrob	antimicrob	PROPN
njb-69	284	5	.	.	PUNCT
njb-69	285	1	2017	2017	NUM
njb-69	285	2	16(1):62	16(1):62	NUM
njb-69	285	3	.	.	PUNCT
njb-69	285	4	21	21	NUM
njb-69	285	5	.	.	PUNCT
njb-69	286	1	poudyal	poudyal	PROPN
njb-69	286	2	s	s	PROPN
njb-69	286	3	,	,	PUNCT
njb-69	286	4	bhatta	bhatta	PROPN
njb-69	286	5	dr	dr	PROPN
njb-69	286	6	,	,	PUNCT
njb-69	286	7	shakya	shakya	PROPN
njb-69	286	8	g	g	PROPN
njb-69	286	9	,	,	PUNCT
njb-69	286	10	upadhyaya	upadhyaya	PROPN
njb-69	286	11	b	b	PROPN
njb-69	286	12	,	,	PUNCT
njb-69	286	13	dumre	dumre	PROPN
njb-69	286	14	sp	sp	PROPN
njb-69	286	15	,	,	PUNCT
njb-69	286	16	buda	buda	PROPN
njb-69	286	17	gc	gc	PROPN
njb-69	286	18	,	,	PUNCT
njb-69	286	19	et	et	PROPN
njb-69	286	20	al	al	PROPN
njb-69	286	21	:	:	PUNCT
njb-69	286	22	extendedspectrum	extendedspectrum	PROPN
njb-69	286	23	beta	beta	PROPN
njb-69	286	24	-	-	PUNCT
njb-69	286	25	lactamase	lactamase	NOUN
njb-69	286	26	producing	produce	VERB
njb-69	286	27	multidrug	multidrug	NOUN
njb-69	286	28	resistant	resistant	ADJ
njb-69	286	29	clinical	clinical	ADJ
njb-69	286	30	bacterial	bacterial	ADJ
njb-69	286	31	isolates	isolate	NOUN
njb-69	286	32	at	at	ADP
njb-69	286	33	national	national	ADJ
njb-69	286	34	public	public	PROPN
njb-69	286	35	health	health	PROPN
njb-69	286	36	laboratory	laboratory	PROPN
njb-69	286	37	,	,	PUNCT
njb-69	286	38	nepal	nepal	ADJ
njb-69	286	39	.	.	PUNCT
njb-69	287	1	nepal	nepal	PROPN
njb-69	287	2	med	med	PROPN
njb-69	287	3	coll	coll	PROPN
njb-69	287	4	j.	j.	PROPN
njb-69	287	5	2011	2011	NUM
njb-69	287	6	13(1):34	13(1):34	PROPN
njb-69	287	7	-	-	SYM
njb-69	287	8	38	38	NUM
njb-69	287	9	.	.	NUM
njb-69	287	10	22	22	NUM
njb-69	287	11	.	.	PUNCT
njb-69	287	12	nepal	nepal	ADJ
njb-69	287	13	hp	hp	PROPN
njb-69	287	14	,	,	PUNCT
njb-69	287	15	neopane	neopane	PROPN
njb-69	287	16	p	p	PROPN
njb-69	287	17	,	,	PUNCT
njb-69	287	18	shrestha	shrestha	PROPN
njb-69	287	19	r	r	PROPN
njb-69	287	20	,	,	PUNCT
njb-69	287	21	gautam	gautam	PROPN
njb-69	287	22	r	r	PROPN
njb-69	287	23	,	,	PUNCT
njb-69	287	24	paudel	paudel	PROPN
njb-69	287	25	r	r	PROPN
njb-69	287	26	,	,	PUNCT
njb-69	287	27	ansari	ansari	PROPN
njb-69	287	28	s	s	PROPN
njb-69	287	29	,	,	PUNCT
njb-69	287	30	et	et	PROPN
njb-69	287	31	al	al	PROPN
njb-69	287	32	:	:	PUNCT
njb-69	287	33	biofilm	biofilm	NOUN
njb-69	287	34	formation	formation	NOUN
njb-69	287	35	and	and	CCONJ
njb-69	287	36	antimicrobial	antimicrobial	ADJ
njb-69	287	37	resistance	resistance	NOUN
njb-69	287	38	in	in	ADP
njb-69	287	39	klebsiella	klebsiella	PROPN
njb-69	287	40	pneumoniae	pneumoniae	NOUN
njb-69	287	41	isolated	isolate	VERB
njb-69	287	42	from	from	ADP
njb-69	287	43	patients	patient	NOUN
njb-69	287	44	visiting	visit	VERB
njb-69	287	45	a	a	DET
njb-69	287	46	tertiary	tertiary	ADJ
njb-69	287	47	care	care	NOUN
njb-69	287	48	center	center	NOUN
njb-69	287	49	of	of	ADP
njb-69	287	50	nepal	nepal	NOUN
njb-69	287	51	.	.	PUNCT
njb-69	288	1	asian	asian	PROPN
njb-69	288	2	pac	pac	PROPN
njb-69	288	3	j	j	PROPN
njb-69	288	4	trop	trop	PROPN
njb-69	288	5	dis	dis	PROPN
njb-69	288	6	.	.	PROPN
njb-69	288	7	2017	2017	NUM
njb-69	288	8	7(6):347	7(6):347	NUM
njb-69	288	9	-	-	SYM
njb-69	288	10	351	351	NUM
njb-69	288	11	.	.	NUM
njb-69	288	12	23	23	NUM
njb-69	288	13	.	.	PUNCT
njb-69	289	1	raut	raut	PROPN
njb-69	289	2	s	s	PROPN
njb-69	289	3	,	,	PUNCT
njb-69	289	4	gokhale	gokhale	PROPN
njb-69	289	5	s	s	PROPN
njb-69	289	6	,	,	PUNCT
njb-69	289	7	adhikari	adhikari	PROPN
njb-69	289	8	b	b	PROPN
njb-69	289	9	:	:	PUNCT
njb-69	289	10	prevalence	prevalence	NOUN
njb-69	289	11	of	of	ADP
njb-69	289	12	extended	extended	ADJ
njb-69	289	13	-	-	PUNCT
njb-69	289	14	spectrum	spectrum	NOUN
njb-69	289	15	beta	beta	NOUN
njb-69	289	16	-	-	PUNCT
njb-69	289	17	lactamases	lactamase	NOUN
njb-69	289	18	among	among	ADP
njb-69	289	19	escherichia	escherichia	NOUN
njb-69	289	20	coli	coli	NOUN
njb-69	289	21	and	and	CCONJ
njb-69	289	22	klebsiella	klebsiella	PROPN
njb-69	289	23	spp	spp	PROPN
njb-69	289	24	isolates	isolate	VERB
njb-69	289	25	in	in	ADP
njb-69	289	26	manipal	manipal	ADJ
njb-69	289	27	teaching	teaching	NOUN
njb-69	289	28	hospital	hospital	NOUN
njb-69	289	29	,	,	PUNCT
njb-69	289	30	pokhara	pokhara	PROPN
njb-69	289	31	,	,	PUNCT
njb-69	289	32	nepal	nepal	NOUN
njb-69	289	33	.	.	PUNCT
njb-69	290	1	j	j	PROPN
njb-69	290	2	microbiol	microbiol	PROPN
njb-69	290	3	infect	infect	PROPN
njb-69	290	4	dis	dis	PROPN
njb-69	290	5	.	.	PROPN
njb-69	290	6	2015	2015	NUM
njb-69	291	1	5(2):69	5(2):69	NUM
njb-69	291	2	-	-	SYM
njb-69	291	3	75	75	NUM
njb-69	291	4	.	.	NUM
njb-69	291	5	24	24	NUM
njb-69	291	6	.	.	PUNCT
njb-69	292	1	franklin	franklin	PROPN
njb-69	292	2	c	c	PROPN
njb-69	292	3	,	,	PUNCT
njb-69	292	4	liolios	liolio	VERB
njb-69	292	5	l	l	PROPN
njb-69	292	6	,	,	PUNCT
njb-69	292	7	peleg	peleg	PROPN
njb-69	292	8	ay	ay	PROPN
njb-69	292	9	:	:	PUNCT
njb-69	292	10	phenotypic	phenotypic	ADJ
njb-69	292	11	detection	detection	NOUN
njb-69	292	12	of	of	ADP
njb-69	292	13	carbapenem	carbapenem	NOUN
njb-69	292	14	-	-	PUNCT
njb-69	292	15	susceptible	susceptible	ADJ
njb-69	292	16	metallo	metallo	ADJ
njb-69	292	17	-	-	PUNCT
njb-69	292	18	beta	beta	NOUN
njb-69	292	19	-	-	PUNCT
njb-69	292	20	lactamase	lactamase	NOUN
njb-69	292	21	-	-	PUNCT
njb-69	292	22	producing	produce	VERB
njb-69	292	23	gramnegative	gramnegative	ADJ
njb-69	292	24	bacilli	bacilli	NOUN
njb-69	292	25	in	in	ADP
njb-69	292	26	the	the	DET
njb-69	292	27	clinical	clinical	ADJ
njb-69	292	28	laboratory	laboratory	NOUN
njb-69	292	29	.	.	PUNCT
njb-69	293	1	j	j	PROPN
njb-69	293	2	clin	clin	PROPN
njb-69	293	3	microbiol	microbiol	PROPN
njb-69	293	4	.	.	PUNCT
njb-69	294	1	2006	2006	NUM
njb-69	294	2	44:3139	44:3139	NUM
njb-69	294	3	-	-	SYM
njb-69	294	4	3144	3144	NUM
njb-69	294	5	.	.	PUNCT
njb-69	295	1	25	25	NUM
njb-69	295	2	.	.	PUNCT
njb-69	296	1	gaur	gaur	PROPN
njb-69	296	2	a	a	PROPN
njb-69	296	3	,	,	PUNCT
njb-69	296	4	garg	garg	PROPN
njb-69	296	5	a	a	PRON
njb-69	296	6	,	,	PUNCT
njb-69	296	7	prakash	prakash	PROPN
njb-69	296	8	p	p	PROPN
njb-69	296	9	,	,	PUNCT
njb-69	296	10	anupurba	anupurba	PROPN
njb-69	296	11	s	s	PROPN
njb-69	296	12	,	,	PUNCT
njb-69	296	13	mohapatra	mohapatra	PROPN
njb-69	296	14	tm	tm	PROPN
njb-69	296	15	:	:	PUNCT
njb-69	296	16	observations	observation	NOUN
njb-69	296	17	on	on	ADP
njb-69	296	18	carbapenem	carbapenem	PROPN
njb-69	296	19	resistance	resistance	NOUN
njb-69	296	20	by	by	ADP
njb-69	296	21	minimum	minimum	ADJ
njb-69	296	22	inhibitory	inhibitory	ADJ
njb-69	296	23	concentration	concentration	NOUN
njb-69	296	24	in	in	ADP
njb-69	296	25	nosocomial	nosocomial	ADJ
njb-69	296	26	isolates	isolate	NOUN
njb-69	296	27	of	of	ADP
njb-69	296	28	acinetobacter	acinetobacter	ADJ
njb-69	296	29	species	specie	NOUN
njb-69	296	30	:	:	PUNCT
njb-69	296	31	an	an	DET
njb-69	296	32	experience	experience	NOUN
njb-69	296	33	at	at	ADP
njb-69	296	34	a	a	DET
njb-69	296	35	tertiary	tertiary	ADJ
njb-69	296	36	care	care	NOUN
njb-69	296	37	hospital	hospital	NOUN
njb-69	296	38	in	in	ADP
njb-69	296	39	north	north	PROPN
njb-69	296	40	india	india	PROPN
njb-69	296	41	.	.	PUNCT
njb-69	297	1	j	j	PROPN
njb-69	297	2	health	health	PROPN
njb-69	297	3	popn	popn	PROPN
njb-69	297	4	nutr	nutr	PROPN
njb-69	297	5	.	.	PUNCT
njb-69	298	1	2008	2008	NUM
njb-69	299	1	26(2):183	26(2):183	NUM
njb-69	299	2	-	-	PUNCT
njb-69	299	3	188	188	NUM
njb-69	299	4	.	.	NUM
njb-69	299	5	26	26	NUM
njb-69	299	6	.	.	PUNCT
njb-69	300	1	lee	lee	PROPN
njb-69	300	2	k	k	PROPN
njb-69	300	3	,	,	PUNCT
njb-69	300	4	lim	lim	PROPN
njb-69	300	5	ch	ch	PROPN
njb-69	300	6	,	,	PUNCT
njb-69	300	7	cho	cho	PROPN
njb-69	300	8	jh	jh	PROPN
njb-69	300	9	,	,	PUNCT
njb-69	300	10	lee	lee	PROPN
njb-69	300	11	wg	wg	PROPN
njb-69	300	12	,	,	PUNCT
njb-69	300	13	uh	uh	INTJ
njb-69	300	14	y	y	PROPN
njb-69	300	15	,	,	PUNCT
njb-69	300	16	kim	kim	PROPN
njb-69	300	17	hj	hj	PROPN
njb-69	300	18	,	,	PUNCT
njb-69	300	19	et	et	PROPN
njb-69	300	20	al	al	PROPN
njb-69	300	21	:	:	PUNCT
njb-69	300	22	high	high	ADJ
njb-69	300	23	prevalence	prevalence	NOUN
njb-69	300	24	of	of	ADP
njb-69	300	25	ceftazidimeresistant	ceftazidimeresistant	ADJ
njb-69	300	26	klebsiella	klebsiella	PROPN
njb-69	300	27	pneumoniae	pneumoniae	NOUN
njb-69	300	28	and	and	CCONJ
njb-69	300	29	increase	increase	NOUN
njb-69	300	30	of	of	ADP
njb-69	300	31	imipenem	imipenem	NOUN
njb-69	300	32	-	-	PUNCT
njb-69	300	33	resistant	resistant	ADJ
njb-69	300	34	pseudomonas	pseudomonas	PROPN
njb-69	300	35	aeruginosa	aeruginosa	PROPN
njb-69	300	36	and	and	CCONJ
njb-69	300	37	acinetobacter	acinetobacter	PROPN
njb-69	300	38	spp	spp	PROPN
njb-69	300	39	.	.	PUNCT
njb-69	301	1	in	in	ADP
njb-69	301	2	korea	korea	PROPN
njb-69	301	3	:	:	PUNCT
njb-69	301	4	a	a	DET
njb-69	301	5	konsar	konsar	ADJ
njb-69	301	6	program	program	NOUN
njb-69	301	7	in	in	ADP
njb-69	301	8	2004	2004	NUM
njb-69	301	9	.	.	PUNCT
njb-69	302	1	yonsei	yonsei	PROPN
njb-69	302	2	med	med	PROPN
njb-69	302	3	j.	j.	PROPN
njb-69	302	4	2006	2006	NUM
njb-69	302	5	47(5):634	47(5):634	PROPN
njb-69	302	6	-	-	SYM
njb-69	302	7	645	645	NUM
njb-69	302	8	.	.	PROPN
njb-69	302	9	27	27	NUM
njb-69	302	10	.	.	PUNCT
njb-69	303	1	magiorakos	magiorakos	PROPN
njb-69	303	2	ap	ap	PROPN
njb-69	303	3	,	,	PUNCT
njb-69	303	4	srinivasan	srinivasan	VERB
njb-69	303	5	a	a	PRON
njb-69	303	6	,	,	PUNCT
njb-69	303	7	carey	carey	NOUN
njb-69	303	8	rb	rb	NOUN
njb-69	303	9	,	,	PUNCT
njb-69	303	10	carmeli	carmeli	PROPN
njb-69	303	11	y	y	PROPN
njb-69	303	12	,	,	PUNCT
njb-69	303	13	falagas	falagas	VERB
njb-69	303	14	me	i	PRON
njb-69	303	15	,	,	PUNCT
njb-69	303	16	giske	giske	PROPN
njb-69	303	17	cg	cg	PROPN
njb-69	303	18	,	,	PUNCT
njb-69	303	19	et	et	PROPN
njb-69	303	20	al	al	PROPN
njb-69	303	21	:	:	PUNCT
njb-69	303	22	multidrug	multidrug	NOUN
njb-69	303	23	-	-	PUNCT
njb-69	303	24	resistant	resistant	ADJ
njb-69	303	25	,	,	PUNCT
njb-69	303	26	extensively	extensively	ADV
njb-69	303	27	drugresistant	drugresistant	ADJ
njb-69	303	28	and	and	CCONJ
njb-69	303	29	pandrug	pandrug	NOUN
njb-69	303	30	-	-	PUNCT
njb-69	303	31	resistant	resistant	ADJ
njb-69	303	32	bacteria	bacteria	NOUN
njb-69	303	33	:	:	PUNCT
njb-69	303	34	an	an	DET
njb-69	303	35	international	international	ADJ
njb-69	303	36	expert	expert	NOUN
njb-69	303	37	proposal	proposal	NOUN
njb-69	303	38	for	for	ADP
njb-69	303	39	interim	interim	ADJ
njb-69	303	40	standard	standard	ADJ
njb-69	303	41	definitions	definition	NOUN
njb-69	303	42	for	for	ADP
njb-69	303	43	acquired	acquire	VERB
njb-69	303	44	resistance	resistance	NOUN
njb-69	303	45	.	.	PUNCT
njb-69	304	1	clin	clin	PROPN
njb-69	304	2	microbiol	microbiol	PROPN
njb-69	304	3	infect	infect	PROPN
njb-69	304	4	.	.	PUNCT
njb-69	305	1	2012	2012	NUM
njb-69	306	1	18(3):268	18(3):268	NUM
njb-69	306	2	-	-	SYM
njb-69	306	3	281	281	NUM
njb-69	306	4	.	.	PROPN
njb-69	306	5	28	28	NUM
njb-69	306	6	.	.	PUNCT
njb-69	307	1	vaara	vaara	PROPN
njb-69	307	2	m	m	PROPN
njb-69	307	3	:	:	PUNCT
njb-69	307	4	polymyxins	polymyxin	NOUN
njb-69	307	5	and	and	CCONJ
njb-69	307	6	their	their	PRON
njb-69	307	7	potential	potential	NOUN
njb-69	307	8	next	next	ADJ
njb-69	307	9	generation	generation	NOUN
njb-69	307	10	as	as	ADP
njb-69	307	11	therapeutic	therapeutic	ADJ
njb-69	307	12	antibiotics	antibiotic	NOUN
njb-69	307	13	.	.	PUNCT
njb-69	308	1	front	front	ADJ
njb-69	308	2	microbiol	microbiol	PROPN
njb-69	308	3	.	.	PUNCT
njb-69	309	1	2019	2019	NUM
njb-69	309	2	10:1689	10:1689	NUM
njb-69	309	3	.	.	PROPN
njb-69	309	4	29	29	NUM
njb-69	309	5	.	.	PUNCT
njb-69	310	1	petrosillo	petrosillo	PROPN
njb-69	310	2	n	n	PROPN
njb-69	310	3	,	,	PUNCT
njb-69	310	4	taglietti	taglietti	PROPN
njb-69	310	5	f	f	PROPN
njb-69	310	6	,	,	PUNCT
njb-69	310	7	granata	granata	PROPN
njb-69	310	8	g	g	PROPN
njb-69	310	9	:	:	PUNCT
njb-69	310	10	treatment	treatment	NOUN
njb-69	310	11	options	option	NOUN
njb-69	310	12	for	for	ADP
njb-69	310	13	colistin	colistin	PROPN
njb-69	310	14	resistant	resistant	ADJ
njb-69	310	15	klebsiella	klebsiella	PROPN
njb-69	310	16	pneumoniae	pneumoniae	NOUN
njb-69	310	17	:	:	PUNCT
njb-69	310	18	present	present	NOUN
njb-69	310	19	and	and	CCONJ
njb-69	310	20	future	future	NOUN
njb-69	310	21	.	.	PUNCT
njb-69	311	1	j	j	PROPN
njb-69	311	2	clin	clin	PROPN
njb-69	311	3	med	me	VERB
njb-69	311	4	.	.	PUNCT
njb-69	311	5	2019	2019	NUM
njb-69	311	6	8:934	8:934	NUM
njb-69	311	7	.	.	PUNCT
njb-69	312	1	30	30	NUM
njb-69	312	2	.	.	PUNCT
njb-69	313	1	karaiskos	karaiskos	PROPN
njb-69	313	2	i	i	PROPN
njb-69	313	3	,	,	PUNCT
njb-69	313	4	lagou	lagou	PROPN
njb-69	313	5	s	s	PROPN
njb-69	313	6	,	,	PUNCT
njb-69	313	7	pontikis	pontikis	PROPN
njb-69	313	8	k	k	PROPN
njb-69	313	9	,	,	PUNCT
njb-69	313	10	rapti	rapti	PROPN
njb-69	313	11	v	v	PROPN
njb-69	313	12	,	,	PUNCT
njb-69	313	13	poulakou	poulakou	PROPN
njb-69	313	14	g	g	PROPN
njb-69	313	15	:	:	PUNCT
njb-69	313	16	the	the	DET
njb-69	313	17	“	"	PUNCT
njb-69	313	18	old	old	ADJ
njb-69	313	19	”	"	PUNCT
njb-69	313	20	and	and	CCONJ
njb-69	313	21	the	the	DET
njb-69	313	22	“	"	PUNCT
njb-69	313	23	new	new	ADJ
njb-69	313	24	”	"	PUNCT
njb-69	313	25	antibiotics	antibiotic	NOUN
njb-69	313	26	for	for	ADP
njb-69	313	27	mdr	mdr	PROPN
njb-69	313	28	gram	gram	NOUN
njb-69	313	29	-	-	PUNCT
njb-69	313	30	negative	negative	ADJ
njb-69	313	31	pathogens	pathogen	NOUN
njb-69	313	32	:	:	PUNCT
njb-69	313	33	for	for	ADP
njb-69	313	34	whom	whom	PRON
njb-69	313	35	,	,	PUNCT
njb-69	313	36	when	when	SCONJ
njb-69	313	37	,	,	PUNCT
njb-69	313	38	and	and	CCONJ
njb-69	313	39	how	how	SCONJ
njb-69	313	40	.	.	PUNCT
njb-69	314	1	front	front	ADJ
njb-69	314	2	public	public	ADJ
njb-69	314	3	health	health	NOUN
njb-69	314	4	.	.	PUNCT
njb-69	315	1	2019	2019	NUM
njb-69	315	2	,	,	PUNCT
njb-69	315	3	7:151	7:151	NUM
njb-69	315	4	.	.	PROPN
njb-69	315	5	31	31	NUM
njb-69	315	6	.	.	PUNCT
njb-69	316	1	world	world	PROPN
njb-69	316	2	health	health	NOUN
njb-69	316	3	organization	organization	NOUN
njb-69	316	4	(	(	PUNCT
njb-69	316	5	who	who	PRON
njb-69	316	6	):	):	PUNCT
njb-69	316	7	global	global	ADJ
njb-69	316	8	action	action	NOUN
njb-69	316	9	plan	plan	NOUN
njb-69	316	10	on	on	ADP
njb-69	316	11	antimicrobial	antimicrobial	ADJ
njb-69	316	12	resistance	resistance	NOUN
njb-69	316	13	.	.	PUNCT
njb-69	317	1	in	in	ADP
njb-69	317	2	.	.	PUNCT
njb-69	318	1	edited	edit	VERB
njb-69	318	2	by	by	ADP
njb-69	318	3	(	(	PUNCT
njb-69	318	4	who	who	PRON
njb-69	318	5	)	)	PUNCT
njb-69	318	6	who	who	PRON
njb-69	318	7	.	.	PUNCT
njb-69	319	1	geneva	geneva	PROPN
njb-69	319	2	:	:	PUNCT
njb-69	319	3	who	who	PRON
njb-69	319	4	;	;	PUNCT
njb-69	319	5	2015	2015	NUM
njb-69	319	6	.	.	PUNCT